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Abstract 
Aromatic building blocks are amongst the most important bulk feedstocks in the chemical 
industry. As these compounds are commonly derived from petrochemistry, obtaining them 
is becoming more and more a matter of costs and sustainability. Biochemistry gives rise to 
a wealth of compounds that can potentially replace current petroleum-based chemicals or 
be used for novel materials. The aromatic compounds para-aminobenzoic acid (pABA) 
and para-hydroxybenzoic acid (pHBA) and the aromatics derived compound cis,cis-
muconic acid (ccMA) can be precursors for, but are not limited to, terephthalic or/and 
adipic acid. These are essential feedstocks for the production of PET and nylon. The three 
compounds can be derived from the shikimate pathway, an anabolic pathway leading to 
the biosynthesis of aromatic amino acids, present in certain prokaryotes and eukaryotes, 
including fungi. By combination of metabolic modelling with genetic engineering, a 
microbial production system based on the yeast Saccharomyces cerevisiae can be 
designed, which effectively channels flux into the target compounds. 
In order to develop a competitive bio-based process, yields, titers and rates need to 
be maximized. While productivity or rates in a process can be altered using genetic 
engineering, carbon yield, and pathway feasibility are stoichiometrically and 
thermodynamically predetermined. Both limitations need to be considered when designing 
a microbial production system. 
For formation of adipic acid and precursors many bio-based routes exists. More rational 
than just picking one for in vivo studies rather all available biochemical pathways were 
examined in silico using metabolic modelling. To compare theoretical yields and reaction 
thermodynamics an interface that allowed network-embedded thermodynamic analysis of 
elementary flux modes was developed. This allowed distinguishing between 
thermodynamically feasible and infeasible flux distributions. Feasible maximum theoretical 
product carbon yields were substantially different in E. coli and S. cerevisiae metabolic 
models and ranged from 32% to 92%. Further, many pathways appeared to be restricted 
by a thermodynamic equilibrium lying on the substrate side, some even infeasible. 
The only routes that deliver significant product yields and were thermodynamically 
favoured were shikimate pathway based. Being currently of strong scientific interest, 
recent implementations of these pathways in E. coli and S. cerevisiae were evaluated and 
strain construction strategies optimized, using the concept of constrained minimal cut-sets. 
Especially in S. cerevisiae a single non-obvious knock-out target allowed coupling of 
growth to product formation; in particular, the deletion of the pyruvate kinase reaction 
resulted in a minimum yield constraint of 28%. 
  
Though unique to shikimate pathway, this strategy is transferrable to other products which 
are derived from chorismate and also involve the formation of pyruvate as a by-product. 
This applies to pHBA. With further optimizations, the strategy was applied in vivo for the 
production of this compound in S. cerevisiae. As the pyruvate kinase knock-out entails a 
growth defect on glucose, a synthetic circuit was used, which allowed conditional knock-
down and activation of the determined genetic modifications and by this dynamic control of 
the phenotype. Thus, production could be separated from growth and it could be proven 
that the in silico determined genetic intervention strategy holds valid in vivo, resulting in a 
1.1 mM final product titer. 
Further, production of pABA from shikimate pathway in S. cerevisiae was investigated and 
optimized: Several alleles from different yeast strains of the genes (ABZ1 and ABZ2) for 
pABA formation from chorismate were screened, using a strain genetically engineered to 
channel flux to chorismate. ABZ1 of AWRI1631 and ABZ2 of QA23 delivered the highest 
pABA production. To further increase production, the impact of carbon-source on product 
yield was investigated in silico using metabolic modelling. It was found that combined 
glycerol-ethanol was a superior carbon-source than glucose, glycerol or ethanol alone, 
especially when employed in molar ratios between 1:2 and 2:1. This could be confirmed in 
vivo with carbon yields reaching up to 2.64%. A fed-batch process on glycerol-ethanol 
delivered total aromatics titers as high as 1.73 mM. 
It could be shown that feasibility and viability of adipic acid production greatly 
depends on the pathway and the organism chosen for engineering. Weaknesses of 
existing strain construction strategies for ccMA production could be identified and a radical 
optimization strategy was determined. 
Inferences from metabolic modelling were proven experimentally for pHBA and pABA 
production. The obtained concentrations and yields are the highest in S. cerevisiae to date 
and among the highest in a microbial production system, underlining the potential of yeast 
as a cell factory for renewable aromatic feedstocks. 
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NET-EMA = network embedded thermodynamic elementary mode analysis, OAA = 
oxaloacetate, OD660 = optical density at 660 nm, ORF = open reading frame, P = 
phosphate, PP = pyrophosphate, pABA = para-aminobenzoic acid, PCA = 
protocatechuate, PCK = phosphoenolpyruvate carboxykinase, PEA = phenethyl alcohol, 
PEP = phosphoenol pyruvate, PET = polyethylene terephthalate, pHBA = para-
hydroxybenzoate, PHE = phenylalanine, pHext. = extracellular pH, pHint. = intracellular pH, 
PPP = pentose phosphate pathway, PPS = phosphoenolpyruvate synthase, PPY = phenyl 
pyruvate, PTS = phosphotransferase system, PYK = pyruvate kinase, PYR = pyruvate, QS 
= quorum sensing, RNAi = RNA interference, S3P = shikimate-3-phosphate, SA = 
salicylate, SFL = summed fractional labelling, SNP = single-nucleotide polymorphism, 
SUCC = succinate, SUCC-CoA = succinyl coenzyme A, TCA-cycle = tricarboxylic acid 
cycle, TRP = tryptophan, TYR = tyrosine, WT = wild-type, Ymax = maximum theoretical 
carbon yield, Ymin = minimum theoretical carbon yield, ∆fG = Gibbs free energy of 
formation; ∆rG = Gibbs free energy of reaction; ∆rG’° = transformed standard Gibbs free 
energy of reaction 
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Main text of Thesis 
1. Introduction 
There is a worldwide push in the chemical industry to move from fossil fuel dependency to 
renewable feedstocks. This not only serves the goal to move towards a more sustainable 
society but also helps to maintain current standards of living. For this the availability and 
commercial viability of synthetic materials is essential. Biotechnology is anticipated to be a 
key to solving these problems. In the polymer industry aromatic and aromatic-derived 
compounds are among the most important building blocks. The challenge is the efficient 
and fast production of the products of interest in biological systems. Many microorganisms 
are well studied and understood, their biochemical pathways are extremely versatile, 
giving rise to a wealth of diverse organic compounds. Further, they have a rapid 
metabolism, allowing them to grow to high density rapidly. This makes them very suitable 
for biotechnology and attractive for production on industrial scale. Here the focus is on the 
development of a microbial production system for shikimate pathway derivatives as 
chemical feedstocks, using a systems and synthetic biology approach. 
1.1 General Introduction 
1.1.1 Industrial significance of bio-derived building blocks 
There is currently a strong interest in the metabolic engineering community to develop 
biological replacements for fossil-fuel based feedstocks for chemical industry. It has been 
predicted that bio-feedstocks could increase to 17% of the global chemical business by 
2025, equivalent to 425 billion $US. Recent developments spawn bio-replacement 
chemicals of the classes of diamines, dialcohols and dicarboxylates for nylon and 
polyesters products. Unfortunately to date, the majority of these bio-replacement 
compounds are hardly cost competitive. For many more important compounds, there is 
also not even a bio-process available. This highlights the major hurdle for biotechnological 
production: outperforming existing chemical synthesis. The cost advantage in comparison 
to petrochemical-based adipic acid has been predicted to possibly reach 20 – 30% 
(depending on the feedstock used) (Guzman, 2010), which indicates investment into the 
cleaner bio-production, though this cost advantage will strongly depend on the pathway, 
substrates, and current oil price. 
This project targets aromatic and di-carboxylic organic acids, which can be derived from 
the shikimate metabolic pathway present in certain micro-organisms for example yeasts, 
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or bacteria. In particular target compounds are (i) adipic acid, which can be derived from 
muconic acid (ccMA) via aromatic intermediates of the shikimate pathway and (ii) aromatic 
precursors like para-hydroxybenzoic acid (pHBA) and para-aminobenzoic acid (pABA). 
1.1.1.1 The polymer precursor adipic acid and potential precursors 
Adipic acid (hexanedioic acid, Figure 1) is a main precursor for the production of nylon-6,6 
and polyurethanes (Musser, 2000). The 2010 global production capacity of adipic acid has 
been estimated to be about 2.6 million t with an annual growth rate of about 3% (Centi et 
al., 2009). About 65% of the adipic acid is used for the production of nylon-6,6, 24% for 
polyurethanes (IHS Chemical, 2012, IHS Chemical, 2012) and the remainder for a broad 
range of other applications, including resins, reactants for plasticizers, food acid, and 
lubricants (MCGroup, 2011). Adipic acid is mainly produced through benzene reduction to 
cyclohexane followed by a two-step oxidation via cyclohexanol/cyclohexanone and 
reaction with nitric acid (EPA, 1994, Musser, 2005). This method achieves very high 
yields, however, the precursors are all petrochemistry based and thus non-sustainable. 
Also, considerable amounts of NOx are generated, which have an additional environmental 
impact; especially the greenhouse gas N2O is a large by-product in this process. Adipic 
acid production accounts for up to 10% of the total global anthropogenic N2O emissions 
per year and significantly contributes to global warming and depletion of the ozone layer 
(Sato et al., 1998, Mainhardt & Kruger, 2000, Alini et al., 2007). 
Biotechnological production of adipic acid offers a promising alternative to chemical 
synthesis. Recently emerging papers and reviews emphasize the strong scientific and 
commercial interest to develop a biological replacement for fossil fuel based adipic acid 
(Chen & Nielsen, 2013, Polen et al., 2013, Van Duuren & Wittmann, 2014, Xie et al., 2014, 
Bart & Cavallaro, 2015, Bart & Cavallaro, 2015, Deng et al., 2016). Basically, there are 
three approaches that can be distinguished: (i) direct production of adipic acid, (ii) 
production of the unsaturated adipic acid precursor cis,cis-muconic acid (Figure 1) and (iii) 
production of D-glucaric acid. Muconic and glucaric acid be converted to adipic acid via 
chemo-catalytic hydrogenation, which can only be conducted under high pressure of H2 in 
a Platinum catalysed reaction (Polen et al., 2013, Deng et al., 2016). Nevertheless for the 
conversion of cis,cis-muconic acid (ccMA) to adipic acid an efficient conversion yield of 
97% [moladipate/molccMA] has been reported (Niu et al., 2002). The approach to derive the 
precursor ccMA from shikimate pathway is currently of particular scientific attraction as 
ccMA can also be used for the production of terephthalic acid (Burk et al., 2011) and 
options to obtain it are abundant (Xie et al., 2014). 
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Figure 1: cis,cis-muconic acid and adipic acid 
 
1.1.1.2 The potential polymer precursors pHBA and pABA 
“Polyesters” like PET (polyethylene terephthalate) contribute 18% to the world polymer 
production. PET is composed of ethylene glycol and terephthalic acid (J. Sheehan, 2000). 
Terephthalic acid production accounts for < 50 Mio t/a equivalent to 80 billion $US value. 
Potential bio-replacements for terephthalic acid are para-hydroxybenzoic acid (pHBA) and 
para-aminobenzoic acid (pABA). pHBA and pABA are natural metabolites in S. cerevisiae 
and can both be derived from shikimate pathway. 
pHBA (Figure 2) is used in liquid crystal polymers and has an estimated market value of 
approximately $150 million per annum (Krömer et al., 2013). It is the base material for 
parabens, preservatives in the cosmetic and pharmaceutical industry (Kluczyk et al., 
2002). pABA (Figure 2) is a compound with versatile applicability, it is already being used 
use as a crosslinking agent for resins and dyes, as a precursor in the pharmaceutical 
industry and as a therapeutic itself (e.g. for the drug POTABA®). It is also a good UV filter 
as it absorbs UVB radiation (Krömer et al., 2013). Further pHBA and pABA could be 
chemically converted to terephthalic acid (e.g. via Sandmeyer reaction) making it a 
potential feedstock for polyethylene terephthalate (PET) production. PET is used for 
packaging as well as clothing and recently also in the auto industry (Research, 2014). The 
global market volume for PET packaging was nearing 16 Mt valued at 48.1 billion USD in 
2014 (Pira, 2014). This is expected to rise to 19.9 Mt and 60 billion USD in 2019 (Pira, 
2014). The global market volume for bio-based PET exceeded 540 kt in 2012 and is 
expected to rise sharply till 2020, with a doubling in 2015 and a tripling in 2016 in respect 
to 2014. While current bio-based PET is claimed to be up to 30% sustainable (Heinz, 
2011) in fact only the monoethylene glycol share of the copolymer is derived from 
renewable feedstocks, while the terephthalic acid component, the major part of PET by 
volume and cost, is still petroleum based. Therefore industrial interest in developing a fully 
sustainable PET product is high and substantial investments are being made in order to 
establish bio-based terephthalic acid production (Burk et al., 2011, Osterhout et al., 2013, 
Research, 2014). 
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pABA may also be chemically converted to para-phenylenediamine (e.g. via Kochi- or 
Hunsdiecker reaction followed by nucleophilic substitution), which is (besides terephthalic 
acid) the second building block of the aramid fibre Kevlar®. Global demand for these 
materials, which combine high strength with low weight as well as chemical and heat 
resistance properties, was estimated to 74.5 kt in 2014 and is expected to rise to 110 kt in 
2020 with an estimated value of 4.7 billion USD (Markets, 2014). 
 
 
 
Figure 2: para-hydroxybenzoic acid (pHBA) and para-aminobenzoic acid (pABA) 
 
1.1.2 Yeast in Biotechnology 
Yeast, the oldest organism used in biotechnology, is currently regaining industrial 
relevance (Branduardi & Porro, 2012, Mattanovich et al., 2014), as shown by new biotech-
processes being developed based on yeast, e.g. artemisinin / farnesene by Amyris, vanillin 
by Evolva and dodecanedioic & adipic acid by Verdezyne (Hansen et al., 2009, de Jong et 
al., 2012, Paddon et al., 2013, Polen et al., 2013, Paddon & Keasling, 2014), and even old 
ones being moved to yeast e.g. lactic acid by Cargill (Datta & Henry, 2006). This is due to 
the manyfold cost and operational advantages for commercial processes that the use of 
these very robust microbes offer: Above all yeasts are tolerant to low pH and temperature 
and unsusceptible to phage contamination (Fletcher et al., 2015). This also applies to the 
baker’s yeast S. cerevisiae, which is popular in both, food industries and at laboratory 
scale, as it is well-studied and non-hazardous (Agency, 2012). Recent advances in 
metabolic engineering of S. cerevisiae have shown that systems and synthetic biology 
tools are advanced and readily available nowadays, allowing rational construction of 
capable production strains (Li & Borodina, 2014, Fletcher et al., 2015). Through 
combination of metabolic modelling and genetic engineering S. cerevisiae can be analysed 
and tailored in silico as well as in vivo (Kim et al., 2012, Borodina & Nielsen, 2014). This 
allows even very complex natural product biosynthetic pathways to be reconstructed in this 
organism (Galanie et al., 2015, Kayser & Averesch, 2015).  
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1.1.2.1 Yeast shikimate pathway and derived compounds 
The shikimate pathway is the central metabolic route leading to the formation of tryptophan 
(TRP), tyrosine (TYR) and phenylalanine (PHE). It starts with the condensation of 
intermediates of glycolysis and pentose phosphate pathway (PPP), phosphoenol pyruvate 
(PEP) and erythrose 4-phosphate (E4P), respectively, which enter the pathway through a 
series of condensation and redox reactions via 3-deoxy-D-arabino-heptulosonate-7-
phosphate (DAHP), 3-dehydroquinate (DHQ), 3-dehydroshikimate (DHS) to shikimate. 
Shikimate is subsequently converted to the central branch point metabolite chorismate 
under ATP hydrolysis and introduction of a second PEP. From there the pathway branches 
off to anthranilate and prephenate leading to aromatic amino acid (AAA) and pABA 
synthesis, the latter being a precursor for folate metabolism (Botet et al., 2007). The 
pathway exclusively exists in plants and microorganisms. An overview of the pathway and 
it’s regulation in the baker’s yeast Saccharomyces cerevisiae is given in Figure 3. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3: Biosynthesis of aromatic amino acids in S. cerevisiae including regulatory elements 
- - - feedback inhibition, ··· repression, 
___
 activation, -·-·-· induction (reproduced from (Lingens et al., 
1967)). 
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The shikimate pathway also leads to folate and ubiquinone (coenzyme Q) synthesis via 
the precursor pABA (Marbois et al., 2010). Outgoing from chorismate, pABA is 
synthesised in two subsequent reactions catalysed by aminodeoxychorismate synthase 
and aminodeoxychorismate lyase, the respective yeast genes are ABZ1 and ABZ2. The 
former has similarity to Escherichia coli pABA synthase components PabAp and PabBp, 
indicating that it is a bi-functional enzyme (Edman et al., 1993). The 
aminodeoxychorismate synthase transfers an amino-group from glutamine to the para-
position of chorismate, thus forming glutamate and 4-amino-4-deoxychorismate. The 
aminodeoxychorismate lyase then cleaves the ester-bond between the ring and the C3-
body releasing pyruvate and pABA. Generally pABA is a compound with a relatively low 
concentration in the cell, nevertheless, it is essential to the organism. This is for example 
exploited when screening sulfa-drugs, as these compete with pABA in folate biosynthesis 
(Castelli et al., 2001). In other organisms, like for example E. coli, the first step in 
ubiquinone biosynthesis is the formation of pHBA in a single step bioconversion directly 
from the central shikimate pathway intermediate chorismate. The reaction is catalysed by 
chorismate pyruvate-lyase which is encoded by the gene ubiC (Nichols & Green, 1992). It 
is remarkable that pHBA can also be detected in yeast though no chorismate lyase 
analogue has been described to date (Marbois et al., 2010, Pierrel et al., 2010), indicating 
that either the responsible enzyme has yet to be discovered, or the compound is obtained 
from a different precursor. It has been proposed that this precursor is rather 4-
hydroxyphenylpyruvate then catechol, giving rise to a second pathway to ubiquinone 
synthesis in yeast (Marbois et al., 2010). 
1.1.2.2 Regulation of the yeast shikimate pathway 
Regulation of the shikimate pathway in S. cerevisiae is manifold (Lingens et al., 1967) and 
yet to be fully understood. In general GCN4, the transcriptional activator of amino acid 
biosynthetic genes, controls AAA biosynthesis, tightly regulating expression at 
transcriptional level in response to amino acid starvation (Braus, 1991). 
The initial step of the shikimate pathway is catalysed by two DAHP synthase isozymes 
(Meuris, 1973, Kunzler et al., 1992), encoded by ARO4 and ARO3 and regulated through 
feedback inhibition by TYR and PHE, respectively. Moreover, the ARO4 coded enzyme is 
feedback-inhibited not only by TYR but also high concentrations of PHE and TRP (Kunzler 
et al., 1992). The five subsequent bioconversions are catalysed by a penta-functional 
protein, a conglomerate of mono-functional domains, which is expressed from the gene 
ARO1 (Duncan et al., 1987). 
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The gene ARO7 expresses chorismate mutase which catalyses the conversion of 
chorismate to prephenate where the biosynthesis route to TYR and PHE branches off, it is 
also regulated by GCN4 (Schmidheini et al., 1990). However, this step appears to proceed 
also spontaneously, as a study on the deletion of ARO7 shows (Winter et al., 2014). The 
next step to tyrosine is catalysed by prephenate dehydrogenase, encoded by TYR1. The 
expression is dependent on PHE levels, regulating the equilibrium between the two 
products of this pathway, TYR and PHE (Mannhaupt et al., 1989). 
The initial step to tryptophan biosynthesis is catalysed by anthranilate synthase, encoded 
by TRP2 which forms a multifunctional hetero-oligomeric complex with indole-3-glycerol 
phosphate synthase encoded by TRP3. As well TRP3 (Prantl et al., 1985) as also TRP2 
(Krömer et al., 2013) may have second functions, as deletion leads to a heavy growth rate 
reduction regardless of the supplementation of TRP. 
1.1.3 Previous approaches on production of aromatics and derived compounds 
The aromatic nature of the shikimate pathway intermediates gives rise to the idea to derive 
bio-replacements for fossil-fuel-derived aromatics. By metabolic engineering abundance of 
certain suitable compounds may be increased, while draining flux from other branches off 
the pathway. This was used previously to produce ccMA as well as pHBA and folate 
(metabolic successor of pABA). 
1.1.3.2 Bio-based production of adipic acid and potential precursors 
After early work on muconic acid production in the mid 1990s (Frost & Draths, 1996, Frost 
& Draths, 1997) the target adipic acid has recently moved back into the spotlight with 
several companies (Genomatica, Verdezyne) filing patents (Boussie et al., 2010, Burgard 
et al., 2010, Burgard et al., 2012, Picataggio & Beardslee, 2012, Raemakers-Franken et 
al., 2012) and the metabolic engineering research community re-focussing on this 
compound (Niu et al., 2002, IHS Chemical, 2012, Weber et al., 2012, Curran et al., 2013, 
Sun et al., 2013, Lin et al., 2014, Sun et al., 2014, Yu et al., 2014, Babu et al., 2015, 
Clomburg et al., 2015, Deng & Mao, 2015, Horwitz et al., 2015, Reizman et al., 2015, 
Sengupta et al., 2015, Vardon et al., 2015). Considering the extensive work that has been 
done it is not surprising that there is a wide variety of proclaimed metabolic routes to 
produce adipic acid or the precursors muconic or glucaric acid (Figure 4). Each major 
pathway has several different sub-routes that utilize alternative biochemical conversions, 
which can significantly influence titre, yield and productivity. 
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Figure 4: Overview of metabolic routes to adipic acid and its precursors muconic and glucaric acid. 
Biochemical reduction of muconic and glucaric acid to adipic acid is indicated as hypothetical. 
 
Production of muconic acid was initially reported in Pseudomonas putida deriving it from 
benzoate. Titers of 7.4 g/L with a maximum yield of 91% (Schmidt & Knackmuss, 1984), 
13.5 g/L with productivities ranging from 0.8 to 5.5 g/(L×h) (Choi et al., 1997), and 32 g/L 
(Bang & Choi, 1995) were achieved. Though effective in terms of maximum titer, yield, and 
productivity, benzoate can however hardly be considered a sustainable feedstock. 
De novo production of muconic acid from glucose via the shikimate pathway (Figure 5) has 
been pioneered in E. coli (Draths & Frost, 1994). The optimized process showed high 
maximum titers (36.8 g/L) after 48 h and yields of 22% (mol/mol) (Niu et al., 2002). The 
pathway was established in two steps outgoing from dehydroshikimate (DHS), via 
protocatechuate and catechol (Figure 5 a) by means of the aroZ gene from Klebsiella 
pneumoniae encoding dehydroshikimate dehydratase, the aroY gene from K. pneumoniae 
encoding protocatechuate (PCA) decarboxylase and the catA gene from Acinetobacter 
calcoaceticus encoding catechol 1,2-dioxygenase. The levels of the entry metabolites to 
shikimate pathway PEP and E4P were increased and a feedback inhibition resistant DAHP 
synthase was overexpressed. Further, blocking the pathway below DHS through deletion 
of the DHS dehydrogenase gene aroE, directed carbon flux to ccMA. 
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The E. coli result astonishingly remains unrivaled: Though no less elaborate, recent 
approches employing the same pathway (Figure 5a) in the S. cerevisiae were so far 
unable to achieve comparable titers (1.56 mg/L (Weber et al., 2012), 141 mg/L (Curran et 
al., 2013)). In (Weber et al., 2012) partial deletion of ARO1 (the aroE analogous domain) 
blocked the conversion of 3-dehydroshikimate into shikimate. A DHS dehydratase from 
Bacillus thuringiensis (aroZ), a PCA decarboxylase composed of three different subunits 
encoded by the genes B, C and D taken from K. pneumoniae (aroY) and a catechol 1,2-
dioxygenases from Acinetobacter radioresistens (catA) composed the pathway. The 
bottleneck here is the first step: Only very low PCA levels < 7 mg/L could be detected and 
therefore limited the overall titre (Weber et al., 2012). In (Curran et al., 2013) the DHS 
dehydratase was taken from Podospora anserina and the PCA decarboxylase from 
Enterobacter cloacae. A catechol 1,2-dioxygenase from Candida albicans completed the 
pathway. Knock-out of ARO3 and over-expression of a feedback-resistant ARO4 
increased overall flux to aromatics. Further optimizations on that were the deletion of 
ZWF1 and over-expression of TKL1. The former intended to increase flux to the shikimate 
pathway in order to increase conversion of G6P to E4P, by blocking the channelling of 
G6P into the oxidative branch of the pentose phosphate pathway. The latter favoured the 
conversion of pentoses into E4P by increased transketolase levels. 
Also, production of muconic acid from glucose and glycerol in E. coli via a different branch 
off the shikimate pathway (Figure 5b) could only achieve 390 mg/L muconic acid (Sun et 
al., 2013). Here another route for the production of cis,cis-muconic acid from shikimate 
pathway was established downstream of chorismate, branching off from anthranilate on 
the way to TRP synthesis. This was done by cloning an anthranilate 1,2-dioxygenase from 
Pseudomonas aeruginosa (encoded by the genes antA antB antC, cloned as an operon) 
and catechol 1,2-dioxygenase from Pseudomonas putida (catA1) in E. coli. TRP 
biosynthesis was blocked and over-expression of glutamine synthase resulted in a 
strengthened glutamine regeneration system favouring anthranilate formation. Two more 
variations of this pathway (Figure 5c) for the production of ccMA have been developed by 
this group, both involve the isomerization of chorismate to isochorismate. One proceeds 
via 2,3-dihydroxybenzoate (Sun et al., 2014), the other one via salicylate (Lin et al., 2014). 
The routes delivered respective titers of 480 and 1500 mg/L. In the first case (Figure 5cI) 
this was achieved using a strain with a deletion in entE, engineering to channel flux to 
chorismate as described in another study (Lin et al., 2013), to overexpress the E. coli 
genes entCBA (coding for isochorismate synthase, isochorismatase and 2,3-dihydro-2,3-
DHBA dehydrogenase) along with a Klebsiella pneumoniae 2,3-DHBA decarboxylase and 
 - 10 - 
the same catechol 1,2-dioxygenase as in the previous study (Sun et al., 2013). In the 
second case (Figure 5cII) an “off the shelf” phenylalanine overproducing E. coli strain 
NST 74 (ATCC31884) with deletions in pheA and tyrA was amended with the same 
modifications to increase precursor abundance as described previously (Lin et al., 2013). 
In addition, the genes for isochorismate synthase from E. coli (entC), isochorismate 
pyruvate lyase from Pseudomonas fluorescens (PchB), an optimized salicylate 1-
monoxygenase from Pseudomonas putida (nahGopt) and the catechol 1,2-dioxygenase as 
described before (Sun et al., 2013) were overexpressed. 
Another route to ccMA leads from chorismate via pHBA to PCA, from here the steps 
coincide with the DHS-pathway (Figure 5d). It has been shown in E. coli that PCA and 
catechol can be produced this way, with the highest yield being that of catechol at a titre of 
451 mg/L (Pugh et al., 2014) (equivalent to 3.69% total carbon product yield). Engineering 
was also based on the phenylalanine over-producing strain NST 74. Overexpression of 
chorismate lyase, encoded by ubiC, initiated the pathway, a pHBA hydroxylase (pobA) 
from Pseudomonas aeruginosa and a protocatechuate decarboxylase from Enterobacter 
cloacae completed it. To further increase flux to the target compounds the chorismate 
mutase/prephenate dehydratase (pheA) was disrupted. Recently the complete pathway 
outgoing from glucose until ccMA was established (Sengupta et al., 2015). The engineered 
E. coli strain was capable of producing almost 170 mg/L ccMA. The strain had deletions in 
the genes ptsH, ptsI, crr, and pykF to boost shikimate pathway, further, the E. coli genes 
(aroFFBR, aroE, aroL and ubiC) for DAHP synthase, shikimate 5-dehydrogenase, shikimate 
kinase II and chorismate lyase were overexpressed along with a Pseudomonas putida 
pobA, Klebsiella pneumoniae aroY, and Acinetobacter sp. ADP1 catA coding for 4-
hydroxybenzoate hydrolyase, protocatechuate decarboxylase, and catechol 1,2-
dioxygenase. 
A different approach to sustainable ccMA production proceeds outgoing from lignin-
derived species (Deng et al., 2016). Here a ccMA titer of 13.5 g/L was obtained with a 
yield of 74%. This was done by engineering the metabolism of a Pseudomonas putida 
KT2440 strain. In a pathway that uses downstream AAA-metabolism intermediates like 
coumarate as substrates a route to ccMA was constructed that partially coincides in the 
last steps with the route via pHBA (Figure 5d). 
Another alternative is the production of glucaric acid from sugar. In E. coli 2.5 g/L glucaric 
acid (Moon et al., 2010) could be produced. This was recently further improved by 42% 
(Reizman et al., 2015). 
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Figure 5: Shikimate pathway with routes to muconic acid: Shikimate pathway outgoing from the 
precursors E4P and PEP with routes to ccMA including co-factors in each step. Adjacent pathways 
not involved in ccMA synthesis are greyed out. Triple arrows indicate multiple steps. The DHS-
pathway (a) proceeds via protocatechuate outgoing from 3-dehydroshikimate, while the ANTH-
pathway (b) branches off further downstream from chorismate via anthranilate. The DHBA-pathway 
(cI) and the SA-pathway (cII) both proceed via isochorismate. A route linking the chorismate derived 
routes with the DHS-pathway is the pHBA-pathway (d). Although all routes lead to the formation of 
catechol prior to ring opening release of ccMA, the involved co-factors, and metabolites to catechol 
formation are essentially different. 
 
The direct bio-production of adipic acid was reported for the first time in the pathogenic 
yeast Candida tropicalis using fatty acids and/or sugars as substrates: A 400 L fermenter 
in a pilot plant produced up to 15 kg adipic acid per week. This corresponds to 37.5 g/L per 
week or a productivity of approximately 0.223 g/(L×h) (chemicals-technology.com, 2012). 
In total, an annual production of 800 kg has been reported (Becker et al., 2015). 
Production of adipic acid by reversed fatty acid oxidation and analogous bioconversions 
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has since also been reported in E. coli from glycerol and glucose. Titers were 12 µg/L 
(Babu et al., 2015) and 0.5 g/L (combined C6, C8, and C10 dicarboxylic acids) (Clomburg et 
al., 2015). 
TCA-cycle based pathways are mostly covered in patents (Boussie et al., 2010, Burgard et 
al., 2010, Burgard et al., 2012, Raemakers-Franken et al., 2012) and are E. coli based. 
One pathway establishing adipic acid production via the reverse adipate degradation 
achieved 639 ± 34 μg/L (Yu et al., 2014). Recently the same pathway was reported in 
Thermobifida fusca to reach 2.23 g/L (0.045 g/g glucose yield) (Deng & Mao, 2015). 
1.1.3.1 Bio-based production of pHBA and pABA 
Initial bio-based production of pHBA was established in plants like N. tabacum (Siebert et 
al., 1996, Köhle et al., 2003). More recently two different possibilities to derive pHBA from 
sugarcane have been explored (McQualter et al., 2005). Microbial production of pHBA 
from glucose was first reported using Klebsiella pneumonia to derive it from chorismate 
reaching 120 mg/L (Müller et al., 1995). This was done by introducing the E. coli ubiC 
gene, encoding for chorismate lyase, on a plasmid into a strain deficient in the ability to 
produce AAAs. More recently bacterial production of pHBA has been improved in 
Pseudomonas putida (Verhoef et al., 2010, Meijnen et al., 2011) reaching yields of 
16.3 C-mol%, although these processes are not at commercially viable levels yet. 
Fermentative production of pHBA in E. coli has been patented (Johnson et al., 1998) and 
reported (Barker & Frost, 2001) deriving the compound via shikimate pathway from 
glucose, where a final concentration of 12 g/L and a total carbon yield of 13% [mol/mol] 
was achieved. This was done by overexpression of a DAHP synthase (aroFfbr) feedback 
inhibition insensitive to AAAs and elevation of expression levels of enzymes in the 
pathway. The conversion of chorismate to pHBA was accomplished by the overexpression 
of the ubiC encoded chorismate lyase. It was found that the DAHP synthase was feedback 
inhibited by pHBA while DAHP synthase over-expression reduced chorismate lyase 
expression levels (Barker & Frost, 2001). An active transport of the aromatic out of the cell 
(Van Dyk et al., 2004) may contribute to achieving these comparatively high titers of 
extracellular pHBA. 
Production of pHBA in the S. cerevisiae strain S288c achieved a titer of 0.65 mM (Krömer 
et al., 2013). This was done by overexpressing the E. coli ubiC gene in a double knock-out 
strain (ΔARO7 & ΔTRP3). Overexpressing an ABZ1 gene, coding for 
aminodeoxychorismate synthase, from the wine yeast strain AWRI1631, instead of the 
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ubiC gene, resulted in the production of pABA with a final titer of 0.25 mM (Krömer et al., 
2013). 
Recently also the production of pABA in E. coli has been reported, reaching maximum 
titers of 4.8 g/L at a yield of 21% (Koma et al., 2014). This was accomplished by employing 
the E. coli aroFfbr (DAHP synthase) and pabC (aminodeoxychorismate lyase) genes in 
combination with a Corynebacterium efficiens pabAB (aminodeoxychorismate synthase). 
Production of folates has been accomplished in many different bacteria, with lactic acid 
bacteria leading the way (Sybesma et al., 2003). Also, wild-type yeast has been reported 
to produce considerable amounts of folate (10.8 mg/100 g dry matter) under the right 
circumstances (Patring et al., 2006). 
Utilizing the same biochemical conversion steps as for production of pHBA recently a non-
natural pathway for production of terephthalic acid has been patented: Only outgoing from 
a different precursor (OH group at C2 in E4P replaced with CH3) it rather leads to the di-
acid than the hydroxyl-acid (Osterhout et al., 2013). 
1.2 Research Objectives 
1.2.1 Development of a chassis cell for production of target compounds 
The first objective is the development of a mutant strain of S. cerevisiae, which is 
characterized by enhanced flux to shikimate pathway and impaired AAA synthesis. This 
helps to channel flux into the desired compounds. It also allows studying the function of 
the target genes in a new context, leading to new insights and deepened understanding of 
shikimate pathway. In particular, ARO7 and TRP3 are disrupted and a feedback resistant 
version of ARO4 (Fukuda et al., 1992) is introduced (Figure 6). 
1.2.2 In silico analysis of biological production systems 
Parallel to strain engineering metabolic network modelling is used to describe the cell, 
which is incorporated as the second objective. This helps to understand the impact of 
genetic modifications on cellular metabolism, additionally, it also aids in tailoring the next 
generation production strains: On the one hand identification of thermodynamic limitations 
of alternative product-pathways enables identification of the most promising route. On the 
other hand determination of non-obvious knock-out targets in central metabolism and 
gained insight into carbon utilization is used to further increase product yield. Both will help 
to prioritize research efforts. 
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1.2.3 Establishing production of target compounds 
The third objective is to establish production of the target aromatic compounds. Against 
the backdrop of the previously achieved base level accumulation (Krömer et al., 2013) new 
approaches, identified in the previous step (objective 1 & 2), are used to elevate titre, yield, 
and productivity. For the production of pHBA (blue in Figure 6) the identified knock-out 
targets are applied utilizing a synthetic circuit that allows their dynamic implementation. 
For the production of pABA (red in Figure 6) different ABZ1 and ABZ2 genes from wine 
yeast strains are introduced and compared in order to identify the best enzymes. This is 
based on the knowledge of a dysfunctionality of ABZ1 genes of laboratory yeasts 
(Ambroset et al., 2011). Correlating performance of the different enzymes with the 
sequences of the different genes may also allow drawing of conclusions towards mutations 
that affect the activity. Further the in silico determined impact of the carbon-source is 
investigated in order to increase product yield. 
 
Figure 6: Overview of the simplified shikimate pathway and primary mandatory genetic alterations to 
obtain pHBA (blue) and pABA (red) from genetically engineered shikimate pathway in S. cerevisiae. 
Dashed line: Feedback inhibition of initial step by final metabolites, to be abolished. Highlighted in 
red are designated knock-out targets, green additional genes to be (over)expressed. The central 
intermediates are: 3-deoxy-D-arabino-heptulosonate-7-phosphate (DAHP), 3-dehydroquinate (DHQ), 
3-dehydroshikimate (DHS), shikimate, shikimate-3-phosphate (S3P), chorismate, phenylalanine 
(PHE), tyrosine (TYR), tryptophan (TRP) and para-aminobenzoate (pABA). Important genes and the 
respective enzymes involved are: ARO3/ARO4: 3-deoxy-D-arabino-heptulosonate-7-phosphate 
(DAHP) synthase, ARO7: chorismate mutase, TRP2: anthranilate synthase, TRP3: indole-3-glycerol-
phosphate synthase, ABZ1: aminodeoxychorismate synthase, ABZ2: aminodeoxychorismate lyase. 
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2 Research Outcomes 
2.1 In silico analysis of microbial adipic acid production reveals 
stoichiometric and thermodynamic constraints1 
The first instalment to develop a microbial production system for polymer feedstocks 
was a holistic analysis of the feasibility of proposed potential metabolic routes. This 
allows prioritizing research efforts based on fundamental thermodynamic and 
stoichiometric limitations. 
2.1.1 Abstract 
In the course of the rapidly advancing bio-production of industrial relevant chemicals, 
adipic acid, a nylon-6,6 precursor, has emerged as a very popular target. In the 
present study, 16 different production routes to adipic acid were compared using a 
novel tool for network-embedded thermodynamic analysis of elementary flux modes. 
The tool distinguishes between thermodynamically feasible and infeasible modes, 
which impacted theoretical yields and revealed limitations of metabolite 
concentrations. In particular, maximum product carbon yields ranged from 32% to 
99% on glucose and/or palmitate in E. coli and S. cerevisiae metabolic models, 
heavily depending on the metabolic route. More importantly, metabolite 
concentrations appeared to be thermodynamically restricted in several pathways. In 
consequence, the number of feasible flux distributions was reduced, in some cases 
even deeming the whole pathways infeasible. This highlights the importance of 
pathway choice. Routes that were thermodynamically favourable over a large 
concentration and pH range were shikimate pathway based. The low pH capability of 
S. cerevisiae was found to benefit the thermodynamic equilibrium towards product 
formation, in particular in case of glucaric acid production. This emphasizes the 
significance of the host organism. Furthermore, reversibility of the mitochondrial 
malate dehydrogenase appeared to be controversial and a major restriction in S. 
cerevisiae metabolism. 
 
                                            
1
 This chapter is based on a manuscript previously submitted to Metabolic Engineering, paper under 
revision in 2016 
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2.1.2 Introduction 
The wealth of pathways to adipic acid (Figure 4) creates the challenge of finding the 
most promising route, a problem that has so far been ignored. No comparison of the 
overall potential in terms of maximum theoretical product yields and thermodynamic 
feasibility has been described in the literature. 
In general, optimization of a fermentation process requires yields, rates and titres to 
be maximized (Vickers et al., 2012). One possibility to assess the yields of a 
metabolic network is elementary flux mode (EFM) analysis (EMA) (Schuster & 
Hilgetag, 1994). EMA provides all feasible steady state flux distributions of a 
metabolic network in a single analysis and enables the assessment of maximum 
product yields as well as the determination of the ideal flux distribution in a network 
during optimal production. The approach was previously applied to the development 
of a range of fermentation products, such as glutamate, methionine, succinate, 
isobutanol and other compounds (Diniz et al., 2006, Krömer et al., 2006, Chen et al., 
2009, Chen et al., 2010, Li et al., 2012, Gruchattka & Kayser, 2015). 
Productivity or rates in a process are controlled by capacity- and kinetics-based 
regulation. While capacity can nowadays be routinely altered using gene knock-out / 
knock-in and over-expressions, a reaction only occurs in the thermodynamically 
feasible direction, i.e. where the Gibbs energy (∆rG) is negative (Mavrovouniotis, 
1993, Kümmel et al., 2006, Henry et al., 2007, Fleming et al., 2009). ∆rG is a function 
of the reactants concentrations and the standard Gibbs energy of reaction (∆rG°); 
which depends on the standard Gibbs energy of formation of the reactants (∆fG°) 
and their stoichiometric coefficients in the respective reaction. The range of the ΔrG 
of a biological reaction can be estimated from physiological ranges of metabolite 
concentrations. In reverse, individual irreversible reactions may dictate the range of 
feasible metabolite concentrations and therefore the direction of otherwise reversible 
reactions. A methodology that can be applied to examine a full metabolic network at 
once is network-embedded thermodynamic analysis (NET-analysis) (Kummel et al., 
2006). NET-analysis can thus assess whether metabolite concentrations are feasible 
with respect to the reaction directionalities and assign reaction directionalities based 
on physiological ranges of metabolite concentrations and thermodynamic constraints 
(Martínez et al., 2014). This allows the prediction of a pathway’s thermodynamic 
feasibility based on metabolites concentration ranges. In practical terms, this could 
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mean that a stoichiometrically highly efficient route may be thermodynamically 
infeasible (Boghigian et al., 2010). 
As every EFM basically represents a unique metabolic network itself the 
thermodynamic feasibility of each single flux distribution is not given. Therefore we 
developed “NExT-EMA”, a tool that allows channelling of EFMs (computed with 
EFMTool (Terzer & Stelling, 2008) or other implementations for calculation of flux 
modes, e.g. (van Klinken & Willems van Dijk, 2015)), into NET-analysis, based on 
NExT (Martínez & Nielsen, 2014). 
The concept of thermodynamic analysis of elementary flux modes is not entirely 
new. In the first attempt, the approach was combined with a genetic algorithm to 
design an E. coli metabolic network optimized for product and biomass formation 
(Boghigian et al., 2010). Full NET-analysis of EFMs was applied for the first time in 
combination with flux variability analysis (FVA) to gain insight into S. cerevisiae 
metabolism on a system-level (Jol et al., 2012). This allowed insight into intracellular 
fluxes and combinations of reactions that could not operate under the investigated 
conditions were identified. Recently tEFMA, a tool that integrates evaluation of the 
thermodynamic feasibility of elementary during enumeration of these, was developed 
in order to facilitate the analysis of large-scale metabolic networks (Gerstl et al., 
2015). However, the tool was only demonstrated with a simple E. coli network (Gerstl 
et al., 2015). 
Previous tools were not applicable to our problem, due to certain restrictions and 
disadvantages. Therefore, we designed NExT-EMA with ease of use in mind while 
not sacrificing universal applicability: It requires considerably less input (no FVA data 
needed) and is therefore readily applied and transferred to various metabolisms. 
Further, it is based on the most recent and advanced thermodynamic data (Noor et 
al., 2013) and NET-analysis tool (Martínez & Nielsen, 2014) and allows the analysis 
of fully compartmentalized complex eukaryotic networks (unlike tEFMA). Even then 
computational costs were not an issue (cf. section 2.1.3.10). 
NExT-EMA was used to analyse E. coli and S. cerevisiae metabolic networks 
comparing the yields and feasibility of all currently known routes to adipic acid and its 
biological precursors cis,cis-muconic acid and glucaric acid from glucose and/or fatty 
acids (Figure 4). The present work highlights the importance of pathway choice to 
maximize the potential of the process. 
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The achievable product titre in a process can be further limited by several factors. 
Adipic acid could be directly toxic to the cells, which so far has not been described, 
or the achievable extracellular concentration could be limited by the efficiency and 
mechanism of the product export from the cells (Maris et al., 2004). This is 
particularly important for pathways that have reactions with ∆rG’° close to zero as 
limitations in export can lead to accumulation of intermediates and thus cause a 
reaction to stagnate because of thermodynamic infeasibility. Therefore, also different 
efflux systems for adipic acid in the cell envelope were evaluated in detail. 
2.1.3 Materials and Methods 
2.1.3.1 Biochemical pathways to adipic acid 
Six fundamentally different pathways featuring unique intermediates and enzymatic 
conversions were compiled from patents (Frost & Draths, 1996, Frost & Draths, 
1997, Boussie et al., 2010, Burgard et al., 2010, Burgard et al., 2012, Picataggio & 
Beardslee, 2012, Raemakers-Franken et al., 2012) and scientific publications 
(Draths & Frost, 1994, Weber et al., 2012, Curran et al., 2013, Sun et al., 2013, Lin 
et al., 2014, Sun et al., 2014, Yu et al., 2014, Babu et al., 2015, Clomburg et al., 
2015, Deng & Mao, 2015, Sengupta et al., 2015, Vardon et al., 2015). In total 16 
different main routes for carbon-flow were considered. Each route was implemented 
in two different organism models: E. coli and S. cerevisiae. 
2.1.3.2 Muconic acid production via the shikimate pathway 
It is difficult to define separate routes for the production of ccMA from shikimate 
pathway as many options exist regarding host organism, biochemical route, 
heterologous enzymes, carbon-source and fermentation method (Zhang et al., 
2015). Basically, five different routes were distinguished; three of these contain 
alternative interconversions (Figure 7). The routes were named according to key 
intermediates / branch off from shikimate pathway: dehydroshikimate, anthranilate, 
isochorismate, pHBA and coumarate. To be able to compare this pathway among 
the others for production of adipic acid a hypothetical reductase enzyme that uses 
two redox equivalents (NADPH) was assumed for the biochemical reduction of the 
two double bonds in cis,cis-muconic acid (similar to a fumarate reductase-like 
activity). 
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2.1.3.3 Glucaric acid production via inositol 
D-glucaric acid can be derived from inositol metabolism. From the central metabolite 
glucose-6-phosphate, the start point of the glycolysis and the pentose phosphate 
pathway, myo-inositol is formed in two steps of molecular transformation. In two 
more bioconversions D-glucaric acid is obtained (Figure 7). In order to compare this 
pathway among the others, a theoretical dehydratase utilizing four redox equivalents 
(NADH) to dehydrate D-glucaric acid to adipic acid by removing the four hydroxyl-
groups was assumed (similar to a fumarase like activity with subsequent reduction of 
the double bonds). 
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Figure 7: Glycolysis based pathways for biological production of adipic acid. Intermediates that define a pathway are in bold and underlined; 
central intermediates of a separate route are in bold only. Dashed lines indicate multiple reaction steps. 
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2.1.3.4 Production via the 3-oxoadipate pathway 
The 3-oxoadipate pathway, reported as “reverse adipate degradation” (Burgard et 
al., 2010, Burgard et al., 2012, Yu et al., 2014, Babu et al., 2015), leads over two 
different sub-routes to the intermediates hexa-2-enedioate & 2,3-didehydroadipyl-
CoA (Figure 8). The former is directly converted to adipic acid, the latter is first 
reduced to adipyl-CoA. Hence, four different sub-routes were considered for this 
pathway. For conversion of adipyl-CoA to adipic acid two options were assumed: 
one step release of adipic acid in a hydrolase reaction via an adipyl-CoA 
thioesterase (Babu et al., 2015) or two steps utilizing promiscuous phosphate butyryl 
transferase and butyryl kinase enzymes (Yu et al., 2014). As succinyl-CoA is 
mitochondrial in S. cerevisiae the whole pathway was assumed to be mitochondrial. 
2.1.3.5 Production via the 2-oxoadipate pathway 
Similarly to the 3-oxoadipate pathway also for the production of adipic acid via 2-
oxoadipate multiple routes have been described (Burgard et al., 2010, Burgard et al., 
2012), partially involving identical metabolites. All routes were compiled into one 
interlinked pathway (Figure 8); out of these nine different possible routes for carbon-
flow were identified for analysis, in accordance with the respective patents. While 
every route is essentially unique, the overall stoichiometry may come down to the 
same lumped reaction in some cases. Therefore, carbon yields can be identical 
while thermodynamics may differ. For conversion of adipyl-CoA to adipic acid the 
same reactions as for the 3-oxoadipate pathways were assumed. 
2.1.3.6 Production via lysine degradation 
Generation of adipic acid from lysine (Figure 8) is closely related to 2-oxoadipate 
metabolism. In most bacteria lysine is firstly synthesized from aspartate and then 
broken down via 6-oxohexanoate, which enters the 2-oxoadipate pathway. In most 
prokaryotes, including E. coli, production of lysine from aspartate proceeds via a 
succinylase, while some other prokaryotes, like C. glutamicum, use a 
dehydrogenase. Both options were included in the E. coli model. Yeasts synthesize 
lysine naturally via 2-oxoadipate partially in the mitochondria, rather than through the 
aspartate biosynthesis. Therefore only the last steps of this pathway coincide in the 
prokaryotic and eukaryotic models. 
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Figure 8: TCA-cycle based pathways for biological production of adipic acid. Intermediates that define a 
pathway are in bold and underlined; central intermediates of a separate route are in bold only. Dashed 
lines indicate multiple reaction steps. 
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2.1.3.7 Production from fatty acid metabolism 
A unique variant to obtain adipic acid from engineered microorganisms is fatty acid 
metabolism. Inferred from the molecular structure this seems natural as adipic acid 
consists of a saturated C6-backbone with terminal α,ω-carboxy groups, making it a 
basically short chain dicarboxylic fatty acid. Rather than distinguishing between 
different routes this variant of adipic acid production is determined by the type of 
carbon-source used and the point of entry into the pathway cascade: according to a 
patent, (Picataggio & Beardslee, 2012) both, fatty acids (FA) and glucose can be 
substrates. If glucose is the sole substrate, synthesis proceeds either directly 
outgoing from central metabolism through ω-oxidation to adipate, or via fatty acid 
synthesis (FAS) and subsequent breakdown of the FA through β-oxidation and 
carboxylation via ω-oxidation. If FAs are a carbon-source, these can directly enter 
the β-oxidation and proceed through ω-oxidation to adipic acid. For the pathways 
described above (Figure 9) a mixture of FAs is utilized either solely or in combination 
with glucose to feed the yeast Candida tropicalis for the production of adipic acid 
(Picataggio & Beardslee, 2012). The pathways were transferred to a model of the 
budding yeast S. cerevisiae for a more universal significance and comparability with 
the other pathways. Moreover, the composition of the fatty acid mixture used in the 
patent is not explicitly defined and also might vary between batches. Therefore, the 
most common saturated fatty acid palmitate (C16) was assumed as a representative 
of the FAs mixture. For the conversion of adipyl-CoA to adipate three possibilities 
were examined, according to described enzyme classes (Burgard et al., 2010, 
Burgard et al., 2012): an adipyl-CoA hydrolase (EC 3.1.2.-), an adipyl-CoA synthase 
(EC 6.2.1.-) / phosphotransadipylase/adipate kinase (EC 2.3.1.-/2.7.2.-) and an 
adipyl-CoA:acetyl-CoA transferase (EC 2.3.1.-). 
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Figure 9: FA metabolism based pathways for biological production of adipic acid. Different 
pathways are written in bold and underlined. Rather than distinguishing between different 
routes to adipic acid this variant for adipic acid production is determined by the type of 
carbon-source used (not apparent from the figure) and the points of entry into the pathway 
cascade, which are indicated in bold. 
 
2.1.3.8 Stoichiometric networks of central carbon metabolism 
Metabolic networks of E. coli and S. cerevisiae were based on previously published 
ones (Averesch & Krömer, 2014), expanded by a peroxisomal compartment 
(Hiltunen et al., 2003) and additional transport reactions (Rottensteiner & 
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Theodoulou, 2006) as well as uptake of palmitate as an alternative substrate to 
glucose to realize FA metabolism based production pathways. While glucose 
transport in E. coli and S. cerevisiae can be considered non-limiting under most 
circumstances (Bisson & Fraenkel, 1984), the exact uptake mechanism for FA into 
the cell is currently unclear. Given that the lipophilic character of the uncharged 
alkane residue dominates over the carboxylic acid function (Hamilton, 1998) 
transport should purely depend on the concentration gradient, oil/water interface, 
and partitioning coefficient. Due to the lack of data, we assumed free and non-
limiting palmitate influx. Ab initio reaction directionalities were inferred from 
experimentally curated database data (EcoCyc, SGD). H2O was not balanced (since 
water is necessarily ubiquitous in a biological system) for enumeration of elementary 
flux modes (to reduce the number of irrelevant modes). 
However, water was naturally respected for thermodynamic analysis. Further, 
reactions that consume or produce CO2, needed to be balanced with one equivalent 
of H2O on the opposing side of the reaction to balance oxygen, as in the system the 
total CO2 (co2tot) is distributed among the species HCO3
-, CO3
2, CO2 and H2CO3 in 
the aqueous phase (Alberty, 2003). Global carbon balancing reactions (E. coli R1 – 
R13 & S. cerevisiae R1 – R11) are irrelevant for NET-analysis and were therefore 
disregarded for determination of reaction directionalities, as was the biomass 
equation (determination of ∆rG not applicable, reaction assumed feasible). The full 
networks are included as supplementary material (files 2.1.1 – 2.1.4) as an example 
for use with the NExT-EMA program. 
2.1.3.9 Principles, data, and assumptions for thermodynamic analysis 
Thermodynamic data of compounds (ΔfG°), including pseudoisomers, was obtained 
using the website version (http://equilibrator.weizmann.ac.il) of the eQuilibrator tool 
(Flamholz et al., 2012). Experimental data (Alberty, 2003, Alberty, 2006) was always 
preferred over component contribution method (Noor et al., 2013) derived values, if 
neither was available it was derived by means of group contribution method 
(Jankowski et al., 2008) principles. The different sources of data on Gibbs energy of 
formation were handled as previously reported (Martínez et al., 2014), in order to 
avoid potential inconsistencies. Physical data (pH, ionic strength, electrical potential, 
volume) for the different compartments (extracellular, cytosol, mitochondrial matrix & 
intermembrane space, peroxisome) were largely adopted from previous analyses 
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(Martínez et al., 2014), unless indicated otherwise: an ionic strength of 0.15 M was 
considered for all compartments (Kümmel et al., 2006), respective extracellular and 
cytosolic pH levels of 7.0 and 7.6 were used for E. coli (Zilberstein et al., 1984). For 
S. cerevisiae at an extracellular pH of 6.7 a cytosolic pH of 7.2 and mitochondrial pH 
levels of 7.5 (matrix) and 6.4 (intermembrane space) were used respectively (Orij et 
al., 2009). As peroxisomal pH is highly disputed (latest theories indicate variability 
due to a Donnan equilibrium (Antonenkov & Hiltunen, 2012), suggesting a variable 
pH gradient (Haraldsdóttir et al., 2012)) two scenarios with the maximum and 
minimum (Haraldsdóttir et al., 2012) reported pHs were investigated. Electrical 
potentials were estimated accordingly: based on the proton motive force the 
membrane potential was related to the pH gradient as described previously 
(Haraldsdóttir et al., 2012). Volume of the peroxisomal compartment was adjusted 
depending on the pathway / carbon-source used: while under conditions of growth 
on glucose the peroxisomes typically only make up 1 – 2% of the total volume of the 
cells, it increases with FAs and certain other substrates, in some cases reaching up 
to 80% (Veenhuis et al., 2000). Further, when applying more accurate constraints 
through limited metabolite concentrations, the significance of the results is improved. 
Where available for E. coli and S. cerevisiae metabolism, maximum and minimum 
metabolite concentrations were applied. These were adopted from previous analyses 
(Henry et al., 2007, Jol et al., 2012) or limited between 0.0001 mM and 10 mM 
(Kümmel et al., 2006, Martínez et al., 2014). 
2.1.3.10 Network embedded thermodynamic analysis of elementary flux modes 
EFMs were calculated using the EFMTool 4.7.1, freely available for academic use 
(http://www.csb.ethz.ch/tools/efmtool) (Terzer & Stelling, 2008). The EFMs were then 
analysed with NET-analysis, using a modified version of NExT (Martínez & Nielsen, 
2014) (tool available upon request); the basic workflow is outlined in Figure 10. NET-
analysis was performed at physiological conditions and was limited to modes that 
involved the formation of the product of interest (modes with no flux to adipic acid are 
irrelevant here as the adipic acid yield will always be 0). Computations were 
performed with MATLAB R2015b (The MathWorks, Natick, USA) using the built in 
fmincon solver and the ILOG CPLEX optimizer (IBM, New York, USA) on a desktop 
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computer (Intel Core i7-2600 CPU @ 3.4 GHz, 32 GB RAM).2 The maximum carbon 
yields of the different elementary modes were determined with by drawing carbon 
balances around the transport reactions into and out of the balance area. 
The results of the thermodynamic analysis of the EFMs of the different networks 
were further analysed. First, feasible and infeasible EFMs were compared by means 
of the directionality of the reactions belonging to these two groups, i.e. the reactions 
that always had the same direction in all feasible or all infeasible EFMs were 
identified. By comparing these two groups of reactions potential combinations of 
reactions (patterns) that caused infeasibility could be determined. Then the 
respective network was recursively analysed with NExT using an algorithm, which 
considered all reactions reversible, except the reactions that were always irreversible 
in the infeasible EFMs but not in the feasible ones. In case no clear differences were 
found between the directionality of feasible and infeasible EFMs, the constraints of 
the first infeasible EFM were used. 
The troubleshooting algorithm identified the reaction(s) of a model which became 
thermodynamically infeasible due to their conflicting directionalities under the 
specified conditions of metabolite concentrations and reaction directionalities. The 
algorithm consists of an iterative process where first a reaction that, if removed, 
would render a model thermodynamically feasible, is identified. Then it is verified that 
the directionality in the particular reaction is sufficient to render the model infeasible. 
These steps are repeated until only the smallest set of reactions is found, which is 
required to generate infeasibility. Finally, the infeasible EFMs were crosschecked to 
verify that removing the identified pattern constrains would make them feasible. If 
infeasible EFMs remained after the removal of the constrains, the iterative process 
was repeated with the remaining infeasible EFMs. 
The analysis of the feasible and infeasible EFMs, the identification of infeasible 
patterns and the final check of the infeasible EFMs were scripted in MATLAB (tool 
available upon request). 
                                            
2
 Enumeration of EFMs proceeded at a minimum speed of 3,100 modes/sec when using EFMTool 
and at an average speed of 50,000 modes/sec when using the new FluxModeCalculator (van Klinken 
& Willems van Dijk, 2015). NExT reached a minimum speed of 120 modes/sec in case of the most 
complex S. cerevisiae network when relying on the fmincon solver. A different solver, as for example 
LINDO™, may accelerate the process significantly, especially in combination with parallel computing. 
In case the number of EFMs of a network becomes too high to fit into memory for at once analysis, 
the respective file can be split and analysed step-by-step. This was only necessary for the most 
complex S. cerevisiae network, which had more than 40 million EFMs. 
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Figure 10: Flowchart for network-embedded thermodynamic analysis of elementary flux 
modes. EMA = elementary mode analysis; CCM = component contribution method; NET-A = 
network-embedded thermodynamic analysis; sgn = signum function: Reactions were 
constrained in NET-analysis according to the direction (= sign) of the flux determined by EMA, 
for 0 flux the reaction was unconstrained. 
 
2.1.3.11 Definition of pathway feasibility limits by Gibbs free energies of reactions 
Besides the thermodynamic feasibility analysis of the EFMs, the metabolic networks 
were also subject to a separate full NET-analysis at different physiological conditions 
in order to evaluate the thermodynamic equilibria of the different pathways in depth 
(results are included in supplementary files 3 & 4). In addition to the transformed 
standard Gibbs free energy (ΔrG’°) also the Gibbs free energies at boundary reactant 
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concentrations (ΔrGmin and ΔrGmax) were determined for each reaction. In detail the 
ΔrGmin was determined using highest substrate and lowest product concentrations 
and the ΔrGmax using lowest substrate and highest product concentrations, 
analogous to what has been described previously (Martínez et al., 2014). A reaction 
was considered feasible if at least the ΔrGmin was negative. If further also the ΔrG’° 
was negative, the thermodynamic equilibrium lies on the substrate side and the 
reaction is thermodynamically favoured in the written direction. A unique metabolic 
route to adipic acid was considered favoured if these two criteria applied to all 
reactions on the route. However, if a single reaction had a positive ΔrGmin the whole 
route was considered infeasible. All routes that were neither favoured nor infeasible 
were classified thermodynamically restricted. Further, pH can influence this 
equilibrium in both ways, depending on which side of an equation the protons take 
part in the reaction and for transport reactions in which direction a proton gradient 
exists. In order to investigate this, the Gibbs free energies at lowest feasible 
physiological pH values were studied separately (S. cerevisiae extracellular: 3.5, cytosol: 
4.4 (Imai & Ohno, 1995, Guldfeldt & Arneborg, 1998); E. coli extracellular: 5.9 
cytosol: 6.8 / 6.1 (Diez-Gonzalez & Russell, 1997)). The pH of other compartments 
was scaled relatively to the cytosolic one, e.g. where no mitochondrial pH was 
determined a constant ΔpH of + 0.3 in respect to the cytosol was assumed. 
2.1.3.12 Assessment of cellular transport processes 
Different scenarios for the export of the dicarboxylic acids from the cytosol to the 
medium were investigated in detail. In particular, passive transport via diffusion, 
proton-mediated symport, and active transport coupled with ATP hydrolysis were 
compared. 
As uncharged molecules can virtually travel freely over a cell membrane internal and 
external undissociated forms can be assumed to be equivalent. Knowing that in both 
environments the different protonation states are in equilibrium passive diffusion of 
the uncharged compound over the cell membrane can be described by Eq. (1): 
cint
cext
=
1 + (10pHint−pKa1) × (1 + 10pHint−pKa2)
1 + (10pHext−pKa1) × (1 + 10pHext−pKa2)
                                                                          (1) 
Similarly for a dicarboxylate/proton anionic symport Eq. (2) can be formulated, 
derived from (Maris et al., 2004) it also includes a factor that accounts for the efflux 
of protons: 
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cint
cext
= (10
(n×ΔpH−
(n−1)×Δψ
Z
)
) ×
1 + (10pKa2−pHint) × (1 + 10pKa1−pHint)
1 + (10pKa2−pHext) × (1 + 10pKa1−pHext)
                          (2) 
With n = number of transported protons, ΔpH and Δψ describing the difference in pH 
and redox potential across the membrane and Z = ln(10) T R F-1. While R (gas 
constant) = 8.31446 J (mol K)-1 and F (faraday constant) = 96,485.333 s A mol-1, T 
depends on the (optimum) cultivation temperature (in Kelvin) of the respective 
microorganism. 
In the case of active transport driven by ATP hydrolysis, intracellular and 
extracellular concentrations of a di-acid correlate in a way where Eq. (1) is amended 
by a factor accounting for the additional driving force, as described by (Maris et al., 
2004), resulting in Eq. (3): 
cint
cext
= (10(
ΔGATP
Z×F )) ×
1 + (10pHint−pKa1) × (1 + 10pHint−pKa2)
1 + (10pHext−pKa1) × (1 + 10pHext−pKa2)
                                             (3) 
Where ΔrGATP is the energy obtained from ATP hydrolysis (ATP + H2O  ADP + Pi) 
calculated using NExT (Martínez et al., 2014) and adjusted for the respective 
compartments properties. 
2.1.4 Results and Discussion 
Elementary mode analysis of the different routes to adipic acid production revealed 
fundamental differences in maximum possible carbon yields between the available 
biochemical options. Thermodynamic analysis of the EFMs enabled the exclusion of 
infeasible modes resulting in a more realistic determination of the theoretical yields. 
Estimation of the Gibbs free energy of reactions provided additional insight into 
thermodynamic restrictions affecting metabolite concentrations of the pathways and 
further aided in their classification. Detailed evaluation of different product export 
mechanisms put recently reported titres and pathway thermodynamics into 
perspective. 
2.1.4.1 Stoichiometric limitations of the different pathways to adipic acid 
Elementary flux mode analysis showed a large spread of maximum theoretical 
carbon yields for the different routes (Table 4 & Table 2). The highest maximum 
yields (Ymax) were achieved for the conversion of glucose to adipic acid via the 3-
oxoadipate pathways, which reached to over 90% in both E. coli and S. cerevisiae. 
The high yield is possible because the precursor, succinyl-CoA, can be derived from 
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a reverse operating TCA cycle where no CO2 is formed, and no CO2 is formed in the 
subsequent reactions of the two routes (Figure 8). The route with the second highest 
yield in E. coli, reaching 90%, was derived from lysine degradation, however not so 
in S. cerevisiae: here the Ymax was only 66%. The reasons are differences in the 
pathways leading to the synthesis of lysine rather than the breakdown to adipic acid. 
In particular, partial mitochondrial localization of the pathway in yeast requires 
additional energy for transport of metabolites, also the fact that 2-oxoglutarate 
initiates the pathway has a unique impact (see below). Carbon yields of the 
2-oxoadipate pathways were not much lower than 90% in E. coli; the yield was 
slightly reduced because the formation of the precursor 2-oxoglutarate from TCA-
cycle involves the production of CO2. In S. cerevisiae, however, the yields were very 
low and without biomass adipic acid formation was stoichiometrically impossible. 
This means that product formation is coupled to growth and a direct competition 
exists, which resulted in a reduced product yield (cf. yield vs. biomass plots, 
supplementary files 2.1.5 & 2.1.6). This is because 2-oxoglutarate is a precursor for 
2-oxoadipate pathways: S. cerevisiae does not have transhydrogenases, therefore, 
the only sink for the NADPH, which is produced during 2-oxoglutarate formation from 
isocitrate, is biomass. Shikimate pathway based routes greatly differed among one 
another in their Ymax, which ranged from 57% – 75% in both organisms. In general 
the further downstream the route branches off from the shikimate pathway the lower 
the yield, as additional bioconversions require more resources. The Ymax of the 
inositol route was (almost) as high as the highest shikimate pathway based one. FA 
metabolism based routes were a special case: the routes also showed a wide 
distribution of possible yields, however greatly depended on the carbon-source and 
on the presence of anabolic and catabolic FA metabolism pathways. Highest yields 
were obtained on a glucose-feed with direct synthesis of a C6-body (hexanoate) and 
subsequent ω-oxidation. The overall lowest Ymax of 37.5% was obtained when adipic 
acid was produced from a C16-FA-feed via β-oxidation. This can be explained by the 
incapability to recycle excess acetyl-CoA, which is generated during β-oxidation of 
the C16-FA palmitate. When FA biosynthesis was implemented alongside with β-
oxidation, acetyl-CoA could be recycled and the yield improved to values 
comparable to the sugar based variant. This effect was not present when using 
solely glucose as carbon-source. The assumption that FA biosynthesis and oxidation 
could be metabolically active at the same time, however, opposes natural 
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transcriptional control (Hardie & Pan, 2002) and substantial regulatory redesign of 
FA metabolism would be necessary in order to enable simultaneous FA synthesis 
and ω-, β-oxidation. A combined glucose- and C16-feed could also not improve the 
yield significantly. Further, it is noteworthy that when assuming adipic acid to be the 
final product of β-oxidation, meaning it was only allowed to proceed to a C6-body 
instead of full breakdown of the FA into C2-bodys, a minimum yield constraint of 
37.5% was introduced (cf. yield vs. biomass plots, supplementary file 2.1.5 & 2.1.6). 
Finally, it is noteworthy that shikimate pathway and FA metabolism based pathways 
are both limited to aerobic conditions due to the nature of the product-pathways 
(oxygen is an essential substrate). 
2.1.4.2 Feasibility of elementary flux modes and impact on maximum carbon yields 
NET-analysis was used to distinguish between thermodynamically feasible and 
infeasible EFMs. In some cases, this affected the theoretical maximum product 
carbon yields severely (Table 4 & Table 2, for detailed information on the feasibility 
of the flux modes of each network, refer to supplementary files 2.1.3 & 2.1.4). 
Especially for S. cerevisiae infeasible flux distributions were identified in every 
network. Most of the time the infeasibility could be attributed to two reactions in the 
central carbon metabolism occurring in a certain pattern: a mitochondrial malate 
dehydrogenase (R66) that proceeded in the forward direction (the direction it is 
written in), limited the NADH[m]/NAD[m] ratio to 0.15. This subsequently affected all 
flux distributions where the malic enzyme (R67) was also active in the forward 
direction, rendering all modes with this pattern infeasible. Although the malate 
dehydrogenase (MDH1) has been reported to be reversible, and even favoured in 
forward direction (according to SGD), these findings are in accordance with previous 
ones (Jol et al., 2012). The theoretical carbon yields were unaffected by this co-
factor ratio restriction (cf. supplementary files 2.1.5 & 2.1.6, yield vs. biomass plots of 
feasible and infeasible modes). 
Infeasibility of the 3-oxoadipate pathway was caused additionally by two other 
patterns. The drop in maximum product carbon yield by 1% of the 2,3-
didehydroadipyl-CoA route, of which over half of the EFMs were infeasible, was 
caused by a ratio restriction of ATP[m] / (ADP[m] × P[m]), linked to the directions of 
the mitochondrial succinyl-CoA synthetase and the ATP synthase (R62 & R98). The 
route via hexa-2-enedioate was completely infeasibility due to a contradiction of the 
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3-oxoadipyl-CoA[m] concentration in the reactions of the succinyl-CoA:acetyl-CoA 
transferase / β-ketoadipyl-CoA thiolase and 3-oxoadipyl-CoA transferase (R107 & 
R108): In order for R107 to proceed in forward direction the maximum concentration 
of 3-oxoadipyl-CoA[m] could be no higher than 0.12 mM. This did not comply with 
the subsequent R108, which needed 3-oxoadipyl-CoA[m] at a minimum 
concentration of 0.33 mM in order to proceed in forward direction. 
The fraction of infeasible EFMs was greatest for FA based routes (70%) that 
involved the pathway of FA β-oxidation. Peroxisomal phosphate transport (R85) into 
the cytosol was responsible for the infeasibility and only EFMs, where phosphate 
could be balanced within the peroxisome were feasible. This was only possible in 
one of the three alternatives for release of adipate, namely release of adipate by the 
adipyl-CoA synthetase (EC 6.2.1.-) which allows peroxisomal phosphate to be 
recirculated. However the ∆rGmin of peroxisomal phosphate export appeared to be 
very close to 0 (< than 1 kJ/mol, which is less than the error of the component 
contribution method (Noor et al., 2013)) and strongly dependent on pH (cf. section 
3.3), therefore this infeasibility criterion may not be critical and the respective flux 
distributions may be considered feasible after all. 
For E. coli the different physiological conditions and the greater range of metabolite 
concentrations did not constrain the malate dehydrogenase, therefore, in most cases 
100% of the flux modes were feasible. However some pathways were still affected 
by thermodynamic constraints: all product forming EFMs of the inositol pathway were 
infeasible in E. coli due to the ∆rG’° of the uronolactonase reaction (R79) which was 
largely positive. This is surprising as an in vivo route for the production of glucaric 
acid has been reported previously, reaching significant titers in the g/L range 
(Reizman et al., 2015). A possible explanation is that the uronolactonase is 
dependent on a yet unknown co-factor. It is also possible that the reaction is coupled 
with another one, involving channelling of substrates or products to or from another 
enzyme, which seems particularly likely, as all other reactions in the pathway are 
thermodynamically greatly favoured. Additionally, according to KEGG an alternative 
branch of the inositol pathway may exist, which would avoid the problematic reaction 
by means of a detour via gulonate. 
Further, a portion of the product forming EFMs of the 2-oxopimelate route, part of the 
2-oxoadipate pathway, were infeasible in E. coli. The explanation for the infeasibility 
involves a combination of reactions causing restrictions in metabolite concentrations: 
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the pattern that was found in all modes that were infeasible includes the reactions of 
the glyceraldehyde-3-phosphate dehydrogenase, 3-phosphoglycerate phosphatase, 
phosphoglycerate mutase and phosphopyruvate hydratase (R23, R24, R25, R26) 
proceeding in forward direction, a reverse operating ATP synthase (R71) and R77 in 
the pathway to adipic acid. These six reaction directionalities together evoke a 
maximum NADH[c]/NAD[c] ratio constraint of 0.024. This ratio-limit does not allow 
R77 to proceed in forward direction, thus making the set of all of these reaction 
directionalities together infeasible. The consequence is a thinning out of low biomass 
modes (cf. yield vs biomass plots, supplementary files 2.1.5 & 2.1.6) and a slight 
reduction in the Ymax with biomass formation (cf. Table 1). Although there is in the 
given pathway no impact on the overall maximum theoretical yields, this yet 
demonstrates the potential of NET-EMA: When investigating a particular pathway in 
vivo, narrowing the metabolite constraints with experimentally acquired data may 
generate a more accurate description of the constraints that limit the actual system. 
Product forming EFMs of the pathway to adipic acid via lysine were also partially 
infeasible in E. coli: subsequently, the Ymax dropped to 87%. The cause was the non-
enzymatic reaction in the dehydrogenase branch of the lysine biosynthesis (R86 in 
the network, KEGG reaction number R04336), which was infeasible, although many 
organisms, like e.g. C. glutamicum, use this biosynthetic pathway. This might explain 
why organisms like E. coli utilize the succinylase branch, although the carbon yield is 
slightly lower. Another possibility is that the reaction is enzymatically catalysed after 
all - hypothetical co-factor participation would thus lead to a different ∆rG’° and the 
reaction could become feasible. 
Unlike the previously published tEFMA for calculation of thermodynamically feasible 
EFMs (Gerstl et al., 2015, Gerstl et al., 2015). NExT-EMA provides additional insight 
into metabolism as it allows identification of the cause of infeasibility of certain flux 
distributions. That this can be pivotal for strain and process design has been shown 
for S. cerevisiae by means of the 3-oxoadipate pathways and FA based routes and 
for E. coli by means of the 2-oxopimelate route and lysine degradation pathway. 
Further, the most recent implementation for enumeration of EFMs, 
FluxModeCalculator (van Klinken & Willems van Dijk, 2015), significantly reduces 
computational times and costs. In combination with NExT-EMA this enables the 
analysis of very large scale metabolic networks on non-workstation computers 
(which was so far not possible with EFMTool or tEFMA). 
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Table 1: Numbers of EFMs, Ymax [C-mol/C-mol] and impact of thermodynamics on Ymax for pathways to production of adipic acid in E. coli. For 
details on the reactions that comprise a route refer to Figure 7 - Figure 9 and the full networks in supplementary files 2.1.1 & 2.1.3. 
Super-
pathway 
Pathway 
Route # total 
EFMs  
# product 
forming 
EFMs 
# feasible 
product 
forming 
EFMs 
max. yield 
(w/o 
biomass) 
max. yield 
(w/ 
biomass) 
max. 
feasible 
yield (w/o 
biomass) 
max. 
feasible 
yield (w/ 
biomass) 
Glycolysis 
Shikimate 
dehydroshikimate 663,899 230,271 230,271 74.31 70.04 74.31 70.04 
anthranilate 890,948 457,320 457,320 61.14 55.25 61.14 55.25 
isochorismate 906,377 472,749 472,749 69.48 66.09 69.48 66.09 
pHBA 671,485 237,857 237,857 62.57 52.91 62.57 52.91 
coumarate 2,237,284 1,803,656 1,803,656 59.78 57.59 59.78 57.59 
 inositol 571,656 138,028 0 74.31 68.76 0 0 
TCA-cycle 
3-Oxoadipate 
hexa-2-enedioate 583,044 149,416 149,416 92.31 91.62 92.31 91.62 
2,3-
didehydroadipyl 
808,921 375,293 375,293 92.31 91.62 92.31 91.62 
2-Oxoadipate hexa-2-enedioate 527,563 93,935 93,935 88.30 83.09 88.30 83.09 
2,3-
didehydroadipyl 
1,422,346 988,718 988,718 86.29 82.60 86.29 82.60 
2-oxopimelate 641,999 208,371 202,794 88.30 83.09 88.30 82.90 
 lysine 734,628 301,000 197,966 90.00 85.67 87.10 81.48 
Fatty acid 
metabolism 
Glucose-feed 
ω-oxidation 633,496 199,868 199,868 74.12 65.47 74.12 65.47 
C6-FAS ω-
oxidation 
669,858 236,230 236,230 78.75 76.27 78.75 76.27 
C16-FAS ω- & β-
oxidation 
685,554 251,926 251,926 50.47 46.95 50.47 46.95 
C16-feed ω- & β-oxidation 92,858 70,937 70,937 37.50 37.50 37.50 37.50 
C16-FAS ω- & β-
oxidation 
73,392 73,392 73,392 73.05 69.08 73.05 69.08 
Glucose- & 
C16-feed 
1,542,307 1,108,679 1,108,679 73.05 69.08 73.05 69.08 
 - 36 - 
Table 2: Numbers of EFMs, Ymax [C-mol/C-mol] and impact of thermodynamics on Ymax for pathways to production of adipic acid in S. cerevisiae. 
For details on the reactions that comprise a route refer to Figure 7 - Figure 9 and the full networks in supplementary files 2.1.2 & 2.1.4. 
Super-
pathway 
Pathway 
Route # total 
EFMs  
# product 
forming 
EFMs 
# feasible 
product 
forming 
EFMs 
max. yield 
(w/o 
biomass) 
max. yield 
(w/ 
biomass) 
max. 
feasible 
yield (w/o 
biomass) 
max. 
feasible 
yield (w/ 
biomass) 
Glycolysis 
Shikimate 
dehydroshikimate 1,448,593 323,048 304,332 75.00 66.08 75.00 66.08 
anthranilate 2,291,909 1,166,364 1,103,210 60.84 59.85 60.84 59.85 
isochorismate 2,032,318 906,773 858,520 68.84 68.57 68.84 68.57 
pHBA 1,855,105 729,560 688,924 62.20 60.60 62.20 60.60 
coumarate 2,753,013 1,627,468 1,545,842 57.14 56.66 57.14 56.66 
 inositol 1,746,121 620,576 587,138 74.31 72.22 74.31 72.22 
TCA-cycle 
3-Oxoadipate 
hexa-2-enedioate 3,339,064 1,809,176 0 91.57 90.07 0 0 
2,3-
didehydroadipyl 
6,936,422 5,406,534 2,743,166 91.57 90.07 90.58 90.07 
2-Oxoadipate hexa-2-enedioate 2,749,090 1,219,202 1,140,296 0 38.09 0 38.09 
2,3-
didehydroadipyl 
20,481,631 17,310,438 16,145,432 0 38.09 0 38.09 
2-oxopimelate 4,519,321 1,752,471 1,630,396 0 32.00 0 32.00 
lysine 2,045,778 515,890 482,831 66.66 49.83 66.66 49.83 
Fatty acid 
metabolism 
Glucose-feed 
ω-oxidation 9,162,674 6,395,824 5,989,820 60.00 54.46 60.00 54.46 
C6-FAS & ω-
oxidation 
9,282,723 6,515,873 6,065,029 66.67 65.49 66.67 65.49 
C16-FAS, ω- & β-
oxidation 
18,259,286 9,958,736 3,097,508 48.26 46.71 48.26 46.48 
C16-feed ω- & β-oxidation 1,005,516 692,487 129,201 37.50 37.50 37.50 37.50 
C16-FAS, ω- & β-
oxidation 
596,952 596,946 173,139 68.38 66.00 68.38 66.00 
Glucose- & 
C16-feed 
41,853,761 33,553,211 10,085,903 68.57 60.82 68.57 60.82 
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2.1.4.3 Pathway feasibility limits and impact of pH on Gibbs free energies of reactions 
For pathways with ΔrG’°s close to zero, a change in compartment pH due to environmental 
changes can impact the pathway thermodynamic feasibility. Further, the ΔrG’° at low and 
high ratios between products and substrates can provide an indication on a pathways 
performance. Therefore, after establishing the differences in achievable carbon yields, the 
boundary ΔrG’°s of each reaction of the different networks were determined at different 
physiological conditions in a separate thermodynamic analysis (results are included in 
supplementary files 2.1.3 & 2.1.4). As NET-analysis of the full set of reactions in a 
pathway’s network features the highest constraints the results represent a “worst case 
scenario”. Also, the reader should be aware that the condition ∆rG < 0 is necessary but not 
sufficient for a reaction to occur in vivo. 
Determination of the different ∆rG’°, ∆rG’°min and ∆rG’°max revealed that a range of 
pathways contain reactions with a thermodynamic equilibrium that lies on the substrate 
side. Favourable were only the routes via dehydroshikimate, anthranilate, pHBA and 
2-oxopimelate in both, E. coli and S. cerevisiae, all other pathways contained at least one 
reaction with a (∆rG’°) > 0 (metabolite independent standard Gibbs energy of reaction). 
Further, the malate dehydrogenase reaction appeared to be completely irreversible in the 
forward direction at low pH conditions in S. cerevisiae. At the very lowest boundary of the 
pH range, the inositol pathway became also feasible in E. coli. Especially in S. cerevisiae 
the improvement was larger, as in the yeast generally a lower physiological pH is possible 
than in E. coli. Also, the ∆rG’° of the dehydrogenase reaction in the lysine pathway 
dropped with lower pH; however it failed to become feasible in E. coli due to its narrow pH 
range. As the change of pH can also have the adverse effect, depending on which side of 
the equation the protons take part in, the other pathways did in general not benefit from 
low pH, especially for the 2- and 3-oxoadipate pathways most thermodynamic equilibria 
deteriorated. In case of the FA metabolism based pathways, no definite effect was 
present, as some reactions changed in one and others in the opposite direction. 
Peroxisomal pH, however, had a profound impact on routes involving β-oxidation, which 
were only feasible at high cytosolic pH in combination with an alkaline peroxisome. 
Although a high peroxisomal pH restricts the ATP/AMP antiporter, efflux of phosphate from 
the peroxisome is thermodynamically impossible at low peroxisomal pH. This supports 
studies arguing for an alkaline peroxisome (van Roermund et al., 2004) and the 
postulation of a proton gradient (Rottensteiner & Theodoulou, 2006) that can potentially 
drive transporters. 
 - 38 - 
The phosphate transport problem and the malate dehydrogenase pattern are also good 
examples showing the advantages of combined elementary mode and thermodynamics-
based network analysis: separate NET-analysis of the complete networks is biased, as it 
gives insight into the range of the Gibbs energy of reactions, but is not sufficient in order to 
determine if a certain metabolic state (i.e. EFM) is feasible or infeasible. On the one hand, 
the reactions in question are often not located in the pathway itself and therefore not 
obvious problems, unless combined with flux analysis. On the other hand a critical Gibbs 
energy of reaction does not necessarily deem all EFMs infeasible. Even EFMs that include 
the critical reaction may or may not be feasible due to the presence or absence of other 
constraints, which are pivotal for the particular reaction. A reduced network (that is any 
EFM), which has consequently less constraints than the full set of reactions, can therefore 
still be feasible. 
Another restriction of the FA based routes is related to the nature of these cyclic pathways: 
In normal metabolism, the product of FA β-oxidation, acetyl-CoA, is not accumulated but 
metabolised in various reactions. In the case of adipic acid overproduction acetyl-CoA will 
ultimately accumulate (unless FA biosynthesis and oxidation occur simultaneously), which 
will lead to a product concentration that will shift the thermodynamic equilibrium and stop 
these reactions. This may explain why the process (Picataggio and Beardslee, 2012) could 
only achieve production levels corresponding to a mg L-1 magnitude (chemicals-
technology.com, 2012, Becker et al., 2015). 
Overall, several routes contain reactions that have an extremely narrow concentration 
range beyond which the reactions become infeasible. Therefore, a careful balancing of the 
pathways that are thermodynamically restricted will be a crucial engineering target; 
otherwise thermodynamics will limit the production via these pathways. Pathway balancing 
has to go hand in hand with the engineering of highly efficient product export, as is 
explained in the following. 
2.1.4.4 Evaluation of different scenarios for product export 
A crucial factor that can severely affect the thermodynamic equilibria of the reactions in the 
product-pathway and the achievable product titres in a process is the efficiency and 
mechanism of the product export from the cells (Maris et al., 2004). This is particularly 
important for pathways that have reactions with ∆rG’° close to zero, as limitations in export 
can lead to accumulation of intermediates and thus cause a reaction to stagnate because 
of thermodynamic infeasibility. Therefore, the impact of different efflux systems for adipic 
acid in the cell envelope was evaluated in detail. 
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Diffusion over the cell-membrane is theoretically possible, as long as the driving force (the 
intracellular concentration of product) is high enough. Making use of Eq. (1) to estimate 
adipic acid transport out of the cell it becomes clear that cext will always be magnitudes 
smaller than cint as long as pHint is higher than pHext (in most cases given due to the 
obligatory proton gradient across the membrane). With respective values for pHint of 7.2 
(Orij et al., 2009) and 7.6 (Zilberstein et al., 1984) for S. cerevisiae and E. coli, 
respectively, and when assuming a physiologically very high intracellular concentration of 
adipic acid of 100 mM, a maximum extracellular concentration of 10.3 mM (≈ 1.5 g L-1) for 
S. cerevisiae and 6.4 mM (≈ 0.9 g L-1) for E. coli may be achieved by passive diffusion. 
This becomes substantially worse when assuming a proton symporter (Eq. (2)) as also 
protons are transported against the pH gradient (at cint = 100 mM cext may only reach 0.33 
mM for S. cerevisiae and 0.07 mM for E. coli). In contrast, an active ABC-like transport 
system (Eq. (3)) can achieve extracellular concentrations at the solubility limit with only 
minimal intracellular concentrations (0.08 µM for S. cerevisiae, 0.13 µM for E. coli). 
Given the thermodynamic constraints that many pathways face in terms of feasible 
intracellular concentration ranges, product export seems to be one of the most relevant 
aspects. As demonstrated above, the only scenario suitable to achieve competitive 
product titers is active transporter but to date no such mechanism has been reported for 
adipic acid. In fact, many of the currently published titers for adipic and muconic acid lay 
within the feasible range of passive diffusion or proton symport. This includes works in S. 
cerevisiae (Weber et al., 2012, Curran et al., 2013) and E. coli (Sun et al., 2013, Sun et al., 
2014, Yu et al., 2014, Babu et al., 2015, Sengupta et al., 2015). Exceptions are the early 
work of the Frost lab on muconic acid production from glucose in E. coli (Draths & Frost, 
1994, Frost & Draths, 1997, Niu et al., 2002) and routes via salicylate (Lin et al., 2014) and 
from lignin-derived species (Deng et al., 2016) as well as the production of adipic acid with 
Thermobifida fusca (Deng & Mao, 2015). The higher muconic acid titers indicate the 
presence of some kind of active transport mechanism. Identification of this transporter 
could be a significant step towards efficient muconic and adipic acid production. While the 
shikimate pathway based routes via dehydroshikimate and anthranilate are 
thermodynamically favoured over a wide range of intermediate concentrations and pH 
levels, recent demonstrations of these pathways in vivo only achieved muconic acid titers 
up to 141 mg L-1 (Curran et al., 2013) in S. cerevisiae and 389.96 ± 12.46 mg L-1 (Sun et 
al., 2013) in E. coli, which is still far from the previously reported titre of 36.8 g L-1 (Niu et 
al., 2002) via the dehydroshikimate route in E. coli. The analysis of intracellular metabolite 
concentrations in these strains may help to answer the question of export limitation.  
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2.1.6 Conclusion 
Known metabolism currently offers 16 different solutions to the problem of biological adipic 
acid production. Ten of these routes lead directly to adipic acid, while six routes would 
yield the precursors cis,cis-muconic or glucaric acid. Here, we present the first 
comprehensive evaluation of differences in theoretical yields and thermodynamic 
feasibility. 
NExT-EMA was developed to perform NET-analysis on elementary flux modes and 
distinguish between thermodynamically feasible and infeasible solutions. The applicability 
of NExT-EMA to real world problems and advantages over existing methods was 
demonstrated by analysing adipic acid production in prokaryotic and eukaryotic models. 
The analysis illustrates that high adipic acid yields in a biological system are theoretically 
achievable but significant differences exist between yields and thermodynamic feasibility of 
the different pathways. Examples are the infeasible inositol pathway and the partially 
infeasible lysine degradation in E. coli, as well as the infeasible route via hexa-2-enedioate 
of the 3-oxoadipate pathway in S. cerevisiae. In some cases extreme differences between 
the organisms were found, in particular the 2-oxoadipate based routes delivered high 
yields in E. coli but featured the lowest in S. cerevisiae. In both organisms the routes via 3-
oxoadipate achieve the highest yields but are limited by a thermodynamic equilibrium on 
the substrate side. The only thermodynamically favoured routes are those based on the 
shikimate pathway (dehydroshikimate, anthranilate and pHBA routes) and the 2-
oxopimelate route, which can achieve moderate to high yields. However, recent 
publications of the dehydroshikimate and anthranilate routes show so far at best mediocre 
product titres, hinting at kinetic and/or product export limitations. Low pH capability 
influenced the thermodynamic equilibrium of the critical reaction in the inositol pathway in 
favour of product formation. Yields of FA based pathways appeared to be strongly 
dependent on the applied carbon-source and capability of acetyl-CoA recycling as a by-
product of β-oxidation. In S. cerevisiae peroxisomal pH was found to have a crucial 
thermodynamic impinge on FA energy metabolism and the reversibility of the malate 
dehydrogenase was identified as a crucial element, strongly depending on the redox-
cofactor ratio and therefore the feasibility of a large number of modes. 
The minimization of intracellular intermediate accumulation and active product export were 
identified as pivotal for any process to be successful. Despite the theoretical nature of our 
analysis or perhaps exactly due to that, we were able to identify fundamental 
predetermined restrictions for adipic acid formation, providing a profound guidance for the 
development of worthwhile bio-production. 
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2.2 Tailoring strain construction strategies for muconic acid production in 
S. cerevisiae and E. coli3 
From the holistic feasibility analysis in chapter 2.1 the undertaking arose to analyse the 
shikimate pathway based routes in depth regarding optimizations, in order to find a 
constraint that could warrant a minimum efficiency in respect to yield and therefore a 
significant improvement. Especially non-obvious knock-out targets, for application in vivo 
in different microbial production systems, were determined (Averesch & Krömer, 2014). 
2.2.1 Abstract 
There is currently a strong interest to derive the biological precursor cis,cis-muconic acid 
from shikimate pathway-branches to develop a biological replacement for adipic acid. 
Pioneered by the Frost laboratory more than two decades ago, this concept has regained 
interest. However, recent approaches suffer from low product titers and yields. Therefore, 
an in silico comparison of all strain construction strategies was conducted to highlight 
stoichiometric optimizations. Using elementary mode analysis new knock-out strategies 
were determined in S. cerevisiae and E. coli. The strain construction strategies are unique 
to each pathway-branch and organism, allowing significantly different maximum and 
minimum yields. The maximum theoretical product carbon yields on glucose ranged from 
86% (dehydroshikimate-branch) to 69% (anthranilate-branch). In most cases a coupling of 
growth to product formation was possible. Especially in S. cerevisiae chorismate-routes a 
minimum yield constraint of 46.9% could be reached. The knock-out targets are non-
obvious, and not-transferable, highlighting the importance of tailored strain construction 
strategies. 
2.2.2 Introduction 
2.2.2.1 Muconic acid production via the shikimate pathway 
Biotechnological production of ccMA recently experienced a renaissance being 
implemented in yeast (Weber et al., 2012, Curran et al., 2013) and a new route being 
introduced in E. coli (Sun et al., 2013, Lin et al., 2014, Pugh et al., 2014, Sun et al., 2014). 
From the shikimate pathway five stoichiometrically unique routes lead to ccMA (cf. Figure 
5). In this study the routes were named according to the key intermediates in the 
respective pathways: dehydroshikimate = DHS-pathway, anthranilate = ANTH-pathway, 
                                            
3
 This chapter is based on a paper published in Metabolic Engineering Communications in 2014 
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2,3-dihydroxybenzoate = DHBA-pathway, salicylate = SA-pathway and para-
hydroxybenzoate = pHBA-pathway. The latter four have in common to proceed via 
chorismate and are therefore collectively referred to as chorismate derived routes. All 
routes branch of from shikimate pathway at different intermediates (protocatechuate, 
anthranilate, isochorismate, para-hydroxybenzoate) and differ in their co-factors and co-
metabolites, which makes a significant difference for stoichiometric carbon yields as well 
as in terms of energy demand and redox equivalents required for ccMA synthesis. 
First reported in E. coli (Frost & Draths, 1996) production of ccMA from glucose branching 
off the shikimate pathway from dehydroshikimate (Figure 5a) was recently also reported in 
S. cerevisiae (Weber et al., 2012, Curran et al., 2013). The latter approaches however only 
achieved 23590- and 261-fold lower titers and marginal carbon yields (0.01% and 0.9%) 
than in the earliest study. Also novel pathways leading to ccMA further downstream in the 
shikimate pathway in E. coli via the anthranilate branch (Sun et al., 2013) (Figure 5b), 
utilizing the siderophore-biosynthesis pathway via isochorismate (Figure 5c), deriving 
ccMA from 2,3-dihydroxybenzoic acid (cI) (Sun et al., 2014) and from salicylic acid (cII) 
degradation (Lin et al., 2014) only achieved a 94-, 77- and 25-fold less ccMA titers on a 
glucose and glycerol co-feed (4%, 4.95% and 15.48% total carbon product yields 
respectively). Another shikimate pathway based route, which is a hybrid of the other 
pathways, producing ccMA from glucose via pHBA (Figure 5d) in E. coli (Sengupta et al., 
2015) achieved only a titer that was 216-fold below the benchmark, at a yield of 2.155%. 
While all these routes feature a sophisticated rearrangement of bioconversions on the way 
to ccMA, they mostly focus on the shikimate pathway locally and are based on obvious 
knock-out targets and modifications to shift flux distribution within the pathway. The only 
rational approach to incorporate modifications that are not located within the shikimate 
pathway used flux balance analysis to pursue further optimizations (Curran et al., 2013): 
When flux was directed through glucose-6-phosphate dehydrogenase (G6PD) the 
transketolase would form fructose-6-phosphate (F6P) and glyceraldehyde-3-phosphate 
from erythrose-4-phosphate and xylulose-5-phosphate. This resulted in a decreased 
theoretical carbon yield of 60.9% (Curran et al., 2013). Based on these findings pentose 
phosphate pathway was modified: Deletion of ZWF1, the gene coding for G6PD (R24 in 
supplementary file 2.2.2), would result in carbon flux to enter pentose phosphate pathway 
via transketolase (R31 in supplementary file 2.2.2). The gene coding for this (TKL1) was 
over-expressed in order to favour this. Thus, by blocking the channelling of G6P into PPP 
and favouring the conversion of pentoses into E4P, flux to the shikimate pathway would 
increase through higher E4P levels derived from F6P. 
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Other attempts that can be seen as more general approaches to metabolic engineering 
are strengthening of glutamine regeneration in order to favour anthranilate formation (R65 
in supplementary file 2.2.3) (Sun et al., 2013) and overexpression of the 
phosphoenolpyruvate synthase and transketolase 1 (Lin et al., 2014) to channel carbon 
flux to the shikimate pathway. Yet the beneficial impact of these modifications cannot be 
easily foreseen without holistic insight into the metabolism. E.g. transamination is a very 
common process in many pathways and global effects are unknown. 
Given the fact that the shikimate pathway is deeply anchored in central metabolism a more 
rational approach considering the whole metabolism at once could open unknown 
opportunities to increase production with less effort by e.g. identifying one or two essential 
knock-out targets in order to significantly minimize the possible metabolic adjustments of 
the organism and force it into a state of product formation. It may also help to identify 
crucial elements of the metabolism which serves a better understanding of its peculiarities. 
Enroute to ensure product formation on a global level, in silico modelling by means of 
RobustKnock was used to determine target reactions that would improve ccMA production 
via the pHBA pathway, if deleted. In particular, the phosphotransferase system (PTS) and 
the pyruvate kinase were identified and applied as knock-out targets, in order to increase 
PEP availability (Sengupta et al., 2015). 
Many computational approaches exist to determine knock-out targets, e.g. the bi-level 
programming frameworks OptKnock (Burgard et al., 2003), the more recent RobustKnock 
(Tepper & Shlomi, 2010) or OptFlux (Rocha et al., 2010), which combines strain 
optimization tasks with pathway analysis. A recent example for model-guided network 
engineering on yeast shikimate pathway (Brochado & Patil, 2013) shows the potential of 
these approaches. The issue with these tools is that only one particular solution is 
computed, resulting in a narrow solution space that draws an incomplete picture of the 
cells resulting metabolism, thus these tools are considered biased (Lewis et al., 2012). 
This can explain the issues of the optimization strategy in (Curran et al., 2013): Elimination 
of a route leading to a reduced maximum yield (deletion of ZWF1) is necessary, but may 
not be sufficient in order to create a metabolism that operates at high yields. It is still 
unforeseeable in which other states the cell may be able to operate, potentially evading a 
high-yield metabolism. 
This can be addressed by determining the complete solution space e.g. with elementary 
mode analysis (EMA) (Schuster & Hilgetag, 1994). In EMA, an array of flux distributions 
can be compared, which makes it possible to assess the reduction of metabolic freedom 
(minimum / maximum product / biomass yields) in favour of product formation. This 
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delivers a more universal description of the metabolisms degree of freedom after 
application of the respective deletions. Outgoing from this, a minimum efficiency network 
may be designed through minimizing the metabolic functionality. That this can be applied 
in vivo was shown in (Trinh et al., 2008). 
Elementary Mode Analysis (EMA) by means of EFMTool (Terzer & Stelling, 2008), was 
combined with a holistic approach to compute constrained minimal cut-sets (cMCs) 
(Hadicke & Klamt, 2011). These cut-sets represent all available genetic intervention 
strategies to introduce a constraint that allows a minimum efficiency greater than zero with 
respect to the desired product. That this concept can be easily transferred and applied to 
various strain optimization problems shows e.g. the study in (Gruchattka et al., 2013). A 
maximum of five gene deletions was allowed in order to keep the deletion strategy realistic 
with respect to experimental effort. 
2.2.3 Methods 
2.2.3.1 Elementary flux mode analysis 
EFMs were calculated using EFMTool 4.7.1 (Terzer & Stelling, 2008) freely available from 
http://www.csb.ethz.ch/tools/efmtool in MATLAB R2012b (The MathWorks, Natick, USA) 
on the HPC cluster (Barrine) of the University of Queensland using a node with four eight-
core X7550 CPUs @ 2 GHz and 1024 GB of 1066 MHz RAM running a PBSPro batch 
system. Each mode represents a feasible, steady-state, flux distribution of a metabolic 
network. The maximum carbon yields of the different elementary modes were calculated in 
MATLAB by drawing carbon balances around the transport reactions into and out of the 
network. The yield for each product in each mode is defined by: 
YP = vp × np / vs × ns 
vp and vs represent the flux rates for products and substrates leaving and entering the 
balance area, np and ns are the numbers of carbon atoms in the product and substrate. 
Yields were converted to percent; for a graphical depiction of the distribution of modes the 
biomass yields were plotted against the yields of the desired product for a given network. 
2.2.3.2 Construction of metabolic networks 
Stoichiometric networks of E. coli and S. cerevisiae were compiled based on literature 
(Krömer et al., 2006, Jol et al., 2012, Krömer et al., 2013) and metabolic pathway 
databases (Kanehisa & Goto, 2000, Cherry et al., 2012, Keseler et al., 2013, Caspi et al., 
2014, Kanehisa et al., 2014) and can be found in the supplementary material 
(supplementary file 2.2.1). The two different branches to ccMA via shikimate pathway were 
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compiled from literature (Draths & Frost, 1994, Sun et al., 2013) and named according to 
its branch off metabolite (DHS or ANTH). These networks contain central carbon 
metabolism, which is only comprised of glycolysis, EDP (E. coli only), PPP, TCA-cycle, 
glyoxylate cycle, anaplerosis, glutamate / glutamine interconversion, electron transport 
chain, and biomass formation which was broken down to central metabolism derived 
precursors (supplementary file 2.2.1, R95 in S. cerevisiae network and R76 in E. coli 
network). Amino acid biosynthesis was not included in the model; this concerns also 
routes to AAAs. In the case of the shikimate pathway, this already corresponds to obvious 
knock-out targets where production of AAAs and folate precursors is inhibited to direct flux 
to the sole product ccMA. 
2.2.3.3 Determination of knock-out targets 
For determination of knock-out targets, the method of constrained minimal cut-sets was 
used, as described in (Hadicke & Klamt, 2011). The desired modes were defined 
depending on the Ymax of each network: S. cerevisiae DHS-pathway modes with a 
yield > 60%, S. cerevisiae ANTH-pathway modes with a yield > 50%, E. coli DHS-pathway 
modes with a yield > 70%, E. coli ANTH-pathway modes with a yield > 45%. Of these 
"desired modes" at least 10% had to remain after application of the determined cut-sets. 
All remaining “target modes” were to be abolished. Cut-sets were calculated allowing five 
or less knock-outs with respect to the feasibility of the targets (Ruckerbauer et al., 2014): 
E.g. reactions that are catalysed by the same enzyme cannot be separate knock-out 
targets (for instance transketolase), neither can spontaneous reactions be targets (ATP 
hydrolysis). Biomass formation was also defined to be not a knock-out target, as all sets 
that abolish growth are infeasible. The reactions that are excluded from the cut-set are 
highlighted in supplementary file 2.2.1. 
2.2.4 Results 
Not only the knock-out targets but also the availability of a feasible strategy depends as 
much on the pathway as on the organism’s individual metabolism. This resulted in 
significant differences in the maximum and minimum yields that could be achieved in the 
different scenarios. 
The maximum yields of the pathways were essentially different in both organisms. The 
highest theoretical carbon yield (Ymax) of the product in respect to the substrate glucose 
was obtained for the DHS-pathway with 85.7% (0.676 gccMA/gglucose). For chorismate 
derived pathways most yields were significantly lower and varied between 68.8% 
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(0.5427 gccMA/gglucose) for the ANTH-pathway in E. coli and 80% (0.631 gccMA/gglucose) for the 
DHBA-pathway in S. cerevisiae. When comparing the two organisms, S. cerevisiae 
performed generally slightly better than E. coli. This is most significant when comparing 
the Ymax that also allows growth (formation of biomass), e.g. for the DHS-pathway Ymax 
with biomass is 5.35% lower in E. coli than in S. cerevisiae (cf. Figure 12 E vs. Figure 11 
E). All yields can be found in the figures of the respective networks EFM distribution or in 
supplementary table 1. 
For comparability with the results obtained in (Sun et al., 2013, Lin et al., 2014, Sun et al., 
2014) the Ymax’ on glucose and glycerol co-feed were calculated for E. coli. These can also 
be found in supplementary table 2. These were slightly higher (e.g. 89.6% for the DHS-
pathway and 73.3% for the ANTH pathway). Carbon-sources different to glucose were not 
subject to further analysis. 
The respective approaches failed to reach these maxima by a big margin. The dashed 
green vertical lines in Figure 11 A and B indicate the yields reached in (Weber et al., 2012) 
and (Curran et al., 2013) respectively. For the approaches in E. coli the yields are 
indicated in the same way in supplementary figure 5 A for (Niu et al., 2002), 
supplementary figure 5 D for (Sun et al., 2013), supplementary figure 5 F for (Sun et al., 
2014) and supplementary figure 5 H for (Lin et al., 2014). In order to optimize flux 
distribution of the metabolisms to favour a higher yield, knock-out targets were determined 
for each pathway in both organisms. The respective Ymax and Ymin of the knock-out 
networks are indicated on the respective figures or can be found in the supplementary 
tables 3 & 4. 
2.2.4.1 Two knock-out targets favour high yield metabolism in S. cerevisiae DHS-pathway 
The effect of the deletion of ZWF1, previously applied in vivo (Curran et al., 2013), was 
investigated. As can be seen from Figure 11 B the deletion of ZWF1, encoding for G6PD, 
(cf. supplementary file 2.2.1, R24) eliminates a large number of high biomass + low 
product yield modes, as desired. This effect can be expanded when combining a G6PD 
deficiency with a deletion of the glycerol-3-phosphate dehydrogenases (GPDH) (R43) as 
can be seen in Figure 11 D. Although this removed the bulk of modes with a product yield 
less than 40%, still a large number of modes with zero product yield remains. No cut-sets 
with five or less knock-out targets could be determined that would result in a minimum 
efficiency different from zero in respect to the product. 
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2.2.4.2 Two essential knock-outs enforce yield maximization in S. cerevisiae chorismate 
derived pathways 
For the routes via chorismate a coupling of central metabolism to product formation was 
possible, allowing the introduction of a minimum yield constraint to the metabolism. In 
particular deletion of the pyruvate kinases (PYK) (cf. supplementary file 2.2.1, R23) leaves 
no other source for cytosolic pyruvate formation than the release of pyruvate during 
product formation. The effect can be seen in Figure 11 G exemplary for the ANTH-
pathway, where a Ymin of 28.4% was obtained (DHBA-, SA- and pHBA pathway are 
analogue, cf. supplementary figure 6 & 7. When combined with a deletion of the GPDH 
(R43) (which eliminated glycerol formation) Ymin increased even further to 46.9% (Figure 
11 H). Ymax was unaffected, remaining at 65.8% with / 70.4% without formation of biomass 
(compare Figure 11 E with H). 
 
 
Figure 11: Yield vs. biomass plots of knock-out strategies for S. cerevisiae: Product vs. biomass 
yield plots of the EFM distribution of S. cerevisiae DHS-pathway networks. For each pathway four 
scenarios are shown, comparing the wild-type with the determined knock-out metabolism, key data, 
as well as respective knock-outs, are indicated on the charts. Each point in a chart corresponds to 
the specific product and biomass yield of the respective elementary flux mode. Yields are carbon 
yields in %. A dashed vertical line indicates currently achieved product yields in the respective 
approaches. 
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Figure 11 continued: Yield vs. biomass plots of knock-out strategies for S. cerevisiae: Product vs. 
biomass yield plots of the EFM distribution of S. cerevisiae ANTH-pathway networks. For each 
pathway four scenarios are shown, comparing the wild-type with the determined knock-out 
metabolism, key data, as well as respective knock-outs, are indicated on the charts. Each point in a 
chart corresponds to the specific product and biomass yield of the respective elementary flux mode. 
Yields are carbon yields in %. 
 
2.2.4.3 Constraining the minimum yield diminishes Ymax in E. coli DHS-pathway 
Four minimal cut-sets could be found that result in two different flux distributions with a 
minimum efficiency greater than zero. The knock-out of glucose-6-isomerase (GPI) and 
phosphogluconate dehydrogenase (PGD) (cf. supplementary file 2.2.1, R18 & R33) was 
essential, while the final scenarios could be obtained with the knock-out of either 
phosphoglycerate mutase (PGM) (R25) or enolase (ENO) (R26) (Figure 12 C) and 
glyceraldehyde-3-phosphate dehydrogenase (GAPDH) (R23) or phosphoglycerate kinase 
(PGK) (R24) (Figure 12 D). This results in Ymins of 71.6% and 73.3% respectively, while 
Ymax was reduced to just below 75%. No cut-set with five or less knock-outs that did not 
diminish Ymax could be found. 
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Figure 12: Yield vs. biomass plots of knock-out strategies for E. coli: Product vs. biomass yield plots 
of the EFM distribution of E. coli networks. For each pathway four scenarios are shown, comparing 
the wild-type with the determined knock-out metabolism, key data, as well as respective knock-outs, 
are indicated on the charts. Each point in a chart corresponds to the specific product and biomass 
yield of the respective elementary flux mode. Yields are carbon yields in %. 
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2.2.4.4 Alternative knock-out strategies for preservation of Ymax in E. coli 
For E. coli ANTH-pathway four cut-sets consisting of three knock-out targets analogous to 
the DHS-pathway could be found: The knock-out of the GPI and the transaldolase (TAL) 
(cf. supplementary file 2.2.1, R18 & R37) is essential, while the same redundant targets as 
in the DHS-pathway, PGM or ENO (R25 & R26) and GAPDH or PGK (R23 & R24), result 
in alternative flux distributions (Figure 12 G & H). Ymin was 44.9% and 47.5%, respectively. 
However, enforcing a Ymin also greatly reduced the number of modes and, above all, Ymax, 
which was just below 50%, almost 20% less than in the original metabolism. 
In search for knock-out targets that would preserve Ymax and result in a similar pattern as 
for S. cerevisiae, a second strategy was determined, resulting in a cut-set with five knock-
out targets. In particular, the pyruvate forming reactions of the PTS (cf. supplementary file 
2.2.1, R16), PYK (R27), 2-dehydro-3-deoxy-phosphogluconate aldolase (EDA) (R32) and 
the malic enzymes (MAE) (R54 & R55) were identified as compulsory knock-out targets 
(Figure 13 G). In addition, deletion of the fumarate reductase (FRD) (R47) allowed Ymin to 
be raised from 5.2% to 25% (Figure 13 H). This knock-out strategy was also applicable to 
the other chorismate derived pathways (cf. supplementary figure 8 & 9). 
 
 
Figure 13: Yield vs. biomass plots of alternative knock-out strategy for E. coli ANTH-pathway: 
Product vs. biomass yield plots of the EFM distribution of E. coli networks. Four scenarios are 
shown, comparing the wild-type with the determined knock-out metabolism, key data, as well as 
respective knock-outs, are indicated on the charts. Each point in a chart corresponds to the specific 
product and biomass yield of the respective elementary flux mode. Yields are carbon yields in %.  
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2.2.5 Discussion 
The advantage of the DHS-pathway over the chorismate derived pathways in terms of 
higher yield can be explained by the higher energy demand of the latter. In particular, the 
DHS-pathway has no need for co-factors other than O2 and the shikimate-pathway 
substrates PEP and E4P (cf. Figure 5). Chorismate derived pathways have direct demand 
for two NADPH and one ATP (cf. Figure 5). In addition, a second PEP is required, which is 
equivalent to the demand for two ATP (if regeneration from PYR is assumed, cf. 
supplementary file 2.2.3 R28 & R74). Indirectly the ANTH-pathway needs another ATP, as 
the transamination step (supplementary file 2.2.2 R104b, supplementary file 2.2.3 R84b) 
requires regeneration of glutamate to glutamine (supplementary file 2.2.2 R86, 
supplementary file 2.2.3 R65). This also explains the advantage of the pHBA-pathway and 
the isochorismate derived routes, as these do not involve a transamination. In addition, in 
the DHBA-pathway, which features the highest yield of all chorismate derived pathways, 
an additional redox equivalent in form of NADH is gained. 
In order to explain the low and extremely low product yields obtained by (Curran et al., 
2013) and (Weber et al., 2012), distribution of modes has to be considered with the 
objective of a microorganism in mind: Naturally it will always try to maximize its growth 
(here the biomass). Looking at the product vs. biomass yield plots (Figure 11 – Figure 13) 
it becomes clear that maximization of growth involves drain of flux from product formation, 
which is thus minimized: The two extremes high product yield and high biomass yield are 
mutually exclusive. 
The lowest carbon yield is obtained by Weber et al. (0.01%). Looking at the distribution of 
modes of the respective network (Figure 11 A) this is no surprise, as the applied strategy 
does not constrain the Ymin. (Curran et al., 2013) apply the ZWF1 knock-out, taking out the 
G6PD (Figure 11 B) in order to favour a higher carbon yield. This knock-out is also 
confirmed in this study as an essential requirement to optimize the pathway. When the 
elementary flux modes (EFMs) for this network are analysed (Figure 11 B) though, it 
becomes evident that this is not sufficient: Still every distribution of a product carbon yield 
between 0 and 85% is possible while the majority features a low yield. From a 
stoichiometric viewpoint, this can explain why the in vivo product carbon yield of Curran et 
al. (0.9%), though almost 100-fold higher than in any other study in S. cerevisiae, still 
remains below the potential of the pathway. To overcome this problem it needs to be 
approached from a different angle, in order to actually make use of the microorganism’s 
goal to maximize its growth, as explained in the following. 
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2.2.5.1 Metabolic peculiarities of S. cerevisiae facilitate knock-out strategies 
During the elementary mode analysis (EMA) it became obvious, that out of the two 
precursors for the shikimate pathway, PEP and E4P, the former is crucial. This has 
already been realized by (Niu et al., 2002) where a difference in theoretical maximum 
yields of 43% was determined, depending on the availability of PEP. For the production of 
one mol ccMA, one mol of PEP is consumed in the DHS- and two moles in the chorismate 
derived branches of the shikimate pathway while only one E4P is needed. In the pathways 
via chorismate per mol ccMA one mol PYR is released again. If PYR production in central 
metabolism is taken out, flux to product needs to be proportionally high in order to obtain 
enough PYR to feed central metabolism. Why is this knock-out strategy now so applicable 
to and effective in S. cerevisiae? The explanation lies in the nature of the eukaryote’s 
metabolism. It is possible because in yeast central metabolism no pyruvate producing 
reactions other than PYK and MAE exist. Apart from the products of shikimate pathway 
only the biosynthesis of glycine from glyoxylate, the homocysteine production through 
transsulfuration and the degradation of alanine and serine also produce pyruvate (Cherry 
et al., 2012). The anabolic pathways (glycine and homocysteine) are linked to biomass 
formation themselves and therefore cannot provide additional PYR in order to increase 
biomass formation. Alanine itself is made from PYR and therefore cannot be regarded an 
alternative source of PYR while the serine degradation pathway is used for the 
degradation of extracellular serine as the sole nitrogen source. In addition, it is unique to 
the shikimate pathway that PEP is a substrate while all other pyruvate producing reactions 
start from different metabolites. Also, the S. cerevisiae compartmentalization is an 
advantage, as the malic enzyme is localized in the mitochondria (Boles et al., 1998) it does 
not have a direct influence on the cytosolic shikimate pathway. Thus, coupling of central 
metabolism to product formation is in silico possible with deletion of only one target (PYK) 
when using pathways via chorismate for production. Not only the increase in availability of 
PEP as an educt (which is the main focus in common strain construction strategies) but 
also the formation of PYR as a by-product is essential in order to realize this knock-out 
strategy. By taking out the conversion of PEP to PYR in central metabolism the shikimate 
pathway replaces this function, thus enforcing product formation. 
2.2.5.2 Feasibility of theoretical knock-out targets for practical application 
In the strain construction strategy pictured in this study for pathways via chorismate in S. 
cerevisiae, cytosolic PYR can only be derived in combination with product formation. This 
is based on current knowledge, assuming that PYR cannot readily cross the mitochondrial 
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membrane back into the cytosol. While the structure responsible for the uptake of pyruvate 
into the mitochondria has recently been revealed (Bricker et al., 2012, Herzig et al., 2012), 
the reverse, that is the export of PYR from mitochondria into the cytosol, has not been 
reported to date. Although studies of a PYK knock-out mutant indicate that PYR formed by 
MAE in the mitochondria can have an influence on cytosolic central metabolism to some 
extent (Boles et al., 1998), growth of the mutant is only possible on lactate or ethanol and 
glycerol as carbon-source (Boles et al., 1997). Thus, even if transport of mitochondrially 
formed PYR into the cytosol would be possible, in the case of glucose feed, carbon would 
have to pass through glycolysis and the shikimate pathway with product coupling first, 
before malate would be available to MAE. Only in the case of ethanol or lactate feed flux 
could enter the TCA-cycle downstream of PYR, thus allowing circumvention of product 
formation. 
A possible concern when arguing that product formation is coupled to central metabolism 
is that formation of PYR does not occur during the final step of ccMA formation. E.g. in the 
case of the ANTH-pathway it could be sufficient for the organism to proceed to anthranilate 
in order to obtain PYR, thus rather accumulating anthranilate than ccMA. From a 
thermodynamic point of view, this is unlikely as the ΔrG'°s for the two subsequent 
reactions from anthranilate to ccMA are extremely negative (Flamholz et al., 2012), 
meaning the reaction equilibrium is largely on the product side. A high anthranilate 
concentration would even boost this, favouring the pathway to proceed to the end product 
ccMA. The same applies for the SA-pathway, while for the DHBA- and the pHBA-pathway, 
which both proceed via different isomers of dihydroxybenzoic acid, the ΔrG'° of the 
reaction to catechol is close to 0. This may give preference to the ANTH- and the SA-
pathway, although their yields are lower. 
Further concerns are related to in vivo application difficulties of the identified knock-out 
targets in S. cerevisiae. Deletion of the paralogs, which code for the two PYK isozymes 
(see supplementary table 5 for more details), results in a severe growth defect(Boles et al., 
1997). The same applies for the two GPDH isozymes (Hubmann et al., 2011). For GPDH a 
knock-down strategy exists that retains a viable metabolism while almost completely 
inhibiting glycerol formation (Hubmann et al., 2011). When combining this with an 
overexpression of the alternate PYR synthesis route (that is the product-pathway) this 
should enable growth again. In terms of PYK also regulatory factors play a role, as not 
both isozymes are always expressed to the same level at the same time (Boles et al., 
1997), so that deletion of CDC19 only could be sufficient. 
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2.2.5.3 Metabolic peculiarities of E. coli hinder knock-out strategies 
The knock-out strategy for E. coli DHS-pathway and the first one for ANTH-pathway 
similarly introduce a minimum yield constraint: Biomass formation is limited by forcing all 
flux through the EDP. For this the deletion of GPI is essential in both cases and blocks the 
entrance (R18) of glycolysis. In the DHS-pathway the oxidative part of PPP is blocked by 
knock-out of PGD (R33) (Figure 12 B); for the ANTH-pathway deletion of TAL (R37) has a 
similar effect (Figure 12 F). The four alternative knock-outs PGM, ENO, GAPDH and PGK 
(R23 – 26) constrain flux to the biomass precursor 3-PG from either side, resulting in a 
very narrow distribution of modes. This is very unrefined, resulting in a massive reduction 
of Ymax. Further, it also limits the cell’s metabolic freedom to adjust to its environmental 
settings. Therefore, the value of this strategy for in vivo application is questionable. This 
extremely constraining knock-out strategy also explains the reduction of Ymax and 
underlines that not always the most minimal intervention strategy is necessarily also the 
best. A longer cut-set can sometimes also be of advantage, as outlined in the following. 
An alternate knock-out strategy can preserve Ymax in the ANTH-pathway (and the other 
chorismate derived pathways) and results in similar coupling of growth to product 
formation as in S. cerevisiae. However, the PEP-pyruvate node in E. coli is significantly 
different from S. cerevisiae and three additional PYR producing reactions (PTS, EDA, 
MAE) besides PYK hamper the application of the same knock-out strategy. A knock-out of 
the phosphotransferase system is known in the literature (Escalante et al., 2012) allowing 
a change of glucose uptake mechanism especially if combined with overexpression of 
hexose permease (Hernandez-Montalvo et al., 2003). Also, combinations of PTS and PYK 
knock-out (Lee et al., 2005) have been applied successfully, especially in respect to the 
production of AAAs (Gosset et al., 1996, Meza et al., 2012, Papagianni, 2012). Also very 
recently the knock-out of PTS and PYK by means of ptsH, ptsI, crr, and pykF has been 
described and applied for ccMA production from pHBA (Sengupta et al., 2015). Of the 
remaining targets (EDA and MAE) each of the single knock-outs is possible (Baba et al., 
2006). However, more combinations of these knock-out targets have to our knowledge not 
been described so far. This could be due to the extensive mutations in central metabolism 
having unpredictable consequences, even though modelling predicts that the resulting 
metabolism should be viable (see supplementary table 5 for more details on genes coding 
for the respective enzymes). 
Further, the formation of succinate as a by-product has been identified as one of the major 
features in modes with low product yields (Figure 13 G). Succinate, a product of mixed 
acid fermentation in E. coli, is in these modes formed by R47 (cf. supplementary file 2.2.1). 
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It can drain carbon flux from shikimate pathway, as it is obtained from PEP in four steps 
via oxaloacetate, malate and fumarate (Thakker et al., 2012). The enzyme identified as 
knock-out target (FRD) is only active under anaerobic conditions while the TCA-cycle is 
inactive (aerobically succinate is only produced if the glyoxylate cycle is active) (Cecchini 
et al., 2002, Thakker et al., 2012). A knock-out may not be necessary as aerobic 
fermentation is obligatory for ccMA formation (in the last step oxygen is incorporated in the 
ring structure of catechol between the two hydroxyl groups, thus releasing ccMA). 
One possible approach to facilitate critical knock-outs is the knock-down of the respective 
target genes. sRNAs in E. coli can be utilized for posttranscriptional repression of a gene 
(Sharma et al., 2013). Although more tricky in prokaryotes, as the lack of a nucleus 
reduces the chance for the interaction of the sRNAs with the mRNA between transcription 
and translation, it is still a promising approach. It results in attenuation rather than full 
silencing, which can also be important to retain a basal activity of critical target genes. This 
could be combined with an inducible system (a wealth of approaches exists E. coli 
(Baneyx, 1999)) in order to further facilitate the cultivation of the strain. 
So far it has only been discussed which reactions need to be taken out additionally in 
respect to yeast in order to also couple product formation to central metabolism. But why is 
a yield reduction observed in the knock-out strategy for the DHS-pathway and the first 
ANTH-pathway knock-out strategy in E. coli (Figure 12)? This is due to limited possibilities 
to recycle PYR, which exits shikimate pathway, back into central metabolism. Of the 
replenishing reactions that fill up the PEP-pyruvate-oxaloacetate node in E. coli (Sauer & 
Eikmanns, 2005, Papagianni, 2012) only the phosphoenolpyruvate carboxykinase (PCK) 
and the PPS remain. Thus the formation of PEP can either happen from PYR at the 
expense of two ATP equivalents (PPS) or from oxaloacetate (PCK). In contrast to S. 
cerevisiae, E. coli does not possess a pyruvate carboxylase which incorporates one CO2 
into PYR to form oxaloacetate. 
Only two options remain to convert PYR to OAA: One way is to further metabolise the PYR 
via acetyl-CoA. This leads to decarboxylation. The acetyl-CoA can then only be 
assimilated via the glyoxylic shunt and one-third of the carbon is lost as CO2. The other 
possibility for PYR conversion to OAA is the reverse operation of MAE in concert with the 
malate dehydrogenase and PCK, which would lead to a carbon neutral but ATP-
dependent conversion of PYR back to PEP. Because of the lower energy demand and the 
absence of CO2 formation, the final option has a higher carbon yield. The in vivo 
observation that the MAE is up-regulated in a fully PYK deficient E. coli mutant and the 
PCK is also highly active (Emmerling et al., 2002) supports this. 
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2.2.6 Conclusion 
When using pathways via chorismate it was possible to apply a minimum yield constraint 
with as little as one knock-out in S. cerevisiae without any loss in Ymax. Although the Ymax 
of the DHS-pathway is higher, only the chorismate derived pathways allow for this strain 
construction strategy. In E. coli, five knock-outs are necessary to achieve a similar picture 
without a drop in Ymax. Therefore, yeast seems to be the favourable organism for 
production of ccMA in terms of knock-out strategies. 
This study not only highlights the importance of pathway choice, but also clearly points out 
how differences in central metabolism of the host organism can affect a synthetic pathway. 
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2.3 Application of in silico determined knock-out targets for production of para-
hydroxybenzoic acid4 
The approach described in chapter 2.2 is transferrable to other shikimate pathway derived 
metabolites that also involve the formation of pyruvate as a by-product. For the production 
of pHBA from shikimate pathway in S. cerevisiae, the strategy was applied in vivo using 
gene silencing under the control of a synthetic circuit (Williams et al., 2013) that enabled 
dynamic metabolic pathway control (Williams et al., 2015). 
2.3.1 Abstract 
Some of the most productive metabolic engineering strategies involve genetic 
modifications that cause a severe metabolic burden on the host cell. Constraining genetic 
modifications, including those limiting growth, can be more effective if they are ‘switched 
on’ after a population growth phase has been completed. This can be achieved by means 
of dynamic regulation using a synthetic quorum sensing circuit previously established in S. 
cerevisiae. The circuit autonomously triggers gene expression at a high population density, 
and was linked with an RNA interference module to enable target gene silencing. The 
circuit was used to control flux through the shikimate pathway for the production of para-
hydroxybenzoic acid (pHBA). Dynamic RNA repression allowed gene knock-downs which 
were identified by elementary flux mode analysis as highly productive but with low biomass 
formation to be implemented after a population growth phase, resulting in the highest 
published pHBA titer in yeast (1.1 mM). 
2.3.2 Introduction 
The metabolic engineering which is required to over-produce many commercially valuable 
bio-products at high yields can impose a severe metabolic burden on native cellular 
processes (Bentley et al., 1990, Lee et al., 2008), limiting population growth and therefore 
product titer. This is because engineered pathways compete with native metabolism for 
carbon flux, ATP, and redox cofactors, and can result in the accumulation of toxic 
compounds (Keasling, 2008, Lee et al., 2008). Furthermore, many of the most productive 
gene deletion or overexpression strategies identified by in silico modelling are not feasible 
for constitutive application in vivo due to the limitations they impose on cell growth or 
survival. This study demonstrates that this problem can be overcome by largely separating 
                                            
4
 This chapter is based on a paper published in Metabolic Engineering in 2015 
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growth phases from production using an autonomous genetic regulatory circuit, which 
enables dynamic modulation of gene expression. 
The number of well-characterized genetic induction systems in S. cerevisiae is limited. 
Most popular are the GAL promoters and the heterologous doxycycline responsive Tet 
promoters (Blount et al., 2012). These systems are inherently limited by the requirement 
for the addition of expensive inducers to the media, and in the case of the GAL promoters 
by the repression of gene expression on glucose. Furthermore, they do not truly separate 
growth from production since cell-cycle continues when gene expression is induced. In this 
study, the use of a recently developed synthetic quorum sensing circuit (Williams et al., 
2013) for the dynamic control of metabolism and the separation of growth and production 
phases in yeast via a cell-cycle arrest phenotype was investigated. 
In nature, many microorganisms are able to coordinate population-wide gene expression 
according to population density via cell-to-cell communication with extracellular signalling 
molecules. This phenomenon, termed ‘quorum sensing’ (QS) holds promise as a 
mechanism for separating growth from production in industrial microorganisms for the 
production of growth-limiting compounds (Choudhary & Schmidt-Dannert, 2010) and QS 
has been explored for application in biotechnology (March & Bentley, 2004, Tsao et al., 
2010, Song et al., 2011). A previously developed QS circuit enables the spatiotemporal 
control of gene expression, and is activated using an ‘AND’ gate system requiring both 
high population density and the presence of low concentrations of AAAs in the media. One 
limitation of the pheromone QS circuit is the lack of a mechanism for repression or 
silencing of gene expression. To enable the dynamic repression of gene expression the 
QS circuit was interfaced with an RNA interference (RNAi) module (Drinnenberg et al., 
2009). This RNAi module has the potential to repress the translation of any mRNA via the 
transcription of simple hairpin RNA constructs which target mRNAs for degradation 
according to simple base-pair complementarity. 
As a mechanism for dynamic pathway control and product formation the pheromone QS 
system was used to apply a novel, in silico determined, knock-out strategy for production 
of para-hydroxybenzoic acid (pHBA) in S. cerevisiae, which would result in vivo in a severe 
growth defect on glucose if applied constitutively (Averesch & Krömer, 2014). It is not only 
unique to shikimate pathway derived products that involve the formation of pyruvate as a 
by-product, but also to the organism S. cerevisiae (Averesch & Krömer, 2014), thus 
making the RNAi interfaced S circuit the ideal system to test it. 
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2.3.3 Materials and Methods5 
2.3.3.1 Elementary flux mode analysis 
EFMs were calculated using EFMTool 4.7.1 (Terzer & Stelling, 2008) freely available from 
http://www.csb.ethz.ch/tools/efmtool in MATLAB R2014a (The MathWorks, Natick, USA) 
on a desktop computer (Intel Core i7-4770 CPU @ 3.4 GHz and 32 GB RAM). The 
maximum carbon yield of the different elementary modes was calculated in MATLAB by 
drawing carbon balances around the transport reactions into and out of the network. The 
stoichiometric network analysis of S. cerevisiae was based on a previously published 
study (Averesch & Krömer, 2014). The metabolic network can be found in the 
supplementary material, it comprises the central carbon metabolism as well as the 
chorismate biosynthesis and a chorismate lyase (ubiC) reaction that catalyses pHBA 
formation from chorismate. 
2.3.4 Results and Discussion 
2.3.4.1 Strain design and metabolic network modelling 
The most promising targets for gene knock-out to enhance flux towards pHBA carry a 
severe growth penalty. In earlier studies the knock-out of ARO7 (encoding chorismate 
mutase) and TRP3 (encoding anthranilate synthase) has been described as a way to 
increase chorismate availability for pHBA formation (Krömer et al., 2013). However, this 
strategy also causes phenylalanine, tyrosine and tryptophan auxotrophy and the 
associated growth defect, even when cells are fed these amino acids (Winter et al., 2014). 
To avoid the auxotrophies associated with gene deletion during the growth phase, these 
mutations were selected for conditional knock-down using a novel QS circuit (Williams et 
al., 2013) combined with RNAi. However given that the QS circuit is activated by the 
presence of tryptophan in the growth medium, and considering that tryptophan causes 
strong feedback inhibition of anthranilate synthase (Miozzari, et al., 1978, Graf, et al., 
1993), targeting of anthranilate synthase (TRP3) was not necessary. 
In addition to the targeting of ARO7 an advanced genetic intervention strategy that would 
more radically affect metabolism on a global cellular level and ensure pHBA production 
was identified. Using a metabolic modelling approach a stoichiometric model of central 
carbon metabolism, that already had the chorismate mutase (ARO7) and anthranilate 
                                            
5
 For materials and methods of work performed by other contributors to this study (media, growth conditions, 
strains and plasmids, analytics, quantitative real-time PCR, enzyme assays and statistical analysis) refer to 
the full manuscript in the supplementary. 
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synthase (TRP3) knock-outs applied, was subject to elementary flux mode analysis. A 
single target reaction was identified to significantly constrain the system: The knock-out of 
the pyruvate kinase reaction (catalysed by the homolog gene products of CDC19 and 
PYK2) would result in a minimum efficiency of the metabolism in respect to product 
formation. This becomes evident from Figure 14, where the biomass yield of all possible 
flux distributions is plotted against the carbon yield: While in Figure 14 A the pHBA yield is 
not restricted and can be zero, the knock-out of the pyruvate kinase (Figure 14 B) results 
in the introduction of a minimum yield constraint. The underlying fundamentals of this 
effect are the same as explained in-depth in chapter 2.2. As an inevitable side effect, 
maximum biomass yield is also affected, being more than halved. Consequentially CDC19 
mutants are growth impaired when glucose is the sole carbon-source (Sprague, 1977). 
Thus, traditional gene deletion is not feasible for glucose-based fermentations, which are 
favoured at large scale due to feedstock cost and availability. It was, therefore, essential to 
implement pyruvate kinase repression dynamically along with chorismate mutase (ARO7) 
repression. 
 
Figure 14: Elementary flux mode distribution of knock-out networks. Each point in a plot represents a 
feasible flux distribution (elementary mode) the cell can operate in. Elementary modes are shown 
with relative contributions to biomass (y-axes) and product formation (x-axes) for a network of S. 
cerevisiae on glucose as the carbon-source with (A) chorismate mutase and anthranilate synthase 
knock-outs and with (B) pyruvate kinase also removed. The deletion of the pyruvate kinase function 
results in coupling of growth (biomass formation) to product formation. This confers a minimum 
productivity to the metabolism in respect to pHBA formation, even in a state of growth arrest 
(biomass yield = 0). 
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2.3.4.2 Interfacing pHBA production with the QS regulatory network and RNAi 
Argonaute (AGO1) and Dicer (DCR1) genes from the related yeast S. castelii were 
imported into S. cerevisiae, so that mRNAs could be targeted for degradation via the 
transcription of double-stranded hairpin RNA with complementarity to the target 
(Drinnenberg et al., 2009). 
Expression of the relevant genes to establish transcription of hairpin RNA constructs and 
enhanced pHBA production was required to be controlled by the pheromone responsive 
FUS1J2 promoter (Ingolia & Murray, 2007). When an AAA such as tryptophan is present in 
the medium the α-pheromone peptide is expressed from the ARO9 promoter and secreted 
from the cell (Williams et al., 2013). At a high population density the extracellular 
pheromone triggers gene expression from the FUS1J2 promoter and causes cells to arrest 
growth in the G1 phase of the cell-cycle (cf. full manuscript in supplementary for a detailed 
description of the circuit). This mechanism serves the decoupling of population growth and 
production phases, allowing growth limiting engineering strategies to be implemented. 
During the pheromone auto-induced growth arrest, pHBA production is switched on 
(Figure 16) via the expression of the relevant pathway genes and RNAi repression 
constructs from the FUS1J2 promoter. Specifically, several pathway enzymes were 
dynamically expressed along with the knock-down targets (Figure 15). Previous work has 
identified TKL1p and the feedback-inhibition resistant ARO4K229Lp as important enzymes 
for the production of shikimate-derived compounds (Luttik et al., 2008, Curran et al., 2013). 
Finally ubiCp, the enzyme that catalyses pHBA production from chorismate (Siebert et al., 
1994), was also expressed under QS regulation to dynamically control production. 
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Figure 15: The shikimate pathway feeds AAA biosynthesis using PEP and E4P. The supply of these 
precursors was increased by overexpressing TKL1 and targeting CDC19 for repression using RNA 
interference. In order to enhance flux through the shikimate pathway in response to pheromone, a 
feedback resistant version of ARO4 (K229L) was placed under the control of the FUS1J2 promoter. S. 
cerevisiae has no known native enzyme for pHBA formation, therefore, a codon optimised version of 
the E. coli chorismate pyruvate lyase (ubiC) was incorporated under the control of the FUS1J2 
promoter to catalyse pHBA formation from chorismate. Chorismate availability was increased via the 
expression of an RNAi repression construct for ARO7. 
 
 
Figure 16: As a quorum sensing population grows over time the concentration of α-pheromone 
increases. At a high population density a critical α-pheromone concentration is reached which 
triggers gene expression from pheromone responsive promoters. Cells arrest growth and switch on 
the production of pHBA as part of a coordinated production phase (figure by (Williams et al., 2015)). 
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2.3.4.3 Stepwise verification of modification for improved pHBA production 
pHBA titers were measured with and without QS activated in the same strain after the 
introduction of each genetic modification (Figure 17). In every case pHBA production was 
significantly lower without the activation of the QS circuit, demonstrating the dynamic 
functionality and range of the engineered regulation. 
QS-mediated expression of a codon-optimised E. coli chorismate lyase (ubiC) in strain 
PHB04 resulted in pHBA production reaching 46 µM. This was a 77% increase over the 
tryptophan-treated control strain (PHB03), which contained only the QS and RNAi modules 
and produced endogenous levels of pHBA (Figure 17). The addition of purified α-
pheromone to yeast cultures has previously been shown to result in cell death while 
deletion of the FUS1 gene (involved in facilitating membrane fusion of mating partners) 
reduced mortality from 30% of a population to 5% (Zhang et al., 2006). Given that the QS 
system relies on the production of α-pheromone it was possible that cell death in response 
to pheromone would limit pHBA production. Therefore increased pHBA production in a 
quorum sensing strain which had the FUS1 gene deleted was expected (PHB05). 
Interestingly, pHBA accumulation was not significantly different from PHB04. This 
suggests that cell death in response to pheromone was not a limiting factor in this system. 
The additional QS-mediated expression of a feedback resistant 3-deoxy-D-arabino-
heptulosonate-7-phosphate (DAHP) synthase enzyme (ARO4K229L) increased PHBA titer a 
further 5.7-fold to 297 µM (Figure 17; strain PHB06). This is consistent with previous data 
showing that over-expression of ARO4K229L enhances flux through the shikimate pathway 
4-5 fold (Luttik et al., 2008). 
All strains carried an RNAi module (in the form of Argonaute and Dicer genes). When an 
ARO7-targeted RNAi hairpin was expressed, pHBA titer increased 80% (in respect to 
PHB06) to 534 µM (Figure 17, strain PHB07). This suggests that conditional repression of 
Aro7p during the production phase increases chorismate availability for the ubiCp enzyme 
(Figure 15). 
It has previously been demonstrated that the overexpression of TKL1 re-wires pentose 
phosphate pathway flux to increase erythrose 4-phosphate supply to the shikimate 
pathway (Curran et al., 2013). When pheromone-responsive TKL1 expression was 
introduced, pHBA titer increased by further 49% to 795 µM (strain PHB08). Expression of 
TKL1 also increased the pHBA titer in the non-QS-activated control cultures, although this 
effect was not as prominent in subsequent strains. This effect can be attributed to the 
combinatorial leaky expression of pathway components from the FUS1J2 promoter. 
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In order to fully exploit the use of dynamic regulation, the CDC19 gene was conditionally 
repressed. CDC19 encodes a pyruvate kinase enzyme; ΔCDC19 strains are not viable for 
growth on glucose (Giaever et al., 2002). QS-linked RNAi-mediated repression of CDC19 
resulted in a further 35% increase in pHBA titer over the previous strain (PHB08), to 1070 
µM (Figure 17; strain PHB10). This proved that the in silico determined knock-out strategy 
is valid in vivo. This final strain represented a 37-fold increase in titer over the base strain 
(PHB03), and a yield of 4.93 mg/gGlucose. 
 
Figure 17: pHBA titers of shake-flask 
fermentations using quorum sensing 
mediated modulation of target genes. 
Black bars indicate active QS while 
grey bars indicate inactive QS. Light 
squares represent the absence of the 
listed modification while tinted 
squares indicate the presence. ubiC, 
ARO4
K229L
 and TKL1 were up-
regulated, while ARO7i and CDC19i 
represent the introduction of RNAi 
hairpins which target the 
corresponding genes for repression. 
ΔFUS1 indicates the absence of the 
gene (deletion). Strain names are 
listed below each column. The control 
strain PHB03 only had a QS circuit 
and RNAi module (figure reproduced 
from (Williams et al., 2015)). 
 
2.3.4.4 Validation of separated growth and production 
Correlating growth and production profiles of PHB10 over the course of the fermentation 
verified that the rate of pHBA production was highest when cell division arrested due to 
induction of QS by means of a sharp increase in pHBA concentration (data not shown, cf. 
full manuscript in supplementary). Without QS activation the same strains grew to a higher 
population density. However QS populations continued to increase in optical density due 
to increasing cell size, but ultimately reached a much lower level than non-QS populations 
due to the arrest of cell division. This is due to cells continuing to grow larger than their 
counterparts in non-QS populations while arrested in G1 phase (Bardwell, 2005). 
 - 65 - 
2.3.4.5 Level of repression and residual enzyme activity of knock-down targets 
RNAi module functionality was examined by means of the level of target gene mRNA 
using RT-qPCR. ARO7 and CDC19 mRNA levels were compared between the final 
production strain (PHB10) and a strain with no hairpin RNA expression constructs but 
which is otherwise identical (PHB11, cf. full manuscript in supplementary). 
Expression of the ARO7 RNAi construct appeared to be leaky, as mRNA levels of ARO7 
were already significantly lower compared to the control, prior to induction. This was 
surprising given that the FUS1J2 promoter is known to have very low basal expression 
levels in the absence of pheromone (Ingolia & Murray, 2007) but reflects the sensitivity of 
the RNAi system, which was previously noted for its extreme leakiness (Drinnenberg et al., 
2009). CDC19 mRNA levels were not significantly different compared to the control. This 
difference can be attributed to the fact that CDC19 transcript was highly abundant: mRNA 
levels were 132 times higher than those observed for ARO7 prior to the activation of QS, 
so that leaky expression was insufficient to repress CDC19 (before QS activation). 
When QS response was fully activated, there was significant further repression of ARO7 
mRNA, and repression of CDC19 mRNA was evident. Late in the fermentation ARO7 and 
CDC19 repression decreased. This was most likely due to weaker hairpin expression from 
the FUS1J2 promoter as cells become gradually desensitized to pheromone over time 
(Bardwell, 2005). 
Further enzyme activity assays were used to assess whether the RNAi system was 
effectively decreasing protein levels for the target genes, as protein abundance and mRNA 
levels are often not well correlated in yeast (Greenbaum et al., 2003). Chorismate mutase 
(ARO7p) activity was significantly reduced to 17.6% of that observed in the control strain. 
Pyruvate kinase (result of CDC19p and PYK2p) activity was reduced to 11.1% of the 
control (cf. full manuscript in supplementary for details). 
2.3.4.6 Correlation of in vivo results with metabolic modelling 
Although the dynamic repression of the essential CDC19 gene resulted in a significant 
increase in pHBA titer, the yield was nowhere near that predicted by elementary mode 
analysis of the pyruvate kinase knock-out (Figure 14, ≥ 30% carbon yield when pyruvate 
kinase reaction is removed) whereas the carbon yield obtained using RNAi knock-down of 
CDC19 was 0.75% [C-mol/C-mol] of glucose). This can be attributed to several factors, 
first of all the dynamic RNAi approach did not completely remove target mRNA from the 
system, even though there was a dramatic repression effect. Although CDC19 was 
effectively repressed by the hairpin construct, there was still residual pyruvate kinase 
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activity. This may be attributed to the expression of the CDC19 paralog PYK2, which is 
transcriptionally de-repressed under low glucose conditions (Boles et al., 1997). Rather 
than a knock-out this knock-down was anticipated and intended to support the viability of 
the induced cells. Other explanations for the discrepancy between theoretical and actual 
yields regard the assumptions taken by the modelling approach. Namely, steady-state 
growth with glucose as the sole carbon-source, further enzyme kinetics and product 
inhibition are not considered. These assumptions are violated by the dynamic nature of the 
system, the fact that little is known about any metabolic perturbations associated with the 
unique pheromone response phenotype and G1 cell-cycle arrest, and the shift from 
glucose to ethanol consumption. In fact, when assuming ethanol as sole carbon-source in 
elementary mode analysis, the minimum yield is reduced to 1.5% (Figure 18), which is 
significantly closer to what has been observed. This makes sense, as the knock-downs, 
and therefore, the pHBA production phenotype, are only fully active after a certain growth 
phase, where presumably a major fraction of glucose already has been consumed (without 
significant amounts of pHBA being produced) and / or converted into ethanol, which 
serves as carbon-source after the diauxic shift. 
 
 
Figure 18: Elementary flux mode distribution of knock-out networks. Each point in the plot 
represents a feasible flux distribution (elementary mode) the cell can operate in. Elementary modes 
are shown with relative contributions to biomass (y-axes) and product formation (x-axes) for a 
network of S. cerevisiae on ethanol as carbon-source with (A) chorismate mutase and anthranilate 
synthase knock-outs and with (B) pyruvate kinase also removed. The coupling of growth (biomass 
formation) to product formation by deletion of the pyruvate kinase function confers a minimum 
productivity to the metabolism in respect to pHBA formation, even in a state of growth arrest 
(biomass yield = 0). 
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The reason, why on ethanol still a minimum constraint, although lower than on glucose, 
exists, lies in the fact that S. cerevisiae is a compartmentalized organism. This means that 
firstly not all central metabolism reactions, especially those of TCA-cycle, are present in 
mitochondria and cytosol, and secondly not all metabolites are transportable between the 
compartments. If now ethanol feeds via acetyl-CoA directly into the TCA-cycle, 
intermediates can transfer into the mitochondrion and PYR can again be derived via the 
malic enzyme. This explains the lower minimum yield. However, only the mitochondrial 
(although the major) share of the PYR required for biomass formation can be obtained this 
way. PYR is not easily transportable from the mitochondria back into the cytosol, and no 
other reaction that delivers PYR exists in the cytosol (Averesch & Krömer, 2014). PEP, 
however, can be formed in the cytosol by phosphoenolpyruvate carboxykinase. 
Conversion of cytosolic PEP to PYR can still only proceed via shikimate pathway in 
combination with product formation. This explains why still a minimum yield constraint 
exists. For details on the biochemical and transport reactions present in S. cerevisiae 
central metabolism refer to the metabolic network, supplementary file to the manuscript 
incorporated in this chapter and further the metabolic maps, supplementary files to the 
manuscript incorporated in chapter 2.2. 
2.3.5 Conclusion 
Strain construction strategies that evoke a tight metabolic constraint in order to maximize 
product formation inevitably achieve this on the cost of growth. Separating growth from 
production using dynamic regulation of metabolism is a promising approach to implement 
genetic modifications that are difficult or inconvenient to be implemented constitutively. 
The principal barrier to realizing dynamic metabolic control in yeast has been the lack of 
suitable mechanisms for both activating and repressing gene expression. The QS-linked 
RNAi circuit is capable of achieving these objectives, allowing both the expression and/or 
repression of genes that would normally prevent biomass accumulation (and hence 
product titer if controlled constitutively). Using this system, populations maintain normal 
growth prior to the activation of quorum sensing and the cell-cycle arrested production 
phase. The maximum titer of 1.07 mM (148 mg/L) was only obtained when combining 
shikimate pathway modifications with the in silico determined global genetic intervention 
strategy, proving the in vivo validity of the determined targets. This 37-fold improvement 
over the base strain also represents the highest recorded pHBA level in S. cerevisiae, with 
previous efforts using extended bioreactor fermentation resulting in a titer 0.65 mM 
(Krömer et al., 2013). 
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2.4 Production of para-aminobenzoic acid in Saccharomyces cerevisiae6 
For the production of pABA the same genetic intervention strategy that couples 
product formation to growth holds valid, however, application in vivo appeared to be 
hampered significantly by the insufficiency of flux to pABA and therefore PYR 
availability. Thus, focus was here on improving the channelling of flux through 
shikimate pathway and maximizing pABA formation. 
2.4.1 Abstract 
Biological production of the aromatic compound para-aminobenzoic acid (pABA) is of 
great interest to the chemical industry. Besides its application in pharmacy and as a 
crosslinking agent for resins and dyes pABA is a potential precursor for the high-
volume aromatic feedstocks terephthalic acid and para-phenylenediamine. The yeast 
S. cerevisiae synthesises pABA in the shikimate pathway: Outgoing from the central 
shikimate pathway intermediate chorismate, pABA is formed in two enzyme-
catalysed steps, encoded by the genes ABZ1 and ABZ2. In this study S. cerevisiae 
metabolism was genetically engineered for the overproduction of pABA. Using in 
silico metabolic modelling an observed impact of carbon-source on product yield was 
investigated and exploited to optimize production. 
A strain that incorporated the feedback resistant ARO4K229L and deletions in the 
ARO7 and TRP3 genes, in order to channel flux to chorismate, was used to screen 
different ABZ1 and ABZ2 genes for pABA production. In glucose based shake-flasks 
fermentations the highest titer (600 µM) was reached when over-expressing the 
ABZ1 and ABZ2 genes from the wine yeast strains AWRI1631 and QA23, 
respectively. In silico metabolic modelling indicated a metabolic advantage for pABA 
production on glycerol and combined glycerol-ethanol carbon-sources. This was 
confirmed experimentally, the empirical ideal glycerol to ethanol uptake ratios of 1:2 
– 2:1 correlated with the model. A 13C tracer experiment determined that up to 32% 
of the produced pABA originated from glycerol. Finally, in fed-batch bioreactor 
experiments pABA titers of 1.73 mM (237 mg/L) and carbon yields of 2.64% could be 
achieved. 
                                            
6
 This chapter is based on a manuscript revised and resubmitted to Microbial Cell Factories in 2016, 
paper currently under review 
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In this study, a combination of genetic engineering and in silico modelling has proven 
to be a complete and advantageous approach to increase pABA production. 
Especially the enzymes that catalyse the last two steps towards product formation 
appeared to be crucial to direct flux to pABA. A stoichiometric model for carbon-
utilization proved useful to design carbon-source composition, leading to increased 
pABA production. The reported pABA concentrations and yields are, to date, the 
highest in S. cerevisiae and the second highest in a microbial production system, 
underlining the great potential of yeast as a cell factory for renewable aromatic 
feedstocks. 
2.4.2 Introduction 
2.4.2.1 Significance of bio-derived aromatic feedstocks for chemical industry 
Microbial metabolic pathways give rise to many compounds that can potentially 
substitute currently petroleum-based chemicals with bio-derived ones or replace 
them with bio-based alternatives. Using metabolic engineering these capabilities are 
already being exploited to create new organisms that use abundant and renewable 
feedstocks to efficiently produce an expanding spectrum of valuable chemicals (Jang 
et al., 2012, Chen & Nielsen, 2013, Becker & Wittmann, 2015). In particular 
aromatics have great potential for bio-based production as the shikimate pathway 
gives rise to a wealth of aromatics and derived compounds, with diverse applications 
in different industries, including the chemical one (Hansen et al., 2009, Curran et al., 
2013, Krömer et al., 2013, Jendresen et al., 2015, Rodriguez et al., 2015, Williams et 
al., 2015). The shikimate pathway intermediate para-aminobenzoic acid (pABA) is 
one of these aromatics with versatile applicability. 
2.4.2.2 Aromatic compounds derived from yeast shikimate pathway 
pABA is naturally produced by yeast as an intermediate in the shikimate pathway, 
the central metabolic route leading to the formation of the AAAs phenylalanine, 
tyrosine, and tryptophan (Braus, 1991). A simplistic reproduced of the pathway can 
be found in Figure 6. Outgoing from chorismate the AAAs and pABA are formed, 
synthesis of the latter is comprised of two key enzymes encoded by the genes ABZ1 
(aminodeoxychorismate synthase) and ABZ2 (aminodeoxychorismate lyase). 
Regulation of the shikimate pathway is tightly controlled by its end-products, 
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foremost by inhibition of its initial step by phenylalanine and tyrosine (Luttik et al., 
2008). However, a point mutation in the ARO4 gene (leading to a changed amino 
acid sequence, ARO4K229L) has been reported that makes the gene product largely 
resistant to feedback inhibition (Luttik et al., 2008). 
Despite the biosynthesis route to pABA being present in S. cerevisiae, common 
laboratory strains like S288c and CEN.PK derived ones, suffer a growth deficit if 
pABA is omitted from media, supposedly due to reduced functionality of the ABZ1 
gene (Ambroset et al., 2011). In the comparative study that examined this, it was 
also found that the wine yeast EC1118 carries a more functional version of this gene 
(Ambroset et al., 2011). In fact, a previous study on pABA production in S288c 
showed that overproduction could be achieved using the ABZ1 gene from the wine 
yeast AWRI1631, which is identical to the EC1118 one (Krömer et al., 2013). The 
study identified yeast as a suitable host, with regard to in silico determined 
theoretical maximum yields (0.53 g/gGlucose) and in vivo toxicity limits (50% growth 
rate reduction at 0.62 g/L) (Krömer et al., 2013). However, the production was 
moderate (250 µM), raising the question, if ABZ2 might be currently limiting pABA 
production in yeast. Recently overproduction was reported in E. coli (4.8 g/L) where 
also the choice of the bacterial analogues to ABZ1 and ABZ2 (pabA & pabB / pabAB 
and pabC) was shown to be crucial (Koma et al., 2014). 
In the present study overproduction of pABA in S. cerevisiae from different carbon-
sources is improved using genetic engineering and metabolic modelling. In 
particular, the metabolic bottleneck to pABA formation from chorismate and the use 
of glycerol as an alternative carbon-source were investigated. Glycerol is a by-
product of both the biodiesel and the bioethanol industries and is considered an 
inexpensive and sustainable feedstock that does not directly compete with resources 
of the food industry (da Silva et al., 2009, Clomburg & Gonzalez, 2013). In this study 
a mixed glycerol-ethanol (GLY/ETH) feed with a high glycerol-share was used to 
maximize pABA production and yield. 
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2.4.3 Materials and Methods 
2.4.3.1 Metabolic network analysis 
Metabolic modelling was conducted by means of elementary mode analysis using 
EFMTool (Terzer & Stelling, 2008). The framework was modified from what has been 
described before (Averesch & Krömer, 2014). In particular, metabolic networks were 
amended with additional reactions for pABA formation and glycerol / ethanol uptake. 
The networks are given in supplementary file 2.4.2. 
2.4.3.2 Media and strain maintenance 
S. cerevisiae strains were propagated on yeast extract peptone dextrose (YPD) 
medium, 1 L was composed of 10 g yeast extract, 20 g peptone and 20 g dextrose 
(D-glucose) in H2O. For strain construction the antibiotics G418 (geneticin) and 
clonNAT (nourseothricin) were added into the medium to final concentrations of 200 
mg/L and 100 mg/L, respectively. Also for strain construction as well as maintenance 
selective synthetic complete medium was used. It was made up from 6.8 g/L yeast 
nitrogen base without amino acids (Y0626 Sigma) and 1.92 g/L drop-out supplement 
without uracil (Y1501 Sigma) with 20 g/L glucose or 10 g/L glycerol and 30 g/L 
ethanol as carbon-source. Solid media contained 20 g/L agar. 
For cultivation of yeast chemically defined minimal medium (CDM) was used, 1 litre 
was composed of: 2 g (NH4)2SO4, 1 g (NH4)2HPO4, 5.28 g NaH2PO4, 0.5 g MgSO4⋅7 
H2O, 0.015 g EDTA, 1 g KCl, 0.15 g CaCl2⋅2 H2O, 0.85 g Na2HPO4 amended with 
trace elements and vitamins in aqueous solution. Trace elements (per 1 litre H2O): 
4.5 mg ZnSO4⋅7 H2O, 3 mg Fe(III)Cl3⋅6 H2O, 1 mg H3BO3, 0.85 mg MnSO4⋅H2O,0.4 
mg NaMoO4⋅2 H2O, 0.3 mg CoCl2⋅6 H2O, 0.3 mg CuSO4⋅5 H2O, 0.1 mg KI. Vitamins 
(per 1 litre): 3 mg myo-inositol, 1 mg calcium D-pantothenate, 0.3 mg thiamine 
hydrochloride, 0.075 mg pyridoxine hydrochloride, 0.0015 mg D-biotin. In the case of 
the knock-out strain 76 mg/L tyrosine, phenylalanine and tryptophan were 
supplemented, while for the background strain 0.2 mg/L pABA were essential for 
growth. The pH was adjusted to 6, carbon-sources were glucose (GLC) glycerol 
(GLY), ethanol (ETH) or a glycerol-ethanol mix (GLY/ETH) with amounts as given in 
Figure 21 for the respective experiments. For the tracer experiments 20 g/L fully 
labelled U-13C glucose (Cambridge Isotope Laboratories, Tewksbury, MA) or 2 g/L of 
fully labelled 13C ethanol (99%, ICON isotopes, Summit, NJ) and 20 g/L unlabelled 
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glycerol were used as carbon-source. Medium for the constant-feed bioreactor 
experiment initially contained the two-fold ammonium source and 20 g/L glycerol + 
10 g/L ethanol. The feed solution was CDM +ETH with the two-fold ammonium 
source and 10% ethanol (v/v). For the pulse-feed fermentation, the C-source was 
changed to 10 g/L glycerol + 30 g/L ethanol. The three feed pulses were of different 
composition to suit the demands of the fermentation: The first was a 0.76 g/L AAA 
stock solution, the second CDM +ETH with 100 g/L ethanol and 0.38 g/L AAAs, the 
third was GLY+ETH 1:2 (w/w). 
E. coli plasmid maintenance strains were cultivated in lysogeny broth (LB) 
supplemented with 100 mg/L ampicillin. Strains were grown at 30°C with 200 rpm 
orbital shaking. All cryo-cultures were stored in 25% glycerol at -80°C. 
2.4.3.3 Strain and plasmid construction 
Strain construction was based on the S. cerevisiae strain CEN.PK113-5D. ABZ1 and 
ABZ2 genes originated from different sequenced and commercially available wine 
yeast strains ( 
Table 5). Cloning was routinely conducted following standard protocols (White, 2008) 
and using enzymes obtained from New England Biolabs to manufacturer 
instructions. In particular Q5® Hot Start High-Fidelity DNA Polymerase and High-
Fidelity (HF®) Restriction Endonucleases were used. For sub-cloning, the E. coli 
strain DH5α was utilized. Plasmids and PCR products were purified using the 
Thermo Scientific GeneJET Plasmid Miniprep and PCR Purification Kits. Cloned 
PCR products were verified by sequencing (Sanger service by AGRF, Brisbane, 
AU). 
The TRP3 deletion was carried out by replacing the target gene via homologous 
recombination, integrating the natMX antibiotic marker as described in (Güldener et 
al., 1996) using the lithium acetate method to transform the cells (Gietz & Woods, 
2002). Successful integrations / deletions were verified by PCR using primers 
binding inside and outside of the target / marker gene (verA – verD) as outlined in 
(Güldener et al., 2002). The same principles were used for ARO7 deletion / 
ARO4K229L integration with a few differences: After incorporating the point mutation in 
codon 229 of the original ARO4 (as already described in (Williams et al., 2015)), 
which changes the respective amino acid residue from Lys to Leu and renders the 
protein feedback inhibition resistant, it was cloned to pCV3. The plasmid pCV3-
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ARO4K229L was used directly to obtain an integration cassette comprised of the 
ARO4K229L gene fused with the POL4 terminator and the kanMX marker that would 
integrate at the ARO7 locus, thus replacing it and putting the ARO4K229L under the 
control of the ARO7 promoter, simplifying experimental efforts. The constructed 
strain (CEN.PK113-5D Δtrp3::natMX Δaro7::kanMX-ARO4K229L, PABA0) served as 
the host for the pABA expression plasmids. 
Plasmid vectors for expression of the genes for pABA formation from chorismate 
were constructed based on pSP-G1 (Partow et al., 2010). The ABZ1 genes were 
always cloned to the TEF1 promotor’s multi-cloning site while the ABZ2 genes were 
cloned into the PGK1 promotor’s polylinker. The primers used to amplify the 
respective integration / deletion cassettes and cloning inserts were purchased from 
Integrated DNA Technologies, the sequences can be found in Table 3. For cloning, 
standard desalted primers were used, while for deletion / integration PAGE-purified 
primers proved to be significantly more efficient. 
Vectors were constructed in a way that allowed conclusive comparison of the 
different genes against each other without having to compare each gene separately. 
Plasmids used in this study are given in Table 4. The plasmids were transformed to 
the PABA0 strain, genotypes of the final transgenic production strains (CEN.PK113-
5D Δtrp3::natMX Δaro7::kanMX-ARO4K229L pSP-G1-ABZ1-ABZ2, PABA1 – PABA5) 
can be found in Table 5. 
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Table 3: Primers used in this study. Annealing sites in primers for amplification of integration cassettes are shown in red, while overhangs for 
homologues recombination have been marker blue. For cloning primers the restriction sites are indicated in bold letters. 
Name 5’ to 3’ sequence 
TRP3 del for GCTGGTCAGTATTAACACATTACCAAATCTGTTTGGTTCTACATAGAACGCCCAGCTGAAGCTTCGTACGC 
TRP3 del rev CTTCTATAGGCTACTATACATGAAGGCGTTCGCCCTTACAACGTTAAGTTGCATAGGCCACTAGTGGATC 
ARO7p-3’–ARO4-5’ for CGATTCCGTTTTGCTAACAAATAGCACTCAGCATCCTGCATAAAATTGGTATAAGATATGAGTGAATCTCCAATGT
TCGCTGCCAACG 
ARO7t-5’–TEFt-3’ rev GCGTAGTAATCACTCGGCAATGTGGAATTGTTACCGTGATAGCCTTCATGCTTCGACACTGGATGGCGGCGTTA
GTATCG 
TRP3 verA GTTCGACAAGGAGCTGGTCAG 
TRP3 verB CAAGCAGGATGGTAGGGACG 
TRP3 verC ACGTCAGTGGAGGCACTTGG 
TRP3 verD TACATGAAGGCGTTCGCCC 
nat verB GAGGTCACCAACGTCAAC 
nat verC GTAAGCCGTGTCGTCAAG 
ARO7 verA CTTTATCGTAAATTTTCAATGG 
ARO7 verD GGTTATTGGGTTGATAATTCCT 
ARO4 verB GTTGAGATTCGGTGGTTCTGGC 
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ARO4 verC TTGGCTGATTTGGTCTCCTTCG 
KmR verB TGTACGGGCGACAGTCACAT 
KmR verC GTGTTCCTGCGCCGGTTGC 
ARO7 verA2 CACCTATTGCGCCGCTCGCGGAATACAATTAC 
ARO7 verB GTAATTAACTTCTGGGGCATAAGGCGCC 
ARO7 verC GGTTCTGTTGCCACTAGAGATATAGAATG 
ARO7 verD2 CCAAGACTTTATATGCCAATGGAGGGATAGGCGC 
ABZ1AWRI1631 for BglII CTGAAGATCTAAAAAAATGCTGTCCGATACAATTGAC 
ABZ1AWRI1631 rev SacI AGTCGAGCTCCTACATGAAAATTTGTAAGTTGC 
ABZ1QA23 for BglII CTGAAGATCTAAAAAAATGTCATCTTCTGTGATTAGTG 
ABZ1QA23 rev SacI AGTCGAGCTCCTACATGAAAATTTGCAAGTTGC 
ABZ2S288c for BamHI CTGAGGATCCAAAAAAATGTCACTAATGGACAATTG 
ABZ2S288c rev XhoI AGTCCTCGAGTCAATATTTTGTCTTCACTGTTCCC 
ABZ2AWRI1631 for BamHI CTGAGGATCCAAAAAAATGTTCAACGAAAGGCAATGC 
ABZ2AWRI1631l rev XhoI AGTCCTCGAGTCAATATTTTGTCTTCACTGTTC 
ABZ2QA23 for BamHI CTGAGGATCCAAAAAAATGAACGWATTTTTTTTATTAGATGAAC 
ABZ2QA23 rev XhoI AGTCCTCGAGTCAATATTTTGTCTTCACTGTTCC 
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Table 4: Plasmids used in this study as a template for amplification of deletion markers and over-expressing of heterologous genes. 
Name Details Origin 
pUG74 PCR template vector, source for loxP-flanked natMX gene deletion marker (Hegemann & Heick, 2011) 
pCV3-ARO4K229L ARO4K229L expression vector, source for ARO4K229L–kanMX integration 
cassette 
(Williams et al., 2015) 
pSP-G1 Ura+ selectable double expression vector, contains TEF1–PGK1 bidirectional 
promoter 
(Partow et al., 2010) 
pSP-G1-ABZ1AWRI1631-
ABZ2AWRI1631½ 
pSP-G1 with ABZ1 and ABZ2 cloned under control of TEF1 and PGK1 
promoter respectively 
this study 
pSP-G1-ABZ1AWRI1631-
ABZ2AWRI1631full 
pSP-G1 with ABZ1 and ABZ2 cloned under control of TEF1 and PGK1 
promoter respectively 
this study 
pSP-G1-ABZ1AWRI1631-ABZ2S288c pSP-G1 with ABZ1 and ABZ2 cloned under control of TEF1 and PGK1 
promoter respectively 
this study 
pSP-G1-ABZ1AWRI1631-ABZ2QA23 pSP-G1 with ABZ1 and ABZ2 cloned under control of TEF1 and PGK1 
promoter respectively 
this study 
pSP-G1-ABZ1QA23-ABZ2QA23 pSP-G1 with ABZ1 and ABZ2 cloned under control of TEF1 and PGK1 
promoter respectively 
this study 
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Table 5: Saccharomyces cerevisiae strains used in this study as a source of gDNA as PCR templates and host organism for genetic engineering. 
Strain Genotype / Plasmid Note Origin 
S288c MATα SUC2 gal2 mal2 mel 
flo1 flo8-1 hap1 ho bio1 bio6 
Reference strain, source of ABZ2S288c 
http://www.yeastgenome.org/strain/S288C/overview 
(Mortimer & Johnston, 1986) 
AWRI1631  Wine yeast strain, source of ABZ1AWRI1631, ABZ2AWRI1631full 
and ABZ2AWRI1631½ 
http://www.yeastgenome.org/strain/AWRI1631/overview 
(Borneman et al., 2008) 
Lalvin QA23  Wine yeast strain, source of ABZ1QA23 and ABZ2QA23 
http://www.yeastgenome.org/strain/LalvinQA23/overview 
(Borneman et al., 2011) 
CEN.PK113-5D MATa ura3-52 MAL2-8c 
SUC2 
Background strain used to construct the production strains 
http://www.yeastgenome.org/strain/CENPK/overview 
Euroscarf 
PABA0 CEN.PK113-5D Δtrp3::natMX 
Δaro7::ARO4K229L-kanMX 
Indole-3-glycerol-phosphate synthase and chorismate mutase 
knock-out strain with feedback resistant 3-deoxy-D-arabino-
heptulosonate-7-phosphate (DAHP) synthase 
this study 
PABA1 PABA0 pSP-G1-
ABZ1AWRI1631-ABZ2AWRI1631½ 
PABA0 strain over-expressing AWRI1631 
aminodeoxychorismate synthase and AWRI1631 
aminodeoxychorismate lyase 
this study 
PABA2 PABA0 pSP-G1-
ABZ1AWRI1631-ABZ2AWRI1631full 
PABA0 strain over-expressing AWRI1631 
aminodeoxychorismate synthase and AWRI1631 
aminodeoxychorismate lyase 
this study 
PABA3 PABA0 pSP-G1-
ABZ1AWRI1631-ABZ2S288c 
PABA0 strain over-expressing AWRI1631 
aminodeoxychorismate synthase and S288c 
aminodeoxychorismate lyase 
this study 
PABA4 PABA0 pSP-G1-
ABZ1AWRI1631-ABZ2QA23 
PABA0 strain over-expressing AWRI1631 
aminodeoxychorismate synthase and QA23 
aminodeoxychorismate lyase 
this study 
PABA5 PABA0 pSP-G1-ABZ1QA23-
ABZ2QA23 
PABA0 strain over-expressing QA23 aminodeoxychorismate 
synthase and QA23 aminodeoxychorismate lyase 
this study 
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2.4.3.4 Strain cultivation 
250 mL Erlenmeyer baffled cell culture vent cap polycarbonate flasks (Corning®, Corning, 
NY) were used for shake-flask experiments (culture volume being 10% of total) using a 
Multitron 3-stack incubation shaker with 25 mm shaking throw at 200 rpm (INFORS HT, 
Bottmingen, Schweiz) for incubation of shake-flasks. Experiments were carried out in 
biological triplicates, single colonies from solid medium were used to inoculate primary 
pre-cultures on liquid medium (CDM). After overnight growth, a secondary pre-culture was 
inoculated to a defined OD660. Cells from log-phase were used to inoculate the main-
culture to an OD660 of 0.8 in the case of ABZ1/ABZ2 performance screening on glucose 
and 0.2 for all other shake-flask experiments. Growth was monitored by means of OD660 
and pH, collecting supernatant for analysis every three hours during exponential growth 
and twice a day in stationary phase (after 9 h in case of GLC, after 24 h in case of 
GLY/ETH). 
Fed-batch bioreactor experiments were carried out in duplicates using a BIOSTAT® B 
(Sartorius, Göttingen, Germany). Shake-flask pre-cultures on GLY/ETH were kept 
exponential (by transferring cells from cultures approaching end log-phase to fresh 
medium, while adjusting volume to not exceed a final OD of 5 in order to suffice oxygen 
demand) until enough cells were collected to inoculate 2x400 mL medium to an OD of 1.8 
or 4.4 for the respective experiments. Cells were washed twice with fresh medium, 
resuspended in 24 mL thereof and transferred into the bioreactors. Feeding was started 
when initial ethanol was nearing depletion (inferred by retardation of growth by means of 
OD). In case of the pulse-feed experiment the three doses were added to the fermentation 
(10-fold concentrated AAA stock added 1:10, concentrated CDM +ETH added 1:10, 
GLY/ETH mix added 1:38.5) at once at the indicated time points (Figure 24). In the case of 
constant-feed experiment, flow was set to 100 µL/min, corresponding to the approximate 
ethanol uptake rate (predetermined in shake-flasks), adjusted to the actual OD. In the final 
stage (cf. Figure 24) the feed was increased by 3.5-fold. Aeration was minimized (0.15 
L/min in case of the pulse-feed and 0.16 L/min in case of the continuous-feed experiment) 
in order to minimize stripping and foaming. However, the system was controlled to be 
aerobic with dissolved oxygen no lower than 80%. The pH was controlled at 6 using 1 M 
H3PO4 and 10% NH4OH. All fermentations were conducted at 30°C. 
  
 - 79 - 
2.4.3.5 Metabolite analysis 
Using an advancement of the method described before (Williams et al., 2015) extracellular 
concentrations of aromatic compounds (pABA, anthranilate, pHBA, PHE, TYR, TRP, PEA, 
tryptophol and folate) were determined. Specifically, cells were removed from 1 mL culture 
by centrifugation at 4°C, for 5 min. at 13,000×g. Clarified supernatant was stored in a 
microcentrifuge tube at -20°C until analysis. Metabolites were analysed by RP-HPLC using 
an Agilent 1200 HPLC system. In brief, samples were kept at 4°C in a high-performance 
auto-sampler (Agilent HiP-ALS, G1367B). 30 µL was injected into a C18 column (Zorbax 
Extend C18, 3.5 µm, 4.6 x 150 mm, Agilent PN: 763953-902) with a guard column 
(SecurityGuard Gemini C18, Phenomenex PN: AJO-7597). The column temperature was 
kept at 35°C in a thermostatted column compartment (Agilent TCC, G1316B), and 
analytes were eluted using gradient chromatography at 1 mL/min. flow rate. The gradient 
method was as follows: 5 – 35% B from 0 – 5 min., 35 – 40% B from 5 – 14 min., 100% B 
from 15 – 18 min., and 5% B from 18.1 – 20 min. using a binary pump (Agilent Bin Pump, 
G1312A). Solvent B was 0.045% TFA in 80% acetonitrile in water while Solvent A was 
0.045% TFA in water. Solvents were degassed using an in-line degasser (Agilent 
Degasser, G1379B). Analytes of interest were monitored using a diode array detector 
(Agilent DAD SL, G1315C) at 206 and 254 nm wavelengths. Spectral scans were also 
performed on each eluting peaks from 190 – 400 nm to confirm their spectral fingerprint 
and purity. Chromatograms were integrated using the Agilent ChemStation 
chromatography software. 
Extracellular glucose, glycerol, ethanol and organic acids were measured as described 
previously (Dietmair et al., 2010) in cell-free supernatants collected as mentioned earlier. 
The metabolite data were analysed and integrated with the fermentation data using 
Microsoft Excel. To determination yields accurately, evaporation was respected: For 
shake-flasks evaporation of total liquid was estimated gravimetrically, using a 
predetermined correlation between ethanol concentration and evaporation of ethanol from 
CDM +GLY/ETH overtime loss of ethanol during fermentation was estimated 
incrementally. The errors of the yields were based on maximum and minimum yields 
determined based on boundaries of ethanol evaporation, as this exceeded standard 
deviation between the triplicates. For the bioreactor experiments, the method described in 
(Duboc & von Stockar, 1998) was employed to determine evaporation of water and 
stripping of ethanol. Yields (in percent C-mol/C-mol) were calculated from the evaporation 
corrected titers while only the metabolised fraction of the carbon-source was respected. 
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13C labelled tracer cultivations were performed on fully labelled glucose (D-Glucose–13C6 
99 atom%; Isotec, Germany) or on a mixture of fully labelled ethanol (13C2 99 atom%; Icon 
Isotopes, USA) and naturally enriched glycerol. Amino acid labellings were obtained from 
cell hydrolysates (filtrate of cell pellet incubated with 250 µL 1 M HCl @ 100°C overnight) 
and analysed using gas chromatography – mass spectrometry (GC-MS) described 
previously (Winter et al., 2014). For this 0.2 mL of supernatant sample or 0.05 mL of cell-
hydrolysate were dried under a stream of N2 and subsequently derivatized with N-methyl-
tert-butyldimethylsilyl-trifluoroacetamide (MBDSTFA; Macherey-Nagel, Düren, Germany) 
as described before (Krömer et al., 2013, Winter et al., 2014). For pABA the ion cluster 
m/z = 308-315 was analysed. It represents the m-57 fragment (full carbon backbone of 
pABA) of MBDSTFA derivatized pABA. The volatile PEA was extracted into hexane (equal 
volume to sample, vortex, decant) and directly injected into GC-MS. For PEA, GC-MS 
settings were modified from the above, by applying a 1:10 split injection. The ion cluster 
m/z 122 – 130 contained the full carbon backbone of PEA and was used to calculate 
enrichment. Generally, labelling distributions were corrected for all naturally occurring 
stable isotopes in the derivatized molecules that do not belong to the biological carbon 
backbone using the software IsoCor (Millard et al., 2012). The corrected mass distributions 
were then used in IsoCor to calculate the mean enrichment of compounds using relative 
summed fractional labelling (SFL) calculated as follows: 
SFL = (0×Im+0 + 1×Im+1 + 2×Im+2 … + n×Im+n) / n 
Where I is the intensity of the (m+i) ion in the ion cluster and n the number of carbon 
atoms in the analysed mass fragment. 
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2.4.4 Results and Discussion 
2.4.4.1 Designing a strain for pABA production - screening of different ABZ1 and ABZ2 
genes connects pABA production to gene sequences 
The production of pABA in S. cerevisiae requires diversion of carbon flux towards pABA 
synthesis through the elimination of competing metabolic pathways and enhancement of 
pABA synthesis through over-expression of key enzymes. Therefore, the TRP3 and ARO7 
genes were deleted and the feedback inhibition resistant ARO4K229L gene was introduced, 
in order to overcome product inhibition and increase flux to the shikimate pathway (Curran 
et al., 2013, Rodriguez et al., 2015, Williams et al., 2015). In the resulting genetically 
modified base strain “PABA0” (cf. Figure 6 & Table 5) ARO4K229L was integrated at the 
ARO7 locus, thus disrupting the ARO7 gene and putting the ARO4K229L under control of 
ARO7’s native promoter in order to achieve a positive feedback loop for high flux to 
shikimate pathway due to AAA starvation. 
PABA0 was used as a chassis cell to screen different alleles of ABZ1 and ABZ2 for their 
effect on pABA production. To start with, sequences were compared in silico, by means of 
the alignment of the 43 different ABZ1 and ABZ2 nucleotide and amino acid sequences, 
derived from SGD (www.yeastgenome.org). With the aim to cover the greatest possible 
variety, the alleles of the lab yeast (S288c) and three wine yeasts (AWRI1631, AWRI796, 
QA23) were chosen. These ABZ1 and ABZ2 genes were compared in detail regarding 
sequence similarities and differences (Figure 19, cf. supplementary file 2.4.1 for full 
sequence analysis). 
 
Figure 19: Simplified depiction of the alignment of ABZ1 and ABZ2 protein sequences. Amino acid 
residues unique to a certain sequence are indicated in green. Sequences are shown from N-terminus 
to C-terminus. 
 
A 
 
 
B 
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The ABZ1 genes (Figure 19A) distinguished not only by SNPs, but also appeared in 
different ORFs. So did the ABZ2 genes, furthermore it was found that the region upstream 
of the annotated ORF of ABZ2AWRI1631 coincides with the nucleotide sequence present in 
the genome of AWRI796. This means that the full ORF of ABZ2AWRI796 is present also in 
AWRI1631. This may indicate a false annotation of either gene. Therefore, both possible 
ORFs (cf. Figure 19B) were included for screening, the putatively falsely annotated gene is 
referred to as ABZ2AWRI1631½ (which corresponds to the original annotation of 
ABZ2AWRI1631) the other one as ABZ2AWRI1631full (which corresponds to the original 
annotation of ABZ2AWRI796). The yeast strain Lalvin QA23 provided other substantially 
different ABZ1 and ABZ2 genes. All four ABZ2 genes and the ABZ1 genes of AWRI1631 
and QA23 were chosen for in vivo comparison. 
The strains “PABA1” – “PABA5” (cf. Table 5), which over-expressed the different ABZ1 & 
ABZ2 genes, were compared in shake-flask experiments with the aim to find the best set 
of ABZ1 and ABZ2 genes for high pABA production. PABA0 already exhibited baseline 
pABA production with respect to the background strain (CEN.PK113-5D), indicating that 
the modifications so far already directed flux towards pABA, even without increased 
expression of ABZ1 and ABZ2. This was supported by the observation that the strain grew 
without supplementary pABA. Over-expression of ABZ1 and ABZ2 led in all cases to 
higher pABA production than PABA0. The highest production was achieved by the 
combination of ABZ1AWRI1631 and ABZ2QA23, which showed a ~35-fold increase in pABA 
concentration compared to PABA0. Further, it can be noted that the full ABZ2AWRI1631 gene 
in PABA3 led to a higher production than the truncated version in PABA2. Finally, PABA5, 
harbouring ABZ1QA23 in combination with ABZ2QA23, was inferior compared to PABA2, 
PABA3, and PABA4. 
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Figure 20: Production of pABA in shake flask experiments of S. cerevisiae strains. WT = CEN.PK113-
5D, PABA0 = CEN.PK113-5D Δtrp3 Δaro7 ARO4
K229L
. PABA1 – PABA5 are based on PABA0, with 
over-expression of additional ABZ1 and ABZ2 alleles on a plasmid expression vector as indicated on 
the figure (for full genotype cf. Table 5). 
 
Inferred from the marginal pABA production of strain PABA1 it appears that also the ABZ2 
gene of S288c and S. cerevisiae strains with an identical sequence is impaired. The most 
obvious explanation seems to be that the two differences in the amino acid sequence of 
ABZ2S288c in respect to ABZ2AWRI796 (cf. Figure 19) reduce the functionality of the enzyme. 
With PABA3 producing nearly twice the amount of pABA compared to PABA2 it is evident 
that ABZ2AWRI1631 was annotated falsely in the AWRI1631 genome, and the larger ORF 
(corresponding to ABZ2AWRI796) is the correct one. Comparing the sequence of ABZ2QA23 in 
PABA4, which excel in pABA production, to the other genes it seems very likely that some 
relation between the unique C-terminus of ABZ2QA23 and its effect on pABA production 
exists. Comparing PABA4 to PABA5 shows that also the choice of ABZ1 has a great 
influence, as only combining ABZ1AWRI1631 with ABZ2QA23 allowed greatly increased pABA 
titers. It seems likely that ABZ1QA23 is dysfunctional due to the 5’-end truncation of the 
gene. However, in general, the differences that arise for pABA production by employing 
different ABZ genes may not be only due to differences in activity of the enzymes but also 
enzyme concentration. This may involve more complex regulation on transcriptional and 
translational levels for example in relation to codon usage and/or mRNA stability. 
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Investigating this in detail may provide advanced knowledge that will allow further 
optimizations. Relating ligand binding sites to the mutations in amino acid sequences of 
the different ABZ genes could, for instance, allow conclusions towards enzyme 
functionality (cf. supplementary file 2.4.1). 
2.4.4.2 In silico analysis of carbon-source composition leads to enhanced pABA 
production in vivo 
During characterization experiments of the PABA strains it could be observed that the 
production of pABA was higher later in the fermentation when glucose was depleted and 
glycerol & ethanol were reassimilated (cf. section 2.4.4.3). To understand this phenotype 
in silico modelling was used: Elementary mode analysis was performed analogous to a 
previous study (Averesch & Krömer, 2014), in order to compare biomass and product 
carbon-yields on the substrates glucose, glycerol, ethanol and glycerol + ethanol. The 
achievable maximum carbon yield for pABA from ethanol is generally lower than from 
glucose or glycerol (Table 6, cf. supplementary file 2.4.2 for distribution of elementary flux 
modes) while glycerol allows a higher theoretical pABA yield than glucose. The highest 
possible carbon yield for pABA with and without biomass formation can be achieved in 
silico from a combination of glycerol and ethanol as feed, which may explain our 
experimental observation of high pABA formation in the second fermentation phase when 
reutilizing ethanol and/or glycerol. 
 
Table 6: Theoretical maximum product carbon yields using different substrates. 
Substrate Glucose Ethanol Glycerol Glycerol+Ethanol 
Maximum pABA yield [%] 84 75 90 92 
Maximum pABA yield with biomass [%] 81 50 86 87 
 
The analysis of the product yield from all elementary modes on GLY/ETH-feed allowed the 
determination of an ideal ratio between glycerol and ethanol. Figure 21 shows that the 
majority of feasible flux distributions feature a GLY:ETH ratio lower than 10 while the 
highest product yields are obtained with GLY:ETH ratios between 0.5 and 2 (magnified 
area in Figure 21). 
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Figure 21: Distribution of pABA yields in dependence of the glycerol to ethanol ratio in elementary 
flux modes in a window with a GLY:ETH ratio ≤ 100 [C-mol/C-mol]. Each point in the chart 
corresponds to the specific product carbon yields [%] and the substrate ratio of the respective 
elementary flux mode. The insert at the bottom right corner is a magnification of the area in the top 
left corner where the modes with the highest yields are located. 
 
Metabolic network modelling revealed that stoichiometry of pABA production is improved 
when glycerol is the carbon-source. Increased Ymax (compared to glucose) can be 
explained with additional reducing power (FADH2) gained during glycerol metabolisation, 
which can be used to regenerate ATP. The initial step of ethanol utilization also reduces 
an extra redox co-factor (NADH); however on ethanol alone very limited metabolic 
freedom exists, as all flux to upstream pathways (glycolysis, pentose phosphate pathway, 
shikimate pathway) has to be derived from acetyl-CoA via phosphoenolpyruvate 
carboxykinase and malic enzyme (cf. EMA networks in supplementary file 2.4.2 for 
reactions). In particular for the formation of the shikimate pathway precursor PEP from 
ethanol, two more mol ATP are required in respect to glucose and four more in respect to 
glycerol. 
This is compensated on a combined GLY/ETH-feed: Separate carbon-flow to the upper 
and lower parts of central metabolism allows full advantage of higher availability of 
reduced redox equivalents, resulting in a higher biomass yield and more modes close to 
the stoichiometric limit (line between max. biomass and max. product yield, cf. 
supplementary file 2.4.2 for biomass vs. product yield plots). In addition, the majority of 
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modes with low product / biomass formation are abolished, as the two major by-products 
on glucose (GLY/ETH) are substrates now. 
In order to reproduce the observed higher pABA production of glucose batches after the 
diauxic shift (when re-utilizing glycerol and/or ethanol) and to test the prediction of the 
elementary flux mode analysis, the impact of the carbon-sources glucose, glycerol, ethanol 
and glycerol+ethanol mixtures was tested in vivo using the PABA4 strain in shake-flask 
experiments. Comparing single carbon-sources the pABA titer was found to be highest on 
glucose, the carbon yield, however, was higher on glycerol (Figure 22A). The product 
carbon yield from ethanol can be noted as lowest, despite a high uncertainty due to high 
evaporation (cf. section 2.4.3.5). Concentrations of C-source where chosen aiming at 
comparable amounts of C-mol, e.g. when using 30 g/L ethanol even in case of < 50% 
substrate loss by evaporation an equivalent amount of C-mol as in the glucose experiment 
was available over the course of the fermentation. 
In general, the highest pABA yields and also titers of all trialled carbon-sources were 
obtained when combining glycerol and ethanol. Different concentrations and ratios were 
tested to determine the ideal ratio of glycerol to ethanol (Figure 22B). It was found that 
initial GLY:ETH ratios > 3:1 g/g allowed for uptake ratios > 0.5 C-mol/C-mol, delivering the 
highest pABA yields. Enforcing an increase in uptake ratio only worked up to a certain 
degree: A 20:2 g/g GLY:ETH feed-ratio only allowed an uptake ratio of 1.1 C-mol/C-mol 
and while the pABA yield was only slightly reduced, the titer was more than halved. 
 
Figure 22: pABA titers (dark grey) and yields (light grey) achieved by PABA4 on different carbon-
sources (A) and GLY:ETH different ratios (B). Titers are evaporation corrected and represent the 
maximum after either carbon-source was used up and/or no further product formation occurred. 
Utilized carbon is the amount of C-mol from either carbon-source that was taken up and actually 
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metabolised. Yields and carbon usage ratios are based on the evaporation corrected titers while only 
respecting the actually metabolised fraction of the carbon-source. 
The results indicate that both, GLY and ETH, were utilized and contributed to pABA 
production, however in different ways. Therefore, the contribution of the carbon from the 
two substrates to pABA formation on a combined GLY/ETH carbon-source was 
investigated in a tracer experiment with 1,2-13C labelled ETH and natural GLY. Enrichment 
analysis of pABA revealed that in total up to 31% were derived from GLY (mean 
enrichment 69%). Further analysis of the labelling of amino acids revealed that glycerol 
was mainly metabolised in the upper part of glycolysis and pentose phosphate pathway, 
with little to no C12-carbon reaching the TCA-cycle (mean enrichment of threonine, 
aspartate, and glutamate 92.2%, 92.9%, 93.9%, respectively). The activity of the threonine 
aldolase pathway for glycine biosynthesis could be seen by a glycine enrichment of 79.5%, 
while serine was only labelled 59.8% and clearly was also derived from glycerol. Since the 
alanine enrichment reached 85.2% it seems that glycerol did not reach the pyruvate pool 
to a large extent. Ethanol finally also reached the pentose phosphate pathway and 
subsequently the biosynthesis of histidine (44.1% enriched) and the aromatics. The fact 
that ethanol served as a precursor for pentose phosphate pathway derived compounds 
points towards a limitation in the supply of C3 molecules from the glycerol uptake. During 
the tracer experiment the GLY:ETH uptake ratio was 1.1 C-mol/C-mol. It is striking that the 
overall glycerol usage is higher than what ends up in pABA (GLY:ETH ratio = 0.47 C-
mol/C-mol). This allows the conclusion that glycerol contributes to pABA production not 
directly by the supply of carbon. Therefore, a benefit in energy metabolism is the only 
possible explanation, the inferences from EMA support this theory. 
2.4.4.3 Carbon-sources composition controls aromatic product spectrum in vivo 
To characterize pABA production on GLY/ETH in more detail, the metabolic profiles over 
the course of fermentations on GLC and GLY/ETH were compared (Figure 23): On GLC 
the maximum pABA titer was reached only after almost 130 h while a major part of pABA 
was produced during re-assimilation of ethanol / glycerol. On GLY/ETH the maximum 
pABA titer was reached within 78 h while the rate of pABA production was highest when 
ethanol was still available (r0-46h = 39.52 µmol/g×h vs. r46-78h = 7.3 µmol/g×h). Albeit pABA 
titer was only slightly higher on GLY/ETH than on GLC, productivity was significantly 
greater (rGLY/ETH = 26.7 µmol/g×h vs. rGLC = 7.2 µmol/g×h). 
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Further, a dependency of the product spectrum on the carbon-source could be observed. 
The major by-product was PEA, which is derived from phenylpyruvate, either as an 
intermediate of PHE degradation or de novo from prephenate (formation of phenylpyruvate 
has been observed in vivo even though ARO7 was knocked out (Winter et al., 2014)) On 
glucose PEA titers even exceeded pABA titers. However on GLY/ETH formation of PEA 
was reduced (3-fold) in favour of increased selectivity for pABA. Further on GLY/ETH it 
was observed that PEA production early in the fermentation correlated directly with the 
decline of PHE (cf. supplementary file 2.4.3). Tracer experiments showed that growing the 
strain solely on U-13C glucose led to no significant labelling of PEA (mean enrichment 3%) 
at the end of the exponential growth (where PHE was depleted), proving that de novo 
synthesis had not occurred. In stationary phase, however, PEA appeared to be partially 
13C enriched (mean enrichment 29%), indicating de novo synthesis from chorismate (cf. 
supplementary file 2.4.3 for details). No other aromatic by- or downstream products of the 
shikimate pathway were found, in particular, no accumulation of AAAs was observed. The 
tryptophan degradation product tryptophol was identified in GC-MS samples of the tracer 
experiments but appeared to be unlabelled and hence originated from tryptophan 
degradation only (not de novo synthesized). Further dihydrofolate and folate (which pABA 
is a precursor for) were also not found to be present in the media in detectable 
concentrations (LOD < 4 µM). 
 
 
Figure 23: Time course of substrate consumption and product formation of main aromatic products 
on GLC (A) and GLY/ETH (B). Titers are corrected for evaporation of H2O to reflect comparable 
metabolite concentrations. 
A B 
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The advantageous stoichiometry for pABA formation on GLY/ETH can explain the initial 
observation that a major fraction of pABA production on glucose only occurred late in the 
fermentation after the diauxic-shift: When glucose was consumed ethanol and glycerol 
were reassimilated, and the major amount of aromatics formed. The fact that production 
and growth only proceeded until ethanol was depleted indicates that ethanol was essential 
in order to sustain a viable metabolism of the cell. This, together with the clues from EMA 
and the tracer experiments, can explain the observed “sweet-spot” of the GLY:ETH ratio 
for pABA production: Ethanol concentration has to be limited in order to not dominate 
carbon supply for the cell (due to faster utilization kinetics) but apparently also needs to be 
high enough to support metabolism and allow sufficient glycerol utilization. The in vivo 
determined ideal glycerol to ethanol uptake-ratio of 0.5 C-mol/C-mol, which delivered the 
highest pABA yields, also correlates with the ideal ratio predicted by modelling (optimum 
between 0.5 and 2 C-mol/C-mol). Interestingly, further enforcing higher glycerol uptake 
affected pABA titer negatively and also slightly diminished the yield. This was most likely 
due to the impaired glycerol uptake mechanism of laboratory yeast (Swinnen et al., 2013), 
presumably resulting in an imbalanced metabolism of the cell if ethanol share in the 
carbon-source is too low. 
While ETH was always depleted in the course of the fermentation, of the initial amount of 
GLY only a minor fraction was utilized. Evaporation of ETH was a major reason for the 
decline of ethanol concentration during the fermentation, accounting for almost half thereof 
(depending on the ethanol concentration). Biomass yields on GLY/ETH were however at 
least equivalent to the ones GLC (data not shown). This also correlates with results from 
EMA where maximum biomass yield was highest on GLY/ETH (cf. supplementary file 
2.4.2). Carbon usage may be improved by elevating glycerol uptake / utilization, therefore 
allowing for greater and quicker glycerol utilization, which would also aid in limiting ethanol 
evaporation. 
2.4.4.4 Controlling by-product formation and maximizing pABA production 
To maximize pABA production a fed-batch bioreactor experiment with a high starting cell 
density was conducted. Therefore a GLY:ETH ratio which delivered the highest pABA 
titers in shake-flask experiments (10:30 g/L) was chosen. Feed pulses were employed 
when growth slowed down (cf. section 2.4.3.4 for process details) to replenish depleted 
substrates. Figure 24A shows the development of substrates and products / biomass 
throughout the fermentation. In this experiment, the highest pABA (1728 ±10 µM 
≈ 237 mg/L) and overall aromatics titers (cf. Table 7) were achieved. pABA share of total 
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aromatics, however, was only 52% (by titer in mM) due to substantial PEA formation 
(especially shortly after AAAs were added, therefore presumably derived from PHE 
degradation). Further small amounts of para-hydroxybenzoic acid (pHBA) (< 50 µM) were 
detected. Growth appeared to be limited by the availability of AAAs. Glycerol utilization 
was marginal (ratio of used GLY/ETH < 0.05 C-mol/C-mol), negatively impacting the 
carbon yield (Table 7). Stripping appeared to be a significant reason for ethanol reduction. 
To limit stagnation of growth due to immediate degradation of abundant AAAs and to 
further improve pABA production and yield, an experiment with a continuous feed stream 
was designed. This also intended to explore if higher GLY utilization could be enforced 
through the limitation of ETH availability. In theory, this would compensate for the slower 
kinetics of GLY uptake and minimize substrate loss by evaporation. Utilization of a greater 
share of GLY while minimizing ETH usage was anticipated to benefit product yield (cf. 
section 2.4.4.2). The fed-batch bioreactor experiment was conducted with an ETH-feed in 
the order of the cells ETH uptake rate (cf. section 2.4.3.4 for process details). As can be 
seen from Figure 24B stripping of ETH was successfully minimized. Also, the PEA titer 
could be successfully reduced, in comparison to the previous bioreactor experiment (cf. 
Table 7), which benefited the fraction of pABA (> 83% by titer in mM) of total aromatics. 
Final pABA titer could not be improved, due to the continuously diluting feed stream, 
however, the highest product carbon yield (2.64%) in this study could be reached. The 
early formation of PEA largely corresponded to the decline of the initial PHE in the medium 
(data not shown). The steady supply of AAAs successfully maintained growth throughout 
the fermentation while no more PHE was degraded to PEA. Also, pHBA was detected 
again, reaching up to 100 µM. GLY utilization could be increased (ratio of used GLY/ETH ≈ 
0.07 C-mol/C-mol), benefiting the pABA yield (Table 7). Interestingly the highest GLY 
utilization was observed towards the end of the fermentation when ethanol concentration 
peaked due to increased feed rate. 
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Figure 24: Substrate uptake and aromatic product formation over time in the bioreactor fermentation 
on GLY/ETH with (A) feed-pulse and (B) continuous-feed. Profiles of consumed substrates have been 
adjusted / corrected for dilution to reflect actual substrate uptake. Dashed vertical lines indicate a 
feed-pulse and activation / increase of the feed respectively. 
 
Sharply increasing PEA titers after each spike with AAAs in the pulse-feed bioreactor 
compared to the continuous-feed bioreactor correlate with the results from the tracer 
experiments, where most PEA on GLY/ETH was derived from PHE degradation and little 
to no PEA was formed de novo. The same correlation can be seen in the initial hours of 
the continuous-feed bioreactor experiment. However additional PHE, contained in the 
gradually added feed-solution in this experiment (and thus added to the fermentation over 
time), was apparently not degraded to PEA. This also explains why growth in the 
continuous-feed bioreactor was largely sustained, while the pulse-feed bioreactor suffered 
from impaired growth, although sufficient carbon-source was available throughout the 
fermentation: High concentrations of AAAs were rapidly degraded into higher alcohols, 
thus depleting quickly. This highlights the advantage of the continuous-feed bioreactor. 
With improved growth also glycerol usage increased, especially towards the end of the 
continuous-feed bioreactor experiment where growth was fastest. This is in accordance 
with the theory that ethanol is needed in order to support glycerol utilization. 
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Table 7: Maximum titers and product carbon yields of key aromatic compounds and total aromatics 
obtained from batch bioreactor fermentations. Yields are based on dilution / evaporation corrected 
concentrations to account for actual substrate utilization. 
 
Pulse-feed fermentation 
Compound pABA PEA Total# 
Titer [mM] 1.73 1.21 3.31 / 1.75 de novo 
[mg/L] 237 148 444 
Yield [%] 1.52 0.4* 1.9* 
 
Continuous-feed fermentation 
Compound pABA PEA Total# 
Titer [mM] 1.57 0.16 1.9 / 1.67 de novo 
[mg/L] 215 19.5 270 
Yield [%] 2.64 0* 2.8* 
#
 Total aromatics titer is comprised of pABA, PEA, pHBA, and tryptophol 
* Carbon yields of PEA and total aromatics were estimated to reflect only the de novo synthesized fraction 
 
In both bioreactor experiments, the final pABA titer was reduced because of dilution by the 
feed stream. When accounting for dilution of the medium due to the feed volumes in both 
experiments, it appeared that the theoretical final pABA production was higher for the 
continuous-feed experiment (1.57 mM × 2.12) than for the pulse-feed experiment 
(1.73 mM × 1.356). This influenced the final pABA yield (Table 7) and can be explained 
with the greater substrate specific yield coefficients (Table 8) of the experiment with the 
continuous-feed. 
The greater pABA yield and product specific yield coefficients also show the advantage of 
the continuous-feed. Also, the productivity was significantly greater, with the final titer 
reached more than 2.56 times faster. However, the biomass specific yield coefficient for 
pABA was greater in the pulse-feed experiment in the second and third phase. This means 
that pABA production was still high, even though growth was slowing down, possibly 
hinting at a strategy that might in the future allow separation of production from growth. 
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Table 8: Yield coefficients for pABA in respect to biomass and the two substrates glycerol and 
ethanol in the bioreactor experiments. Values are based on dilution / evaporation corrected 
concentrations to account for actual substrate utilization. 
 
Pulse-feed fermentation Continuous-feed fermentation 
 phase 1 phase 2 phase 3  
YpABA/Biomass [mmol/(gCDW)] 1 2.5 100 1 
YpABA/GLY [mmol/mol] 69 169.5 188.7 270.27 
YpABA/ETH [mmol/mol] 1.9 4.9 4.4 11.3 
 
The results from the bioreactor experiments represent the upper limits of the currently best 
strain for pABA production, which are constrained by substrate utilization: If growth is 
limited (either by means of low ethanol concentrations or depletion of AAA) then glycerol is 
hardly utilized. If ethanol and AAAs are present in excess, more glycerol is utilized, but flux 
overflow and degradation of AAAs diverts carbon to PEA and results in loss of substrate 
due to evaporation. Balancing this represents the first major challenge. The defective 
glycerol utilization mechanism in S. cerevisiae laboratory strains, which diminishes 
productivity and increases ethanol demand, may be alleviated by over-expression of STL1, 
GUT1CBS6412-13A and GUT2 as described before (Swinnen et al., 2013). Improved glycerol 
uptake and flux into central metabolism could help to not only enhance growth but also 
production on glycerol. It may allow reduction of the ethanol share of the carbon-source, 
simultaneously reducing process costs and possibly also resulting in an improved yield 
while utilizing a more sustainable carbon-source. 
The final challenge is to further optimize the formation of pABA by means of increasing the 
activity of the ABZ1p and ABZ2p in order to drain flux faster and more efficiently from 
shikimate pathway. Initial conclusions drawn from the screening of the different ABZ genes 
towards their sequence may help to prioritize efforts to further optimize the enzymes. 
These would then also reduce the risk of flux overflow towards PEA, which would become 
critical again once carbon-source utilization has been optimized. 
2.4.4.5 Metabolic bottlenecks of carbon-source utilization and aromatics production 
It was recently shown that ethanol stress reduced the production of higher alcohols of 
AAA, including PEA (Avbelj et al., 2015). This was believed to happen via upregulation of 
the genes ARO8, ARO9 and ARO10. However, these genes evoke in combination the 
formation of PEA via catabolism of AAAs. Thus, this can in the present study not fully 
explain the observed accumulation of PEA from glucose to concentrations greatly higher 
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than the amount of supplemented AAA. Therefore, another reason for reduced PEA 
production on ethanol is proposed in addition to the described effects: 
It was recently demonstrated that the conversion of chorismate to prephenate / 
phenylpyruvate in a ∆aro7 strain proceeds also spontaneously (Winter et al., 2014), the 
reaction rate is merely a matter of substrate and product concentrations, temperature and 
pH. Given that pABA production is kinetically limited, in a situation of high flux into the 
shikimate pathway during faster glucose metabolism, chorismate could be accumulating, 
leading to an overflow into PEA (a similar flux overflow resulting in an accumulation of 
PHE and TYR has been reported when producing pABA in E. coli (Koma et al., 2014)). 
During growth on GLY/ETH overall conversion rates are lower, thus, also flux arriving at 
chorismate is lower, so that the kinetics of pABA formation are not overwhelmed and 
chorismate does not overflow into PEA. Thus, the bottleneck of carbon-source utilization 
compensates the bottleneck towards pABA formation. 
2.4.5 Conclusion 
With respective titers of 1.9 mM and 1.73 mM for aromatic compounds in general and 
pABA, in particular, this study demonstrates the potential of S. cerevisiae as a microbial 
cell factory. By means of pABA production, it could be shown that the variability in different 
ABZ1 and ABZ2 sequences of sequenced yeast strains has a great impact on their 
functionality. Two genes could be identified that in combination allow a significant improve 
in pABA production. Further this study demonstrates the potential of metabolic engineering 
when rationally making use of metabolic modelling and genetic engineering: As predicted 
by modelling it could be shown that production of pABA from a combined glycerol-ethanol 
carbon-source was more efficient than from glucose. The benefits are twofold: On the one 
hand, stoichiometry allowed a higher yield (as predicted by modelling); on the other hand 
kinetic limitations (that otherwise result in flux overflow) were less influential resulting in 
increased selectivity for the desired compound pABA. This allowed a more than 6-fold 
increase in product titer and an almost 8-fold increase in yield over the previous 
benchmark (Krömer et al., 2013). The reported results are the highest pABA titer and yield 
in S. cerevisiae to date and the second highest in a biological system. 
The future challenge in order to further increase productivity, titer and yield is to direct flux 
more efficiently to pABA. In particular, further improvement of the ABZ1 and ABZ2 genes 
is essential in order to take pABA production to the next level. Enhancing glycerol uptake 
and metabolisation could then also help to increase the pABA yield (and possibly also titer) 
as well as reduce process costs. 
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3 General Conclusion and Future Perspectives 
3.1 Main Conclusion 
A metabolic modelling tool was developed that allowed holistic in silico analysis of the 
pathways for production of adipic acid and precursors for the hexanedioic acid in the cell 
envelope. Shikimate pathway based routes turned out to be amongst the most promising 
ones. In consequence existing strain construction strategies for muconic acid production 
from shikimate pathway were examined in more detail, identifying weaknesses and 
tailoring optimizations in silico. 
Transferring the in silico determined strain construction strategy for coupling of growth to 
product formation to an in vivo system, production of pHBA was established using a novel 
synthetic circuit for dynamic regulation of gene expression. This verified in vivo validity of 
the in silico determined knock-out strategy. 
Further, a chassis strain was constructed that effectively channelled carbon flux to the 
target products. This also resulted in a deeper understanding of the shikimate pathway, in 
particular, the chorismate (ARO7) mutase reaction was found to proceed also uncatalysed, 
due to the instability of chorismate. 
Screening of different genes for production of pABA identified ABZ1 and ABZ2 genes that 
allowed significantly increased product titers. These originated from the wine yeasts 
AWRI1631 and QA23, respectively. In combination with in silico designed composition of 
carbon-source this improved the product carbon yield while minimizing by-products by 
avoiding loss of carbon due to the leaky ARO7 knock-out. 
3.2 Future Perspectives 
The integrated picture of the different research outcomes defines how research efforts 
need to be focused in the future. This largely relates to the application of the gained insight 
and knowledge in vivo. The overarching goal is to achieve a significant increase in 
aromatics production, the major chance to trigger such a breakthrough is the application of 
the PYK knock-out. Current strains, however, are simply not efficient / effective enough to 
allow this (unpublished data). Therefore, in first instance efforts need to focus on 
enhancing the formation of the respective aromatic products. This is particularly important 
for the production of pABA, which is hindered by several factors. 
Codon optimization of ABZ1AWRI1631 & ABZ2QA23 may help to increase expression of these, 
which was identified as a problem (unpublished data). The prokaryotic functional 
analogous pabAB & pabC are another set of enzymes which seem very promising (Koma 
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et al., 2014) for enhancing pABA formation. Finally, the design of a fusion protein (Chen et 
al., 2013) of the aminodeoxychorismate synthase & aminodeoxychorismate lyase (e.g. 
pabABC) may channel conversion of 4-amino-4-deoxychorismate and thus streamline 
pABA production. 
Further, with increasing reaction rates towards the formation of pABA, the supply of 
substrates for these reaction may also become limiting. Therefore strengthening glutamine 
regeneration, as shown to be beneficial in an analogous study (Sun et al., 2013), may 
require overexpression of GLN1. Increasing chorismate levels is more complex and needs 
to be carefully balanced with downstream product formation due to the high instability of 
chorismate (Winter et al., 2014). Nevertheless, overexpression of aroL has been shown to 
significantly increase flux through shikimate pathway (Rodriguez et al., 2015). Preliminary 
results (unpublished data) show that this is also valid for the production of pHBA. To 
increase overall carbon flux into shikimate pathway, alternatively or additionally to 
ARO4K229L the mutant ARO4Q166K (Galanie et al., 2015) could be employed, going further 
into protein engineering a potential double mutant ARO4Q166K,K229L may be worthwhile 
investigating. 
A different approach, developed from modelling (unpublished data), is to use 
N-acetylglucosamine as combined nitrogen and carbon-source, as shown to be possible in 
S. cerevisiae (Wendland et al., 2009). This could be a promising approach to enforce 
pABA production as pABA would provide a suitable sink for the surplus NH3, thus 
introducing a minimum yield efficiency. 
Knock-outs that were done to channel flux to target products appeared to be problematic 
(excessive amounts of AAAs were required) and imposed constraints for growth, which 
hamper process scale-up and titer maximization. Constitutive knockdowns and promoter 
attenuation (Blazeck et al., 2012, Curran et al., 2014) might alleviate these restrictions; 
there may, however, be more elegant solutions. For pABA production mostly the TRP3 
knock-out constrained growth while the ARO7 knock-out is already more like a knockdown 
(Winter et al., 2014). Nevertheless at least partial reconstruction of the strain(s) seems 
inevitable. This opens the opportunity to implement all acquired knowledge and tackle the 
problem more rationally from a different angle: The idea is to first develop an advanced 
yeast strain generally optimized for production of aromatics, by exploiting the fact that 
shikimate pathway can replace the pyruvate kinase function. This requires minimization of 
auxotrophies in order to maximize growth. Further, for the PYK knock-out to function, 
maximization of PYR production is necessary, in order to meet the demand of central 
metabolism; this may be achieved by combining pABA, oABA & pHBA production. New 
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strains would ideally include all optimizations of the previous ones while omitting identified 
weaknesses. In particular, strains to be constructed could include the following genetic 
modifications: Δaro7, ARO4K229L or/and ARO4Q166K, ubiC or ubiCCCSS, GLN1, aroL, and 
ABZ1AWRI1631-ABZ2QA23 or pabABC. 
In the next step PYK single knock-out strains (Δpyk2 or Δcdc19) with low pyruvate kinase 
activity may already achieve an increase in aromatics production, as well as gain tolerance 
to the mutation(s). Here it is extremely important to reduce auxotrophies, ideally limiting 
them only to PYR. For adaptive evolution of the strains in repeated batch fermentations 
(Zhang et al., 2015) a combined carbon-source of GLC+GLY/ETH or GLC+PYR could be 
used, while reducing the GLY/ETH or PYR share in each step. In fact, in preliminary 
experiments a Δcdc19 mutant, derive from one of the aromatics producing strains, was 
reproducibly able to regain substantial growth on GLC over six cycles of repeated batch 
cultivation (unpublished data). This may finally allow construction of fully pyruvate kinase 
activity deficient strain(s), which achieve tight coupling of growth to product formation. 
Evolutionary force may then unfold its full potential to improve not only fitness but actually 
the overall aromatics yield of the strain(s). Evolved strain(s) could then be characterized 
and sequenced to determine the full phenotype and genotype (possibly identifying new 
feedback inhibition resistant enzymes). These strain(s) may then serve as the basis for 
production of different aromatics, either by tailoring different production platforms using the 
determined mutations or by directly engineering the evolved strain(s) into a distinct 
direction. Promising target products may include anthranilic acid (oABA), muconic acid via 
2,3-dihydroxybenzoic acid and vanillic acid via pHBA, but are not limited to these. 
In case a fully pyruvate kinase deficient strain remains problematic, silencing of CDC19 
and/or PYK2 along with constitutive knock-outs of either one may be worthwhile. For this 
use of a CRISPRi system (DiCarlo et al., 2013, Horwitz et al., 2015) may be the better 
choice than RNAi, as inhibiting transcription rather than translation allows tighter control of 
the system. CRISPRi also features a less complex synthetic circuit with fewer 
heterologous enzymes. Both advantages would significantly reduce the metabolic burden, 
which is important for the Δpyk phenotype to focus resources. 
Transferring the concept to another organism with a more robust secondary metabolism 
may be worthwhile in the long run, i.e. employing (filamentous) fungi that are particularly 
capable of producing aromatics and/or Crabtree negative (Wittmann et al., 2002, Simone 
Maria Menegatti de Oliveira et al., 2013, Kim et al., 2014). Applicability of the PYK knock-
out would, however, have to be proven again for each unique organism. 
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Appendices7 
Supplementary files to chapter 2.1 
Supplementary files 2.1.1 & 2.1.2: EMA networks 
Excel files containing the stoichiometric networks of E. coli and S. cerevisiae for 
Elementary Mode Analysis. Sheets in the excel files are sorted by pathway, with the last 
sheet containing additional information regarding the literature the pathway was compiled 
from, key intermediates in order to identify the pathways, as well as maximum product 
carbon yields. 
Supplementary files 2.1.3 & 2.1.4: NET-analysis networks 
Excel files containing the stoichiometric networks as well as physical data for 
compartments and metabolites of E. coli and S. cerevisiae for Network Embedded 
Thermodynamic Analysis and results of the different thermodynamic analysis’s, including 
detailed information on the infeasibility of the flux modes of each network. 
Supplementary files 2.1.5 & 2.1.6: Yield plots 
Product carbon yield vs. biomass plots of feasible and infeasible modes from EM-NET 
analysis of E. coli and S. cerevisiae. Each point in a chart corresponds to the specific 
product and biomass yield of the respective elementary flux mode. Yields are carbon 
yields in %. 
Supplementary files to chapter 2.2 
Supplementary file 2.2.1 – EMA networks 
Excel file containing the reactions of the central metabolism of each organism 
supplemented by the respective pathway branch. Knock-out targets are highlighted in red. 
The file contains two excel sheets (S. cerevisiae & E. coli), each containing different 
networks for the respective pathways. The determined knock-out targets are indicated in 
red for each cut-set, potential overexpression targets in green. Reactions that were 
excluded from identification as knock-out target are highlighted yellow. 
                                            
7
 For electronic copies of the supplementary files refer to the publications the respective chapters are based 
on or contact NJHA directly at: nils.averesch@uq.net.au 
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Supplementary file 2.2.2 – map of S. cerevisiae metabolic network 
Graphical depiction of the metabolites interactions in the S. cerevisiae network. The 
reactions are identified by their number according to the network file (supplementary file 
1). For better clarity “phosphate” (P) was left out from reactions in the figure unless 
involved in transport. Contribution to biomass formation (R95) is indicated with dashed 
arrows for the respective compounds. The two alternative routes to product formation are 
labelled with “a” to “d” according to Figure 5. Mitochondrial processes are highlighted in 
blue (mitochondrial only) and light blue (reactions exist in mitochondria and cytosol). 
Supplementary file 2.2.3 – map of E. coli metabolic network 
Graphical depiction of the metabolites interactions in the E. coli network. The reactions are 
identified by their number according to the network file (supplementary file 1). For better 
clarity “phosphate” (P) was left out from reactions in the figure unless involved in transport. 
Contribution to biomass formation (R78) is indicated with dashed arrows for the respective 
compounds. The two alternative routes to product formation are labelled with “a” to “d” 
according to Figure 5. Key metabolites for the knock-out strategy are highlighted in grey. 
Supplementary file 2.2.4 – additional tables comparing yields and knock-out targets, 
figures (EFM distribution) for knock-out networks of chorismate-derived routes and 
glucose & glycerol co-feed 
Supplementary table 1: Comparison of maximum product yields of wild-type networks for 
S. cerevisiae and E. coli 
Supplementary table 2: Comparison of maximum product yields on glucose & glycerol co-
feed of wild-type networks for E. coli 
Supplementary table 3: Comparison of maximum and minimum product yields of knock-out 
strategies for S. cerevisiae 
Supplementary table 4: Comparison of maximum and minimum product yields of knock-out 
strategies for E. coli 
Supplementary table 5: Extended information on knock-out targets - enzymes and 
corresponding coding genes 
Supplementary figure 5: EFM distribution of glucose & glycerol co-feed for E. coli wild-type 
networks 
Supplementary figure 6: EFM distribution of knock-out strategies for S. cerevisiae 
isochorismate derived routes 
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Supplementary figure 7: EFM distribution of knock-out strategies for S. cerevisiae pHBA-
pathway 
Supplementary figure 8: EFM distribution of alternative knock-out strategy for E. coli 
isochorismate derived routes 
Supplementary figure 9: EFM distribution of alternative knock-out strategy for E. coli 
pHBA-pathway 
Supplementary files to chapter 2.3 
Manuscript incorporated in chapter 2.3 
Supplementary files to chapter 2.4 
Supplementary file 2.4.1: Sequence analysis & discussion of ABZ1 & ABZ2 
XLS-file containing sequence alignments & codon usage analysis of the different 
examined ABZ1 and ABZ2 genes 
Supplementary file 2.4.2: EMA networks & EFM plots for pABA production from different 
carbon-sources 
XLS-file containing stoichiometric models for elementary mode analysis & result figures of 
product vs. biomass yield plots 
Supplementary file 2.4.3: Design & evaluation of tracer experiments 
PDF-document with additional information regarding results and discussion of the 13C 
enrichment experiments 
